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A series of polypeptides with well-defined sequences, (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, 
(Asp1Phe2)n, and (Asp1Phe3)n, containing the hydrophilic amino acid, aspartic acid (Asp) and 
the hydrophobic amino acid, phenylalanine (Phe), were synthesized. Their behaviour in 
aqueous solution was investigated by performing fluorescence quenching and non-radiative 
energy transfer (NRET) experiments which were complemented by dynamic (DLS) and 
static (SLS) light scattering. The photophysical properties of the polypeptides were 
dependent on their Phe content. An increase in the Phe content led to an increase in the 
extinction coefficient, fluorescence quantum yield, and fluorescence average lifetime of the 
polypeptides. Circular dichroism experiments revealed that except for the (Asp1Phe3)n 
polypeptide, which adopts an α−helical conformation in aqueous solution, the other 
polypeptides did not adopt any known conformation in solution. The fluorescence quenching 
studies performed using molecular pyrene  physically bound to the polypeptide via 
hydrophobic interactions resulted in protective quenching for the (Asp1Phe1)n, (Asp1Phe2)n, 
and (Asp1Phe3)n polypeptides, with some pyrenes having a lifetime of ~300 ns. Evidence for 
protective quenching was also observed in the polypeptides richer in Phe, when pyrene was 
covalently attached onto the polypeptides. However pyrene was found to be fully exposed to 
the quencher solution for the more hydrophilic polypeptides. The presence of NRET between 
a naphthalene labeled polypeptide and a pyrene labeled polypeptide for the (Asp1Phe2)n and 
(Asp1Phe3)n polypeptides and its absence for the (Asp3Phe1)n, (Asp2Phe1)n, and (Asp1Phe1)n 
polypeptides led to the conclusion that those polypeptides richer in Phe generate 
interpolymeric aggregates which provide protection to a hydrophobic cargo like molecular 
pyrene whereas the hydrophilic polypeptides exist predominantly as unimolecular micelles. 
 iii

























 I would like to express my gratitude and appreciation to Professor Jean Duhamel, my 
supervisor for his guidance and help throughout the course of my graduate program. I will 
forever be grateful to him for the support and patience that he has given me.  
 I am indebted to the members of my thesis advisory committee, Professor Susan 
Mikkelsen, Professor France-Isabelle Azanneau, and Professor Mario Gauthier for their 
feedback and useful suggestions. Particular thanks are due to Professor Mario Gauthier for 
his valuable comments and suggestions which have been very helpful to the development of 
this project. I would also like to thank all the helpful people whom I have dealt with during 
my stay here. These include the Department secretarial staff, the technicians and the people 
at the Chemistry Stores. 
 I would like to acknowledge some of the funding agencies which have made it 
possible for me to come to Canada in the pursuit of higher education. The Ministry of 
Science and Technology, Government of Pakistan for providing me a TROSS scholarship for 
4 years. To the University of Waterloo and the Department of Chemistry for granting me 
admission and use of their facilities and NSERC for their financial support. My employers 
back home who gave me a study leave and their blessing to improve my qualifications, which 
are greatly appreciated.  
 I take this opportunity to thank the members of the Duhamel group both past and 
present, especially Christine Keyes-Baig, Mark Ingratta and Howard Siu and to the co-op 
students, Thomas O’Brien and Jimmy De Leon, who assisted me in various aspects of my 
project, for creating a pleasant work environment. Their help and suggestions during my 
project have been greatly appreciated.  It has been a pleasure to know them all as they have 
 v
made my stay here both pleasant and very informative. The members of the Gauthier group 
also deserve a special thank you.  
 Finally I would like to thank each and every member of my family. Without their love 
and encouragement it would not have been possible for me to get through these past five 
years. My sister, Naila, who helped me get settled here at the University and then took over 
the family responsibility back home, deserves my eternal gratitude. My mother and sister 














































Table of Contents…………………………………………………………………..... viii
List of Tables……………………………………………………………………….... xii
List of Schemes…………………………………………………………………….... xiv
List of Figures……………………………………………………………………….. xv
List of Symbols and Acronyms……………………………………………………… xx
Chapter 1: Introduction…………………………………………………………… 1
 1.1. Self-assembly………………………………………………………... 2
 1.2. Self-assembling systems…………………………………………….. 3
 1.2.1. Surfactants…………………………………………………………… 3
 1.2.2. Block copolymers……………………………………………………. 6
 1.2.3. Hydrophobically modified polymers………………………………... 9
 1.2.4. Polypeptides…………………………………………………………. 11
 1.3. Drug delivery………………………………………………………... 15
 1.4. Methods…………………………………………………………….... 18
 1.4.1. Circular dichroism…………………………………………………… 19
 1.4.2. Dynamic light scattering…………………………………………….. 20
 1.4.3. Fluorescence…………………………………………………………. 21
 1.4.3.1. Jablonski diagram……………………………………………. 22
 1.4.3.3.  Fluorescence lifetime and quantum yield..…………………... 23
 viii
 1.4.3.4.  Chromophores……………………………………………….. 25
 1.4.3.5.  Pyrene excimer……………………………………………… 26
 1.4.3.6.  Medium effects………………………………………………. 29
 1.4.3.7.  Fluorescence quenching……………………………………... 34
 1.4.3.7.1.  Protective quenching………………………………………… 36
 1.4.3.8.  Fluorescence resonance energy transfer……………………... 37
            1.5. Project objectives……………………………………………………. 39
            1.6. Thesis outline………………………………………………………... 41
            1.7. References…………………………………………………………… 42
Chapter 2: Polypeptide Synthesis…………………………………………………. 50
 2.1. Introduction………………………………………………………….. 51
 2.1.1. Coupling methods.……………………………….………………….. 54
 2.1.2. Protecting groups.…………………………………………………… 58
 2.1.3. Polymerization.……………………………………………………… 60
 2.1.4. Monomer synthesis.…………………………………………………. 61
 2.2. Experimental..……………………………………………………….. 64
 2.3. Peptide synthesis..…………………………………………………… 65
 2.3.1. Synthesis of poly(Asp1Phe1)…………….…………………………... 65
 2.3.2. Synthesis of poly(Asp3Phe1)..……………………………………….. 72
 2.3.3.  Synthesis of poly(Asp2Phe1)..……………………………………….. 77
 2.3.4.  Synthesis of poly(Asp1Phe2)..……………………………………….. 79
 2.3.5.  Synthesis of poly(Asp1Phe3)..……………………………………….. 83
 2.4. Results and Discussion.……….……………………………………... 87
 ix
 2.5. References…………..……………………………………………….. 90
 2.6. Appendix…………...………………………………………………... 92




3.4. Results and Discussion………………………………………………. 123
3.5. Conclusions………………………………………………………….. 134
3.6. References…………………………………………………………… 135
Chapter 4: Characterization of the Self-Association of an Amphiphilic 
Polypeptide………………………………………………………………………….. 137
 4.1. Abstract……………………………………………………………… 138
 4.2. Introduction………………………………………………………….. 138
            4.3.      Experimental………………………………………………………… 142
    4.4.      Results and Discussion………………………………………………. 150
    4.5. Conclusions………………………………………………………….. 177
    4.6. References and Notes………………………………………………... 179
    4.7. Appendix…………………………………………………………….. 182
Chapter 5: Effect of Polypeptide Sequence on Polypeptide Self-Assembly…….. 188
 5.1. Abstract……………………………………………………………… 189
 5.2. Introduction………………………………………………………….. 189
 5.3.      Experimental………………………………………………………… 192
 5.4.     Results and Discussion……………………………………………….. 197
 x
            5.5. Conclusions………………………………………………………….. 229
            5.6. References…………………………………………………………… 231
            5.7. Appendix…………………………………………………………….. 235
Chapter 6: Concluding Remarks and Future work……………………….……... 244
6.1 Summary of accomplished work…………………………………….. 245



















List of Tables 
Table 2.1. Stability of Peptide Protecting Groups………………………………….. 60
Table 3.1. Values for dn/dc, Mw, and A2 obtained for the polypeptides……………. 122
Table 3.2. Pre-exponential factors, decay times, and χ2 values obtained from the fit 
of the fluorescence decays with Equation 3.1…………………………... 131
Table 4.1. Pyrene and  naphthalene contents (λPy, λNp) in moles of chromophore 
per gram of  polymer  and  the molar  fraction  of  labeled  aspartic  
acids  in (Asp1Phe1)n and (Asp)n determined by UV-Vis absorption…… 148
Table 4.2. Peak diameter and their standard deviations for the alternating 
polypeptide samples……………………………………………………... 154
Table 4.3. Summary of the pyrene monomer decay times and pre-exponential 
factors obtained for the polypeptide solutions…………………………... 163
Table 4.4. Summary of the excimer decay and rise times calculated for the 
randomly labeled polypeptides…………………………..……………… 166
Table 4.5. Summary of the parameters retrieved from the analysis with Equations 
4.10-4.13 of the steady-state and time-resolved fluorescence quenching 
trends shown in Figures 4.11 and 4.12….................................................. 175
Table 5.1. Pyrene (λPy) and naphthalene (λNp) contents in moles of chromophore 
per gram of polymer and the molar fraction of labeled (AspxPhey)n and 
(Asp)n determined by UV-Vis absorption………………………………. 196
Table 5.2. Polypeptide samples used for NRET……………………………………. 203
Table 5.3. Fluorescence energy transfer efficiency for the polypeptide sequences... 205
Table 5.4. Summary of the pyrene monomer decay times and pre-exponential 
factors obtained for the polypeptides solutions in 0.01 M Na2CO3 at pH 
9…………………………………………………………………………. 213
Table 5.5. Summary of the excimer decay times and pre-exponential factors 
 xii
calculated for the randomly labeled polypeptides………………………. 215
Table 5.6. Summary of the parameters determined for the quenching of pyrene 
dissolved in the polypeptides……………………………………………. 218






















List of Schemes 
 
Scheme 1.1. Schematic representation of the various excited electronic states of an 
organic molecule, their energy level relationships, and 
interconversion processes……………………………………………... 23
Scheme 1.2. Formation of pyrene excimer through diffusional encounter (Birks’ 
scheme) (A) and through pre-formed pyrene aggregates (B)…………. 29
Scheme 1.3. Quenching of pyrene attached onto the polymer backbone by a free 
quencher molecule………………………………………….................. 34
Scheme 1.4. Fluorescence energy transfer when both the donor and acceptor are 
attached onto the same polymer chain………………………..………. 37
Scheme 2.1. Synthesis of H−Asp(OBzl)Phe−PCP…………………………............. 62
Scheme 2.2. Synthesis of H−Asp(OBut)Phe−PCP…………………………………. 64
Scheme 2.3. Synthesis of Polypeptide (Asp1Phe1)n………….................................... 66
Scheme 2.4. Synthesis of Polypeptide (Asp3Phe1)n…...……………………………. 73
Scheme 2.5. Synthesis of Polypeptide (Asp2Phe1)n…...……………………………. 77
Scheme 2.6. Synthesis of Polypeptide (Asp1Phe2)n……...…………………………. 80
Scheme 2.7. Synthesis of Polypeptide (Asp1Phe3)n…...…….……………………… 84
Scheme 4.1. Energy transfer between the naphthalene and pyrene chromophores… 155








List of Figures 
Figure 1.1. Schematic representation of surfactant aggregates in dilute 
aqueous solutions.………………………………………………... 4
Figure 1.2. Structure of some common surfactants…………………………... 4
Figure 1.3. Self-assembly of a block copolymer into a “Star” micelle………. 6
Figure 1.4. Self-organized structures of block copolymers………………….. 7
Figure 1.5. Structure of α-methoxy-ω-amino PEO…………………………... 8




Figure 1.7. Schematic diagram of the biological functions enabled by the 
self-organization of polymeric structures………………………... 12
Figure 1.8. Formation of an N-carboxyanhydride (NCA)…………………… 13
Figure 1.9. Polypeptide formation through successive addition of NCAs…… 13
Figure 1.10. Solid phase peptide synthesis……………………………………. 14
Figure 1.11. Block copolymers as drug carriers ……………………................ 16
Figure 1.12. Chemotherapy with block copolymer micelles transporting a 
drug into the tumor cell…………………………………………... 17
Figure 1.13. CD spectra of poly(L-lysine) illustrating its ability to adopt 
different secondary structures in different conditions …………... 20
Figure 1.14. Structures of commonly used chromophores and their derivatives 26
Figure 1.15. Steady-state fluorescence emission spectrum of pyrene randomly 
attached onto alternating polypeptide (Asp1Phe1)n………………. 27
Figure 1.16. Theoretically expected geometrical arrangement between the two 
pyrene units constituting a pyrene excimer……………………… 28
Figure 1.17. Fluorescence emission spectra of PRODAN…………………….. 30
Figure 1.18. Chemical structure of dipyme……………………………………. 31
 xv
Figure 1.19. Emission spectra of dipyme in different solvents………………... 31
Figure 1.20. Solvent dependence of the vibronic band intensities of the pyrene 
monomer fluorescence at room temperature leading to different 
values of the I1/I3 ratio.………………..…………………………. 33
Figure 2.1. Chemical structure of an amino acid…………………………….. 51
Figure 2.2. Chemical structure of proline……………………………………. 51
Figure 2.3. Amide bond formation between two amino acids……………….. 52
Figure 2.4. Racemization through an azalactone route………………………. 53
Figure 2.5. Curtius rearrangement: Formation of an isocyanate……………... 55
Figure 2.6. Formation of a peptide bond and hydrozoic acid………………... 55
Figure 2.7. Mixed anhydride reactive sites …………………………………. 56
Figure 2.8. DCC/HOBt activation reaction…………………………………... 57
Figure 2.9. Common activating groups……………………………………... 58
Figure 2.10. Chemical structure of trifunctional aspartic acid and bifunctional 
phenylalanine…………………………………………………….. 59
Figure 2.11. Common protecting groups in peptide synthesis………………… 59
Figure 2.12. Mechanism for the cyclization reaction of the dipeptide resulting 
in the removal of the Bzl protecting group………………………. 63
Figure 3.1. Absorption spectra of the 0.05 g/L polypeptide solutions in 0.01 
M Na2CO3 solution at pH 9……………………………………… 126
Figure 3.2. Massic extinction coefficient, εm, and fluorescence intensity of 
the polypeptides as a function of phenylalanine content, ξ............ 127
Figure 3.3. Fluorescence emission spectra of 0.05 g/L polypeptide solutions 
and L-phenylalanine in 0.01 M Na2CO3 solution at pH 9……….. 128
Figure 3.4. Fluorescence decays of 0.5 g/L polypeptide solutions and L-
phenylalanine in 0.01 M Na2CO3 solution at pH 9. ……………... 130
Figure 3.5. Number-average lifetime of the polypeptides in 0.01 M Na2CO3 
 xvi
solution at pH 9 as a function of Phe content……………………. 132
Figure 3.6. Circular dichroism spectra of the polypeptides.…………………. 133
Figure 4.1. Comparison of the structure of SMA and (Asp1Phe1)n…………... 141
Figure 4.2. Random labeling of pyrene along the polypeptide chain………... 145
Figure 4.3. Samples prepared with (Asp1Phe1)n and pyrene…………………. 149
Figure 4.4. CD spectra of unlabeled and labeled (Asp1Phe1)n  and (Asp)n in a 
0.01 M Na2CO3 solution at pH 9.................................................... 151
Figure 4.5. Particle size distribution determined by intensity, number, and 
volume of (Asp1Phe1)n, EPy−(Asp1Phe1)n−44, 
RPy−(Asp1Phe1)n−132, and (Asp1Phe1)n with molecular pyrene 
in 0.01 M Na2CO3 at pH 9 and at a polypeptide concentration of 
0.05 g/L…………………………………………………………... 153
Figure 4.6. Absorption and emission spectra of pyrene  and naphthalene for 
fluorescence NRET experiments…………………........................ 156
Figure 4.7. Fluorescence  emission  spectra of aqueous  solutions  of  labeled 
polypeptides.……………………………………………………... 160
Figure 4.8. Steady-state emission spectra normalized at 375 nm of 
[EPy−(Asp1Phe1)n], (Asp1Phe1)n + Py, [RPy−(Asp1Phe1)n−70] 
[RPy−(Asp1Phe1)n−132] and [RPy−(Asp1Phe1)n−221] …………. 162
Figure 4.9. Monomer and excimer fluorescence decays of 
RPy−(Asp1Phe1)n−132 in 0.01 M Na2CO3 solution at pH 9 …….. 164
Figure 4.10. Nitromethane quenching of pyrene used as a probe by steady-
state and time-resolved fluorescence…………………………….. 168
Figure 4.11. Stern-Volmer plot obtained with 1.7×10−5 M pyrene dissolved in 
1.5 g/L of polypeptide in 0.01 M Na2CO3 solution at pH 9. ……. 169
Figure 4.12. Stern-Volmer plots obtained for the labeled polypeptides by 
steady-state and time-resolved fluorescence. …………………… 174
 xvii
Figure 4.13. Light scattering intensity and fluorescence emission spectra of 
(Asp1Phe1)n  before and after filtration of 0.05 g/L solutions of 
(Asp1Phe1)n and light scattering intensity of (Asp1Phe1)n + Py 
and fluorescence emission spectra of pyrene before and after 
filtration of 0.05 g/L solutions in 0.01 M Na2CO3 at pH 9............. 176
Figure 5.1. CD spectra of unlabeled and labeled polypeptides. (Asp3Phe1)n, 
(Asp2Phe1)n, (Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n………... 198
Figure 5.2. Particle size distribution by intensity, number, and volume for 
(Asp3Phe1)n and (Asp1Phe3)n…………………………………….. 201
Figure 5.3. Fluorescence emission spectra obtained for NRET for 
(Asp3Phe1)n and (Asp1Phe3)n…………………………………….. 205
Figure 5.4. Steady-state emission spectra obtained for pyrene as a free probe 
with (Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n………………… 207
Figure 5.5. Steady-state emission spectra of pyrene obtained for randomly 
labeled polypeptides.……………………………………….......... 208
Figure 5.6A. Pyrene IE/IM ratios calculated for the randomly labeled 
polypeptides (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, 
(Asp1Phe2)n, and (Asp1Phe3)n……………………………………. 210
Figure 5.6B. Slopes calculated from Figure 5.6A for the randomly labeled 
polypeptides as a function of phenylalanine content in mol%. .… 210
Figure 5.7. Stern-Volmer plots obtained by steady-state and by time-
resolved fluorescence for (Asp1Phe2)n and (Asp1Phe3)n…………. 217
Figure 5.8. Stern−Volmer plots obtained for pyrene labeled polypeptides by 
steady-state and by time-resolved fluorescence for 
EPy−(Asp3Phe1)n−26, RPy−(Asp3Phe1)n−195 
EPy−(Asp1Phe3)n−91, and RPy−(Asp1Phe3)n−72………………... 220
Figure 5.9. Plot of the quenching rate constant kQ as a function of 
 xviii
phenylalanine content in the polypeptide sequences…………….. 223
Figure 5.10. Light scattering intensity and fluorescence emission spectra 
before and after filtration for (Asp3Phe1)n and (Asp1Phe3)n.…….. 226
Figure 5.11. Light scattering intensity and fluorescence emission intensity  
before and after filtration of 0.05 g/L solutions of (Asp3Phe1)n, 
(Asp2Phe1)n, (Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n in 0.01 
M Na2CO3 at pH 9……………………………………………….. 227
Figure 5.12. Light scattering intensity for (Asp1Phe3)n + Py and fluorescence 
emission spectra of pyrene before and after filtration of the 

















List of Symbols and Acronyms 
A Acceptor molecule 
A2 Second virial coefficient obtained from light scattering measurements 
AP Amphiphilic polymers 
Asp Aspartic acid 
a.u. arbitrary units 
CD Circular dichroism 
cmc Critical micelle concentration 
CTAB Cetyl trimethylammonium bromide 
D Donor molecule 
D Translational diffusion coefficient 
DCC Dicyclohexylcarbodiimide 
DCU Dicyclohexyl urea 
DDS Drug delivery systems 




EET Efficiency of energy transfer 
ESI Electrospray ionizer 
fa Fraction of pyrenes accessible to the quencher 
FRET Fluorescence resonance energy transfer  
GS Ground state 
HASE Hydrophobically modified alkali-swellable emulsions 
HEUR Hydrophobically modified ethoxylated urethane 
HHHs Hexagonally packed hollow hoops 
 xx
HMPE Hydrophobically modified polyelectrolytes 
HMWSPs Hydrophobically modified water-soluble polymers 
HOBt 1-Hydroxybenzotriazole 
HOSu N-Hydroxysuccinimide 
I0 Fluorescence intensity without the quencher 
I1 Fluorescence intensity of the first peak of the pyrene monomer 
I1/I3 Ratio of the fluorescence intensity of the first-to-third peak 
I3 Fluorescence intensity of the third peak of the pyrene monomer 
ID Fluorescence intensity of the donor in the presence of the acceptor 
ID0 Fluorescence intensity of the donor in the absence of the acceptor 
IE Pyrene excimer fluorescence intensity 
IE/IM Excimer-to-monomer fluorescence intensity ratio 
IM Pyrene monomer fluorescence intensity 
INp Fluorescence intensity of naphthalene 
INp/IPy Ratio of naphthalene fluorescence intensity-to-pyrene fluorescence intensity 
IPy Fluorescence intensity of pyrene 
IQ Fluorescence intensity with the quencher 
k Rate constant of radiationless decay 
kET Energy transfer rate constant 
kQ Collisional quenching rate constant 
KS Static equilibrium constant 
LCMs Large compound micelles 
LCVs Large compound vesicles 
MSA Methane sulphonic acid 
MW Molecular weight 




NMR Nuclear magnetic resonance 
Np Naphthalene 
NRET Non-radiative energy transfer 




ppm Parts per million 
Py Pyrene 
Py∗ Excited pyrene  
(PyPy)∗ Excited pyrene excimer 
Q Fluorescence quantum yield 
[Q] Quencher concentration 
r Distance between the donor and acceptor molecules 
R0 Förster radius 
RES Reticuloendothelial system 
SANS Small angle neutron scattering 
SAXS Small angle X-ray scattering 
SDS Sodium dodecylsulphate 
SLS Static light scattering 
SMA Styrene maleic anhydride copolymers 
TEA Triethylamine 
TEM Transmission electron microscopy 
TFA Trifluoroacetic acid 
THF Tetrahydrofuran 
TLC Thin layer chromatography 
 xxii
χ2 Chi-square value evaluating the goodness of the fit of the fluorescence decays 
with a given equation 
δ Chemical shift 
ε Extinction coefficient 
η Viscosity 
Γ Emissive rate constant of chromophore 
λem Emission wavelength 
λex Excitation wavelength 
τ Excited lifetime of chromophore 
<τ> Average lifetime of chromophore 
τ0 Natural lifetime of chromophore 
τD Lifetime of donor molecule 
τE Lifetime of the excimer 
τM Lifetime of the monomer 
τQ Lifetime with the quencher 























The aim of this chapter is to give a short review of the basics of the self-assembly of 
macromolecules and of the resulting supramolecular structures. The first part of the chapter 
gives examples of molecules that are known to undergo self-assembly such as surfactants, 
block copolymers, hydrophobically modified polymers, and polypeptides. The synthesis of 
these molecules is also briefly described. This is followed by a discussion on structures 
generated by these self-assembling macromolecules in drug delivery, it being one of the most 
medically relevant applications of these systems. The next section outlines the various 
experimental techniques used in this study, with particular emphasis on fluorescence. The 
last two sections present the project objective and the thesis outline.  
 
1.1. Self-assembly 
 In recent years, molecular self-assembly has attracted considerable attention for its 
use in the design and fabrication of nanostructures leading to the development of advanced 
materials.1-4 The key to self-assembly lies in the design and synthesis of macromolecules that 
organize themselves into desired patterns and functions. Along with chemical composition 
and functionality, the molecular architecture of the macromolecules is the main factor that 
affects the resulting self-assembled structures.5-9 In particular, systems that operate in 
aqueous media have been subject to intense research.10-15 This is mostly because many 
devices must be biocompatible, which implies that they must function in aqueous solutions. 
Over the past few years, new approaches for mimicking cell surfaces or generating 
biocompatible and bioactive drug delivery systems have been developed.16,17 One recent 
development takes advantage of polymeric systems with an enhanced biofunctionality, such 
as amphiphilic copolymers that can act as mimetics for biological membranes.18 Because 
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there are virtually no limits to combinations of monomers, biological and synthetic building 
blocks, ligands, receptors and other proteins, polymer hybrid materials show a great promise 
for applications in biomedicine and biotechnology.19,20 Thus the self-assembly of 
biomolecular building blocks plays an increasingly important role in the discovery of new 
materials and scaffolds with a wide range of applications in nanotechnology and medical 
technologies such as regenerative medicine and drug delivery.21,22 
 
1.2. Self-assembling systems 
 Surfactants, lipids, and copolymers are self-assembling molecules whose assemblies 
exhibit a broad range of properties and applications which are under intense scrutiny.3,23-26 
These materials are used in various technological formulations such as paints, coatings, inks, 
foodstuff and drug delivery in the form of micelles, vesicles, and other types of dispersed 
aggregates. The importance of these systems for drug delivery applications has increased 
during the past decade as a result of many new candidate drugs being sparingly soluble in 
water.26-29 Hence a solubilizing delivery system is frequently required to enable sufficient 
drug bioavailability and/or to facilitate clinical or even preclinical research and development.  
 
1.2.1. Surfactants 
 Surfactant molecules are composed of a polar hydrophilic head, and a non polar 
hydrophobic tail.30 This dual nature endows the surfactants with their unique solution and 
interfacial characteristics. In aqueous solution, surfactant molecules self-assemble to form 
aggregates via the association of their hydrophobic tails. Depending upon the type of 
surfactant and solution conditions, the aggregates may be spherical, globular or rodlike 
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micelles or spherical bilayers.31,32 The closed aggregates with hydrophobic interiors are 
known as micelles whereas the spherical bilayers containing an encapsulated aqueous phase 





Figure 1.1. Schematic representation of surfactant aggregates in dilute aqueous solutions. 
From left to right: spherical, globular, spherocylindrical micelles and spherical bilayer 
vesicles. 
 
 Surfactants can be categorized as anionic, cationic, and nonionic surfactants 
depending on the charge present on the hydrophilic part of the molecule. The most 
investigated anionic surfactant is sodium dodecylsulfate (SDS), whose structure is given in 


























Figure 1.2. Structure of some common surfactants. 
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 Numerous studies have been carried out to characterize the aggregates of 
surfactants.34-39 The features of particular interest to describe surfactant aggregates are the 
critical micelle concentration (cmc)30 which is the concentration at which the surfactant 
aggregates form, the average size and shape of the aggregates, and their polydispersity. One 
of the most important properties of aqueous surfactant solutions is their ability to enhance the 
solubility of hydrophobic solutes that have otherwise very low solubilities in water. This 
solubilization is enabled by the hydrophobic domains generated by the surfactant aggregates 
which can host the hydrophobic compounds to be solubilized. A successful surfactant 
enhances the solubility of a hydrophobic solute by several orders of magnitude compared to 
its solubility in aqueous solution in the absence of surfactant.40 
 Surfactants find numerous applications in the chemical industry, the formulation of 
pharmaceuticals, household products, agricultural chemicals, mineral processing 
technologies, and food processing industries.30,31 Naturally occurring surfactants found in 
plants, animals and humans have important biological or physiological functions. The wide 
range of applications for surfactants is a consequence of the large number of variations that 
are possible in the types of head and tail building blocks constituting any surfactant. The 
variety of molecular structures found with surfactants allows for extensive variation of their 
solution and interfacial properties and hence, rationalizes the efforts being made to discover 
the link existing between the molecular structure of a surfactant and its self-assembling and 
solution properties, with the ultimate goal that surfactants be synthesized or selected 




1.2.2. Block copolymers 
 Macromolecules are particularly well suited for applications where different physical, 
chemical, and biological functions are required simultaneously. This observation has been 
particularly well understood by Nature which uses innumerable examples of biopolymers. 
Polymers have attracted a great deal of interest because they offer a unique platform for the 
development of materials in fields as diverse as biomedicine and packaging.41,42 
Improvements in the molecular and supramolecular control achieved by the chemistry used 
to synthesize macromolecules have enabled the preparation of macromolecules which exhibit 
a predicted physical and biological response.43-47 Amphiphilic block copolymer systems with 
enhanced biofunctionality have been developed that have been shown to act as mimetics for 
biological membranes.18,48 As the combinations of biological and synthetic building blocks 
are practically limitless, it is possible to develop polymeric materials for a large number of 
applications in biomedicine and biotechnology. 
 The self-assembly of amphiphilic block copolymers generates aggregates that have 
various morphologies in solutions. The most commonly observed morphology is that of the 
star-micelles.49,50 Star micelles refer to micelles having a core-corona structure, where the 






Figure 1.3. Self-assembly of a block copolymer into a “Star” micelle.3 
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Depending on the polarity of the solvent, micelles can be categorized as either regular 
micelles in a polar solvent or reverse micelles51 in an apolar solvent. Recently much attention 
has been garnered by the self-assembly of highly asymmetric, amphiphilic block copolymers 
into aggregates for which the term “crew-cut” has been proposed by Halperin.49 The block 
copolymers generating crew-cut micelles are constituted of a long hydrophobic block that 
forms the core of the aggregate and a short hydrophilic block that yields the corona. A 
variety of aggregate morphologies has been prepared by manipulating the relative block 
lengths and environmental conditions, such as solvent composition, presence of additives, 
and temperature.3,52-55 Possible morphologies include spheres, rods, vesicles, lamellae, 
tubules, large compound micelles (LCMs), large compound vesicles (LCVs), and 
hexagonally packed hollow hoops (HHHs). The broad variety of self-organizing structures 
















Figure 1.4. Self-organized structures of block copolymers: spherical micelles, vesicles, 
cylindrical micelles, lamellae, large compound vesicles (LCVs), and large compound 
micelles (LCMs).3 
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 During the last decade, it has become possible to prepare block copolymers of various 
architectures, solubilities, and functionalities. Diblock,53-55 triblock52b and multiblock56 
copolymers can have the different polymeric blocks arranged with a linear, star-like, or comb 
architecture. The solubilities of the various blocks can be adjusted to enable the solubilization 
of block copolymers in solvents ranging from polar solvents such as water to media with 
very low cohesion energies such as silicon oil or fluorinated solvents. The ability to control 
the functionality of specific blocks is extremely important to stabilize metallic,57 
semiconductors,58 ceramic,59 or biological systems.17,18  
 The different synthetic routes to prepare block copolymers are based on living 
polymerization using anionic, and more recently cationic, and radical polymerization. It is 
also possible to combine different polymerization techniques to further increase the variety of 
block copolymers. For instance, functional groups can be attached on a macromolecule to 
initiate the polymerization of the next polymer block (macroinitiators). Figure 1.5 shows an 
example of a block copolymer of a heterobifunctional PEO with end groups that allow for 
adjustment in the physicochemical properties of the resulting material as well as aid in the 
synthesis of hydrophilic/hydrophobic block copolymers.60  
 
 
 CH3O CH2CH2O CH2CH2CH2SCH2CH2NH2n
 
 
Figure 1.5. Structure of α-methoxy-ω-amino PEO 
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 There exist a large number of published strategies for preparing block copolymers by 
living anionic polymerization.41,42 Recent years have seen the development of new methods 
for living cationic and living radical polymerization.3,42  
 
1.2.3. Hydrophobically modified polymers 
 Hydrophobically modified water−soluble polymers (HMWSPs) are polymers made 
up of well-defined hydrophilic and hydrophobic parts. When dissolved in water they often 
undergo aggregation.61-67 There are two broad classes of HMWSPs. They can either have a 
high content of hydrophobic groups, as in the case of alternating copolymers of ionic and 
hydrophobic monomers such as polysoaps,68 or a low content of hydrophobic groups, as for 
example in hydrophobically-modified cellulose ethers69 or polyacrylamides.70,71 The 
functions of these polymers are controlled by a number of factors, including the chemical 
structure and the electrostatic charge of the monomer units and the overall composition and 
the architecture of the macromolecule. In aqueous solutions of HMWSPs, intra− or 
intermolecular association of the hydrophobic segments competes with the solvation of the 
HMWSPs afforded by the hydrophilic segments. Therefore the hydrophilic/hydrophobic 
balance is an important factor to control the shape (star, flower, or networks) of the self-
assembled structures.72 
 Amphiphilic derivatives of polyelectrolytes are of particular importance, as they tend 
to have a higher solubility in water, compared to that of neutral polymers. For 
hydrophobically modified polyelectrolytes (HMPE), the intramolecular association of the 
hydrophobes competes with electrostatic repulsion from the ionic groups. Therefore, the 
balance between the contents of the hydrophobic and charged units in the HMWSPs 
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constitutes a critical factor to determine whether or not self-organization occurs. For 
example, amphiphilic poly(carboxylic acids)73,74 which adopt an extended chain 
conformation that favors intermolecular associations at high pH, collapse intramolecularly to 
form a compact conformation at low pH. On the other hand polysulphonic acids, which are 
“strong” polyelectrolytes show no such pH dependence of their conformation because they 
are fully ionized even at low pH.71 Copolymers of styrene and maleic anhydride studied by 
Duhamel et al.75 are an example of an HMPE where the hydrophobe-to-charge ratio can be 
controlled by adjusting the degree of ionization to either increase or decrease the 
hydrophobic character of the copolymer in aqueous solution. The extent of aggregation was 
also found to increase by having a styrene-to-maleic anhydride ratio greater than 1, which is 
typically encountered for this strongly alternating copolymer.  
 Low concentrations favor intramolecular hydrophobic associations which induce a 
contraction of the molecular dimensions of the modified polymer coil and disfavors 
intermolecular aggregation. Increasing the polymer concentration above the overlap 
concentration enables interchain association of the hydrophobic groups which leads to an 
enhancement of the solution viscosity. Figure 1.6 gives a glimpse of the type of HMWSPs 














water-soluble polymer water-soluble spacer hydrophobic monomer
Hydrophobically modified Ethoxylated
Urethane (HEUR)
Hydrophobically modified Alkali 
Swellable Emulsion copolymer 
(HASE)
 
Figure 1.6. Various types of HMWSPs capable of undergoing hydrophobic associations. 
 
1.2.4. Polypeptides 
 Polypeptides are a class of biopolymers composed of α-amino acids joined by peptide 
bonds. Polypeptides are biological materials with important therapeutic and clinical 
applications.3 Their synthesis has been the subject of special attention.76 In recent years, their 
ability to self-organize into nanostructures such as micelles, vesicles, and gels in aqueous 
solutions have offered new applications such as the encapsulation of therapeutic agents for 
drug/gene delivery, tissue engineering, and surface patterning to better understand the 
biological functions associated with cell adhesion, cell recognition, and various other 
















Figure 1.7. Schematic diagram of the biological functions enabled by the self-organization of 
polymeric structures.3 
 
 Although a number of synthetic methods are available for the synthesis of 
polypeptides,76 no single method is considered the ideal method. Broadly speaking, most 
polypeptide syntheses fall into two major catogories, which are the classical, solution-phase 
syntheses77-80 (explained in much more details in Chapter 2) and the more recently developed 
solid-phase syntheses.81  
Leuches’ anhydrides: A solution-phase method not mentioned in Chapter 2, which has 
received considerable attention for the synthesis of both homopolypeptides and random 
copolypeptides is the N-carboxyanhydrides (NCAs or Leuchs’ anhydrides)82-85 procedure. 
The NCAs are readily prepared by the reaction of an amino acid with phosgene in an aprotic 


















Figure 1.8. Formation of a N-carboxyanhydride (NCA) 
 
Polycondensation to form the polypeptide can proceed through ring opening of the NCA by 
traces of water to yield a carbamic acid which loses carbon dioxide and regenerates the 
amino acid. The amino group of the amino acid then attacks the carbonyl group of a second 
NCA molecule and the coupling reaction is followed by decarboxylation to yield a dipeptide. 






































Figure 1.9. Polypeptide formation through successive additions of NCAs 
 
 This method is not applicable to heteropolypeptides with defined sequences 
containing specifically defined amino acids in predetermined positions in the peptide chain. 
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Solid-phase synthesis: Solid-phase peptide synthesis as described by Merrifield81 has proven 
to be quite successful. In this method, the condensation of individual amino acids is 
performed on a solid support material (preferably slightly cross-linked polystyrene), until 
finally the finished polypeptide is cleaved from the support. 
 Some of the steps involved in the stepwise synthesis of a polypeptide using a solid 
support material using solid-phase synthesis are shown in Figure 1.10. The advantage of the 
Merrifield synthesis is that it is performed in heterogeneous phase, so that the reagents used 
in the peptide synthesis can be easily separated from the actual synthesis product bound to 

























































Figure 1.10. Solid phase peptide synthesis 
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 The disadvantage of this synthesis is that the chemical reactions used for the 
sequential synthesis are not quantitative, so that to some extent, the reaction does not take 
place as desired and therefore unwanted peptides are synthesized simultaneously and can be 
separated only with considerable difficulty. In the case of longer amino acid sequences, i.e. 
those with 50 amino acids and more, even if the individual steps are 99 % effective, the 
multiplicity of the reactions involved results in a large number of by-products in addition to 
the targeted peptide, which may be shorter chains or peptides containing defects in the amino 
acid sequence. Biosynthesis through recombinant DNA86,87 is another method by which 
polypeptides can be synthesized, and this method has the advantage of generating 
monodispersed polypeptides. 
 
1.3. Drug delivery  
 Research in the field of drug delivery and drug targeting at the molecular level has 
increased exponentially due to progress made in biotechnology and immunology.19-22 Drugs 
are susceptible to chemical or enzymatic degradation. They may also lose or change their 
biological functions as a result of, for example, aggregation and conformational changes 
following interactions with various compounds in the biological systems or in the 
formulation. For these types of drugs, carrier systems have been found to improve the drug 
stability and delivery.17,88-92 It is therefore fortunate that the increased need in new and 
efficient delivery systems required for sparingly soluble drugs has been paralleled by the 
progresses made in understanding how surfactants, lipids, block and hydrophobically 
modified polymers self-assemble into stable structures. The improved solubilization of drugs 
is just one of the advantages of these self-assembled structures. Other advantages include 
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protection from hydrolysis and chemical and enzymatic degradation, reduction of toxicity, 
improvement of drug bioavailability, and controlled release.19-22 The self-assembled carrier 
systems can incorporate a drug by either passive association29,93-95 of the drug with the pre-
assembled carrier, or by covalently attaching30,96,97 the drug to the units constituting the 
carrier followed by their self-assembly. These two approaches are depicted in Figure 1.11. 
They have been implemented with block copolymers of poly(ethylene 
oxide)−b−poly(β−benzyl−L−aspartate) (PEO−b−PBLA).30,96 The benzyl group was removed 






Figure 1.11. Block copolymers as drug carriers: Approach A: the drug is present as a free 
molecule. Approach B: the drug is attached covalently onto one block of the copolymer. 
 
 Depending on the properties of the drug, association of the drug with the self-
assembled system might occur in the hydrophilic part, in the hydrophobic part, or at their 
interface. After the polymeric carriers have been brought to their target, the active agent, the 
drug, is released. This can take place either by induced degradation of the polymeric matrix 
or dissociation of the drug from the polymer induced by swelling of the polymer. For control 
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purposes, an actuator function may also be incorporated in the carrier to trigger the release of 
the drug depending on the local conditions such as salt concentration, temperature, and pH. 
 The idea of using block copolymer micelles as carriers for active agents was 
originally proposed by Ringsdorf and co-workers98 who investigated micelles of 
poly(L−lysine)−b−poly(ethylene oxide) (PLys−b−PEO).99 The active agent, i.e. the drug, can 
be covalently attached along the peptidic block of PLys−b−PEO via a covalent bond which is 
then broken by proteases present in increased concentration in many types of tumors. 
Anticancer drugs can also be physically solubilized in the micelle cores of poly(aspartic 
acid)−b−poly(ethylene glycol) (PAsp−b−PEG) as shown by Kataoka et al.93b,100 PAsp 
solubilizes large quantities of drugs and, being a polypeptide, is biodegradable. PEG being 
both water soluble and chemically stable under physiological conditions, it reduces the 
antigen effect of the copolymer/agent conjugate (Figure 1.12).  
 
Drug







Figure 1.12. Chemotherapy with block copolymer micelles transporting a drug into the 
tumor cell.3 
 
 In aqueous solutions, the PAsp−b−PEG micelles prepared by Kataoka et al.100 had a 
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diameter of approximately 60 nm. Their size prevented renal filtration and uptake by the 
reticuloendothelial system (RES). This feature increases the circulation time of these micelles 
in the blood stream. PEO−b−PPO−b−PEO micelles101 conjugated with anthracyclin 
antibiotics (doxorubicin, Ruboxyl, EPI) have also been applied in chemotherapy resulting in 
a 15 % increase in life expectancy and a 90 % inhibition of the growth of the tumor. In some 
cases, the tumor disappeared completely.  
 There is a great need to develop polymeric biomaterials as drug carriers for specific 
applications and functions as most drug delivery systems have to be implanted directly at the 
site.19,102-104 Such is the case for delivering chemotherapeutic agents to malignant gliomas, 
where a poly(anhydride)105 is used as a delivery system. Since the majority of the cases 
require a controlled release of the drug, a delivery system is needed which can not only travel 
to the disease site, but also remain there for prolonged periods before undergoing 
degradation. The polymeric materials used should also be safe for the human body, by 
ensuring that they can easily leave the body once their job is done, or are biodegradable. 
There are a wide variety of polymers available to encapsulate a drug, either via passive 
association or chemical attachment of the drug. A comprehensive review of the broad 




 The characterization of the aggregates formed by self-assembling macromolecules is 
usually accomplished by a combination of several techniques such as fluorescence,106-110 
dynamic light scattering (DLS),10,12,70,74 static light scattering (SLS),66,68a,71c small angle X-
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ray scattering (SAXS),12 small angle neutron scattering (SANS),14,74 electron 
microscopy,51,53-55 and NMR.10,11,15 Among these techniques, fluorescence has been 
extensively used to gain structural information on the aggregates during the self-organization 
of polymeric systems. The techniques employed in this thesis are reviewed hereafter, with a 
detailed account on fluorescence, being the major analytical tool used in this thesis. 
1.4.1. Circular dichroism 
 Circular dichroism (CD) is a valuable technique which has been extensively applied 
to characterize the structure of proteins and polypeptides and monitor changes in their 
conformation.111 The CD spectra are very sensitive to any small alterations of the structure of 
the polypeptide backbone. It has been widely used for both quantitative and qualitative 
purposes to examine the binding of ligands to proteins, as well as to study the nature of the 
interactions taking place between proteins and other macromolecules. CD spectroscopy is a 
form of light absorption spectroscopy that measures the difference between the amount of 
right− and left−circularly polarized light being absorbed by a substance. The CD signal 
between 190 nm and 250 nm can be analyzed to determine the amounts of different 
secondary structures found in proteins such as α-helices, β-sheets, or random coils (Figure 
1.13).112 
 The advantages of using CD for monitoring the conformational changes of biological 
macromolecules include the requirement of small sample quantities, the speed at which these 
experiments can be conducted, and the sensitivity of CD to probe alterations in the 



















































Figure 1.13. CD spectra of poly(L-lysine) illustrating its ability to adopt different secondary 
structures in different conditions; α-helix in basic, β-sheet in neutral, and random coil  in 
acidic solution.112 
 
 Polypeptides that self-assemble in aqueous solutions are being used increasingly to 
carry drugs which are either insoluble or sparingly soluble under physiological conditions. In 
some cases, the drug has to be covalently attached onto the polypeptide backbone, with 
potential effect on the secondary structure of the polypeptide. If the retention of the 
secondary structure is important to maintain the desired properties of the carrier, it is then 
useful to obtain the CD spectra of the polypeptides before and after they have been 
modified.113-115  
1.4.2. Dynamic light scattering  
 Over the years, dynamic light scattering (DLS) has become a powerful technique for 
the characterization of polymers and macromolecules in solution. DLS measures the time-
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dependent fluctuations in the intensity of light scattered by particles undergoing Brownian 
motion in solution. The motion of the particles due to Brownian motion is characterized by a 
relaxation time that is related to the time taken by the species in solution to move in and out 
of the volume irradiated during a DLS experiment. In turn the relaxation time is related to the 
translational diffusion coefficient (DZ). This diffusion coefficient can be converted into a 
particle size using the Stoke-Einstein equation and assuming a spherical shape for the 
particles. 
 The molecular structure, conformation and orientation of the polymer molecules can 
greatly affect the macroscopic properties of their solutions. It is therefore highly informative 
to determine the size of these polymers in solution.116 For example, hydrophobically 
modified alkali swellable emulsion polymers (HASE)117 and copolymers of sodium 2-
(acrylamido)-2-methylpropanesulphonate and dodecyl methacrylate118 exhibit a bimodal 
distribution of relaxation times referred to as the slow and the fast relaxation modes. The 
slow and fast components indicate the presence of polymeric aggregates and single chain 
unimers (unimolecular micelles), respectively. This observation confirms that unimers and 
aggregates (several polymer chains held together by interpolymeric hydrophobic 
interactions) coexist in solution.117 
1.4.3. Fluorescence 
 Fluorescence techniques have been extensively used to characterize the aggregation 
of amphiphilic compounds such as self-assembling polymers and surfactants for more than 
three decades.106-111 Due to its sensitivity and versatility, important information regarding the 
microstructure and molecular dynamics of macromolecules has been obtained. The time scale 
over which information on the dynamics of  macromolecules is available depends on the time 
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window over which the chromophore remains excited. The fluorescence lifetime of a 
chromophore such as pyrene is usually in the 200-400 ns range. However, similar studies 
with phosphorescence can access timescales of the order of seconds to minutes. The 
experiments are usually set up in such a way that the luminescent chromophore is either 
physically bound to the polymer or covalently attached to the polymer or surfactant.  
 The combination of steady-state and time-resolved fluorescence enables one to attain 
quantitative information about the dynamic processes occurring in several photophysical 
processes such as in excimer formation, non-radiative energy transfer (NRET), or 
fluorescence quenching. These fluorescence experiments yield information about the 
compactness of the self-assembled clusters and their microviscosity. Fluorescence probe 
analysis is largely empirical in nature, but when applied with proper care and precautions, it 
can serve in mapping out the complex behaviour of microheterogeneous systems. Sustained 
efforts have been made in this area in order to characterize the dynamics and self-
organization of many hydrophobically modified polymers. 
1.4.3.1. Jablonski diagram 
 When a molecule is raised to its electronically excited state by the absorption of light, 
it can return to the ground state via several unimolecular pathways as shown by the Jablonski 
diagram106 depicted in Scheme 1.1. After absorption of a photon by a chromophore, a very 
rapid relaxation (≤ 10−12 sec) called internal conversion takes place leading to the lowest 
singlet excited state S1. The chromophore in the singlet excited state S1 can either return to 
the ground-state S0 via nonradiative or radiative transitions (fluorescence), or undergo 
intersystem crossing to a triplet state. Due to the spin restrictions, the molecules in the triplet 






























Scheme 1.1. Schematic representation of the various excited electronic states of an organic 
molecule, their energy level relationships, and interconversion processes. 
 
 From the above considerations, the absorption spectrum of molecules reflects the 
vibrational levels of the electronically excited states whereas the emission spectrum reflects 
the vibrational levels of the ground-state. Usually, electronic excitation does not greatly alter 
the spacing of the vibrational energy levels. As a result, the vibrational structures seen in the 
absorption and emission spectra are often mirror images of each others.106  
1.4.3.3. Fluorescence lifetime and quantum yield 
 Fluorescence lifetimes and quantum yields are perhaps the most important 
characteristics of fluorescent substances. Substances with the largest quantum yields, 
approaching unity, display the brightest emission. The lifetime determines the time that the 
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fluorescing molecule remains excited. 
 The fluorescence quantum yield (Q) is the ratio of the number of photons emitted to 
the number of photons absorbed, and can be obtained from Equation 1.1, 
 





=      (1.1) 
 
where Γ is the emissive rate constant of the chromophore, and k is the rate constant for 
radiationless decay of the excited chromophore to the ground-state (GS). The lifetime (τ) of 
the excited state is defined by the average time the molecule remains in the excited state prior 
to returning to the GS. Generally fluorescence lifetimes are around 10 ns and their expression 
is given by Equation 1.2. 
 




=τ      (1.2) 
 
The lifetime of the fluorophore in the absence of nonradiative processes is called the intrinsic 
or natural lifetime and is given by Equation 1.3. 
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1.4.3.4. Chromophores 
 At present, thousands of chromophores are known.106 Chromophores can be broadly 
divided into two main classes, intrinsic and extrinsic.106 Intrinsic chromophores are those 
which are naturally present in a macromolecule such as the benzyl moieties of polystyrene or 
the aromatic amino acids tyrosine, tryptophan, flavins, and the derivatives of chlorophyll in a 
protein.  
 Extrinsic chromophores are those which are added to a sample to provide 
fluorescence when none exists. Extrinsic chromophores include compounds like pyrene, 
naphthalene, anthracene and phenanthrene, generally condensed aromatic compounds whose 
structures are shown in Figure 1.14. Among the fluorescent chromophores employed so far, 
pyrene is “by far the most frequently used chromophores in the fluorescence studies of 
labeled polymers”.109 Due to its long lifetime (150-350 ns), large extinction coefficient, and 
high quantum yield, pyrene is presently still the fluorescent chromophore of choice when it 
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(R = CH2OH, CH2NH2), (CH2)4OH etc.
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Figure 1.14. Structures of commonly used chromophores and their derivatives. 
 
1.3.3.5. Pyrene excimer 
 Pyrene is one of the most widely used chromophores in the characterization of 
polymeric systems because of its spectral features (Figure 1.15).109 It has a well-characterized 
long-lived excited state, it can undergo fluorescence quenching, its emission spectrum is 
sensitive to its microenvironment and most importantly, can form excimers.  
 Since pyrene is often used in this thesis to characterize polypeptide aggregates, the 
effect of excimer formation on the fluorescence spectrum of pyrene is being discussed in 
more detail. The steady-state fluorescence spectrum of pyrene shows two species in solution 
as illustrated in Figure 1.15, the excited pyrene monomer and, when the pyrene concentration 
is sufficiently large, the pyrene excimer. Sharp, well-resolved peaks between 370 nm and 400 
nm are characteristic of the fluorescence of the pyrene monomer and a broad structureless 













































Figure 1.15. Steady-state fluorescence emission spectrum of pyrene randomly attached onto 
the alternating polypeptide (Asp1Phe1)n prepared in this thesis. [Polypeptide] = 0.80 g/L, [Py] 
= 4.14 × 10−5 M in 0.01 M Na2CO3 solution at pH 9, λexc = 346 nm. 
 
 The IE/IM ratio representing the ratio of the pyrene excimer to monomer fluorescence 
intensity is easily obtained from the steady-state emission spectrum of pyrene. The IE/IM ratio 
is usually determined from the area of the spectrum in a selected wavelength range under the 
emission bands of the excimer and the monomer to obtain the quantities IE and IM, 
respectively. The IE/IM ratio gives information about the probability of encounters between 
two pyrenes in solution when the pyrenes are attached onto a polymer. The IE/IM ratio is 
related to the dynamics of the polymer chain, the solvent quality for the polymer, the 
viscosity of the solvent, the presence of microheterogeneous environments, the polymer 
concentration, and the distance between two neighbouring pyrenes in the chain. The IE/IM 
ratio has been used to monitor different polymer systems as a function of pH, ionic strength, 
polymer concentration, hydrophobic content in the polymer chain, and the associations 
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between the pyrene labeled polymers and surfactants.47,118,119 
 An excimer, as defined by Birks,120 is a dimer which is associated in the excited 
electronic state and which is dissociated in the ground-state. The formation of a pyrene 
excimer requires the encounter of an electronically excited pyrene (Py*) with a GS pyrene. 
The excimer state has been described theoretically by a configurational mixing of excitation-
resonance states.109 Based on crystal structure studies (Figure 1.16), a sandwich configuration 
for the pyrene excimer has been proposed in which the excimer is formed by the mutual 






Figure 1.16. Theoretically expected geometrical arrangement between the two pyrene units 
constituting a pyrene excimer. 
 
The interplanar distance has been calculated to be about 3.53 Ǻ.120 The changes in enthalpy 
for the dissociation of excimers equal 39.7 (± 4.0) kJ.109 These numbers reflect a weak 
dissociation energy and a rigid configuration for the excimer.  
 The formation of the excimer can occur either by diffusion (dynamic excimer) 
according to the Birks’ scheme, or fast rearrangement of pre-associated pyrenes which exist 
under certain conditions (static excimers).109 The formation of a dynamic excimer is 
described by the Birks’120 Scheme 1.2A, while excimer formation via the diffusional 
encounters of two pyrenes and direct excitation of a pyrene ground-state dimer is described 
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in Scheme 1.2B.  



















Scheme 1.2. Formation of pyrene excimer through diffusional encounter (Birks’ scheme) (A) 
and through pre-formed pyrene aggregates (B). 
 
1.4.3.6. Medium effects 
 The emission of molecules generally occurs at wavelengths longer than those where 
light absorption occurs. This loss of energy between absorption and emission is known as the 
Stokes’ shift.106 These energy losses can be due to the dissipation of vibrational energy, the 
redistribution of electrons in the surrounding solvent molecules induced by the dipole 
moment of the excited molecule, the reorientation of the solvent molecules and the excited 
state dipole, or to specific interactions between the excited molecule and the solvent. Hence 
the fluorescence emission spectra of many chromophores are sensitive to the polarity of their 
surrounding environment. Figure 1.17 shows the emission spectrum of a fluorescence probe, 
6-propionyl−2−(dimethylamino) naphthalene (PRODAN),121 in solvents of increasing 
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polarity. It can be seen that the emission spectrum shifts to longer wavelengths (Stoke’ shifts) 
as the solvent polarity increases 
 

























































Figure 1.17. Fluorescence emission spectra of PRODAN. From left to right the solvents are 
cyclohexane, chlorobenzene, dimethylformamide, ethanol, and water.121 
 
 Besides polarity, the viscosity of the medium can also influence the emission of the 
probe in the medium. Duhamel et al.75 have investigated the microviscosity of the 
hydrophobic microdomains generated by the oligomers of styrene and maleic anhydride 
(SMA) using dipyme as a chromophore. Dipyme is a molecule made of two 1-
pyrenemethylene moieties connected by an ether linkage (Figure 1.18). At low dipyme 
concentration, excimer formation occurs intramolecularly and the amount of excimer formed 
with respect to the monomer yields information about the viscosity of the environment where 
dipyme is dissolved. A viscous solution will hinder excimer formation whereas a fluid 

























































Figure 1.19. Emission spectra of dipyme in different solvents: acetone, η = 0.306 mPa.s at 
25 oC; THF, η = 0.48 mPa.s at 25 oC; cyclohexanol, η = 41.07 mPa.s at 25 oC.75 
 
 The excimer-to-monomer ratio has been used to obtain qualitative information about 
the microviscosity of surfactant and polymeric micelles.122 No excimer formation was 
observed for dipyme dissolved in any of the SMA solutions which were investigated.75 This 
observation indicated that the interior of SMA aggregates is extremely rigid. Thus, solvents 
affect the emission of a chromophore in many different ways, either through specific solute-
solvent interactions or via bulk effects such as solvent viscosity or polarity.  
 In microheterogeneous systems, changes in the nature of the environment 
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experienced by the probe upon transfer from the aqueous medium to the host, or migration 
from one region of the carrier to another are readily detected in the emission properties of the 
fluorescent probes. This is one of the reasons why fluorescence is widely applied to monitor 
partitioning of the probe between the hydrophobic domains generated by a given carrier and 
the aqueous solution. 
 Another interesting feature about the use of pyrene to study hydrophobic 
microdomains is the sensitivity of the vibrational band structure of its fluorescence emission 
spectrum to the polarity of the environment.123,124 As the solvent polarity varies the relative 
intensities of the peaks in the emission spectrum undergo significant changes. In particular, 
the ratio of the intensity of the first peak (I1) to that of the third peak (I3), the I1/I3 ratio, 
increases with solvent polarity and hence can be used to probe the polarity of the 
microenvironment experienced by the probe (Figure 1.20). The I1/I3 ratio equals 0.58 in 
cyclohexane, while it equals 1.66-1.87 in water.123,124 This feature enables the use of pyrene 
to probe the formation of surfactant micelles. At concentrations lower than cmc, pyrene is in 
water and the ratio I1/I3 equals that of pure water. At concentrations above the cmc, micelles 
are formed and the hydrophobic core of the micelles host pyrene, providing a less polar 
environment reflected by a lower value of the I1/I3 ratio. The surfactant concentration at 
which the I1/I3 ratio changes from a high to a low value is that of the cmc. For instance, the 
cmc of sodium dodecylsulphate (SDS) can be found to equal 8.0 ×10−3 mol/L by monitoring 
the fluorescence of pyrene as a function of SDS concentration.  
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 0.01 M Na2CO3, pH 9 Acetonitrile
n-Butanol Cyclohexane
I1/I3 = 1.03













































Figure 1.20. Solvent dependence of the vibronic band intensities of the pyrene monomer 
fluorescence at room temperature leading to different values of the I1/I3 ratio. (λex = 338 nm). 
 
 The I1/I3 ratio has been used by Horiuchi et al.65b and Kumacheva et al.125 to monitor 
the effect of polymer concentration and the degree of neutralization on the partition of the 
probe between the aqueous phase and the microdomains formed by the hydrophobic groups 
of the polymers under study. The effect of the ionic strength of the solution on this ratio has 
been studied by Magny et al.126 and Morishima et al.118 who have utilized the I1/I3 ratio of a 
pyrene-labeled polymer to study the interactions between other hydrophobic pendants 
attached to the chain.  
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1.4.3.7. Fluorescence quenching 
 Fluorescence quenching refers to any process which decreases the fluorescence 
intensity of a given chromophore such as pyrene via a non-radiative process.106 There are a 
variety of processes which can result in quenching. Some occur over a certain distance, such 
as electron transfer or non-radiative energy transfer. Others occur upon direct contact with 
the quencher such as in collisional quenching. A decrease in the fluorescence of the 
chromophore can also take place by complex formation (static quenching). Different 
quenching scenarios are possible, depending on whether both the chromophore and the 
quencher are attached to the polymer, the chromophore is attached to the polymer and the 
quencher is free in solution, or the reverse situation where the quencher is attached to the 
polymer and the chromophore is free in solution. For pyrene, typical quenchers include ionic 
species such as iodide, copper, thallium, or alkylpyridinium ions, or neutral species such as 










Scheme 1.3. Quenching of pyrene attached onto the polymer backbone by a free quencher 
molecule. 
 
 Both static and collisional quenching requires molecular contact between the 
quencher and the chromophore. In the case of collisional quenching, the quencher must 
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diffuse toward the chromophore during the lifetime of its excited state. The collision between 
the excited chromophore and the quencher induces the chromophore to return to the ground-
state. In the case of static quenching, a complex is formed between the chromophore and the 
quencher. This complex is non−fluorescent. Whether the quenching is dynamic or static, the 
quencher and the chromophore must be in contact. 
 When an external quencher (i.e. not attached to the polymer) is added to a solution 
containing a polymer labeled with pyrene, the chromophore is quenched according to 
Scheme 1.3. A Stern-Volmer plot can be obtained using Equation 1.5 where τ0 and τQ are the 
lifetime and decay time of the chromophore without and with quencher, respectively, and I0 
and IQ are, respectively, the fluorescence intensities of the chromophore without and with 
quencher. kQ is the collisional quenching rate constant and [Q] is the quencher concentration. 
 









+==     (1.5) 
 
 If the quenching is purely diffusional, the ratios τ0/τQ and I0/IQ are equal and increase 
with the quencher concentration. A τ0/τQ ratio lower than the I0/IQ ratio indicates the 
occurrence of static quenching. As already mentioned, collisional quenching of the 
chromophore occurs by diffusional encounters of the excited chromophore with the 
quencher. This means that the collisional quenching rate constant kQ provides information 
about the rigidity of the medium surrounding the chromophore, since a more rigid 
environment will result in a smaller kQ. 
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1.4.3.7.1. Protective quenching 
 In some quenching studies, the Stern-Volmer plot departs from linearity and reaches a 
plateau at higher quencher concentrations. In such a case, protective quenching takes place.75 
Such fluorescence experiments are very important to characterize polymeric systems where 
water-soluble polymers have been hydrophobically modified to generate hydrophobic 
microdomains in aqueous solution. These hydrophobic microdomains can encapsulate 
hydrophobic compounds such as drugs. If they exhibit protective quenching, these 
hydrophobic microdomains provide the drugs with some protection from the aqueous 
environment. A chromophore such as pyrene can be used as either a molecular probe which 
associates passively with hydrophobically modified water-soluble polymers (HMWSPs) or a 
label covalently attached to the backbone of the polymer. Pyrene being hydrophobic 
associates with the hydrophobic microdomains. If these microdomains are sufficiently rigid, 
only those pyrenes close to the surface of the microdomains are exposed to the aqueous 
environment and hence can be quenched by a water-soluble quencher. The fraction of 
pyrenes which are accessible to this quencher can be determined from Equation 1.6 which 
predicts that the I0/(I0-IQ) ratio increases linearly with [Q]−1. 
 










    (1.6) 
 
In Equation 1.6, fa is the fraction of pyrenes accessible to the quencher. It can be obtained 
from the intercept of a plot of I0/(I0-IQ) vs 1/[Q]. The collisional quenching rate constant kQ 
can be calculated from the slope. 
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1.4.3.8. Fluorescence resonance energy transfer 
 Fluorescence resonance energy transfer (FRET) has also been frequently used in 
studies of polymeric systems labeled with a donor (D) and an acceptor (A).106,131 When the 
donor molecule is selectively excited at a wavelength where the acceptor molecule does not 
absorb, the excitation energy can be transferred non-radiatively to the acceptor molecule, 
which results in the acceptor becoming excited. Such a process is known as FRET (Scheme 
1.4). Owing to the strong dependence of FRET on the distance separating the donor and the 
acceptor molecules, it has been frequently referred to as a “spectroscopic ruler”131 and 













Scheme 1.4. Fluorescence energy transfer when both the donor and the acceptor are attached 
onto the same polymer chain. 
 
 Two very important parameters associated with FRET are the rate and efficiency of 
FRET. The rate of energy transfer from a donor to an acceptor is given by Equation 1.7. 
 













    (1.7) 
 
 37
In Equation 1.7, τD is the lifetime of the donor in the absence of acceptor, r is the distance 
between the donor and acceptor molecules, and Ro is the “Förster” radius, which depends on 
the extent of overlap between the absorption spectrum of the acceptor and the emission of the 
donor and the relative orientation of the donor and acceptor transition dipoles. The rate 
constant, kET, is proportional to r−6 which means that the rate constant of FRET is very 
sensitive to r. A small r would result in strong FRET whereas weak FRET would be 
observed for a large r.  
 The FRET efficiency (EET) can be calculated from Equation 1.8,  
 











==     (1.8) 
 
where ID0 and ID represent the fluorescence intensity of the donor in the absence and presence 
of the acceptor, respectively. Similar to kET, EET depends strongly on r, the distance 
separating the donor and the acceptor molecules. When r is significantly smaller than R0, EET 
is close to 1.0, indicating strong FRET. On the other hand when r is much larger than R0, EET 
is closer to 0, resulting in weak FRET.  
 Naphthalene and pyrene, phenanthrene and anthracene, or fluorescein and rhodamine 
are common donor/acceptor probe pairs used in FRET experiments. R0 has been determined 
to equal 2.9 nm132,133 and 3.4 nm,134 2.5 nm,132 and 4.9 nm132 for the naphthalene/pyrene, 
phenanthrene/anthracene, and fluorescein/rodamine pairs, respectively. For the naphthalene/ 
pyrene pair, naphthalene is excited around 290 nm where pyrene absorbs little. The 
naphthalene emission, INp, is monitored at 330 nm, whereas that of pyrene, IPy, is monitored 
at 375 nm. An estimate of EET is obtained from the ratio IPy/INp. Efficient FRET yields a 
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small INp and a large IPy resulting in a large IPy/INp ratio. Inefficient FRET results in a small 
IPy/INp ratio. 
 
1.5. Project objectives 
 In view of the interest for self-assembling systems made up from macromolecules and 
their potential uses in various industries, it is advisable to develop new and improved 
polymeric building blocks which can be used for self-assembly. Most of the recent work 
done in the field of self-assembly, especially for self-assembled carriers used as drug delivery 
systems, makes use of either block copolymers, where one block is water soluble such as 
PEO and the other is either a poly(amino acid), (PEO−PAsp),11,16,17 or poly(styrene) (PS),12,50 
or copolymers where cholesterol15 moieties have been grafted onto the hydrophilic block. 
Not much research has been carried out in the use of alternating copolymers, where the 
hydrophobic and hydrophilic monomers are arranged in a repeating sequence. One such 
study carried out by Duhamel et al.75 makes use of copolymers of styrene and maleic 
anhydride (SMAs). The aggregation behaviour of two SMAs, one of them having an 
alternating sequence, was investigated in alkaline aqueous solution. It was possible to vary 
the hydrophobic character of the SMA not only by changing the hydrophobic character of the 
copolymers, but also by adjusting the degree of ionization of each of the copolymers, thus 
enabling the manipulation of the degree of self-assembly of the system. The SMAs were 
found to self-assemble into nanostructures with diameters of approximately 2 nm with the 
core consisting of mainly styrene pendants stabilized in alkaline aqueous solution by the 
maleate anions. The hydrophobic microdomains thus generated were investigated by making 
use of various fluorescence techniques. From the I1/I3 ratio it was clear that pyrene was 
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located in a hydrophobic environment. It was also possible to load these microdomains with 
large amounts of pyrene, which showed their high capacity for solubilization of hydrophobic 
compounds. The absence of pyrene excimer revealed another interesting feature of these 
hydrophobic microdomains, namely that their local microviscosity was extremely large. This 
was confirmed by FRET with the donor/acceptor pair of phenanthrene/anthracene. This study 
demonstrated that the self-assembly of SMAs led to aggregates whose rigid hydrophobic 
cores could dissolve large quantities of hydrophobic compounds. This study suggested that 
SMA aggregates could be used as carriers when slow release of the hydrophobic cargo is 
required.  
 These exciting results made SMAs very interesting as potential drug carriers. 
Unfortunately, SMAs are not biocompatible. The monomers of SMA are however very 
similar to amino acids, such as phenylalanine (Phe) for styrene and aspartic acid (Asp) or 
glutamic acid (Glu) for maleic anhydride. The objective of this thesis was therefore to 
synthesize a series of polypeptides with different sequences using Phe and Asp as the two 
building blocks, and to investigate their association properties in aqueous solution. The 
polypeptides prepared were (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, (Asp1Phe2)n, and 
(Asp1Phe3)n starting from a hydrophilic polypeptide to a polypeptide with a high hydrophobic 
character. Pyrene was used to investigate the hydrophobic microdomains of these 
polypeptides, first as a free molecule that would passively associate with the polypeptide 
aggregates, and second by randomly attaching pyrene onto the polypeptide at the aspartic 
acid sites. Fluorescence resonance energy transfer was used to determine whether the species 
present were polypeptide aggregates or unimolecular micelles. Fluorescence quenching with 
a water soluble quencher established the accessibility of pyrene to the surrounding. It was 
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expected that as the hydrophobicity of the polypeptides increased, their ability to encapsulate 
pyrene would also increase, and that this effect would be observed by both FRET and 
fluorescence quenching. 
 
1.6. Thesis outline 
 This thesis is organized in the following manner. Chapter 1 provided a literature 
overview on self-assembling systems and a description of their importance with a special 
emphasis on their use for drug delivery. Various techniques used in this thesis to characterize 
the polypeptide aggregates were also described in Chapter 1. Chapter 2 gives a detailed 
description of the synthesis of the polypeptides used in this project. The intrinsic properties 
of the polypeptides in solution are investigated in Chapter 3. The association of the 
alternating polypeptide was characterized by DLS, fluorescence resonance energy transfer 
and fluorescence quenching and the results of this study are presented in Chapter 4. The 
effect of the Phe content of the polypeptides on the aggregation behaviour of the 
polypeptides in solution was investigated by DLS and fluorescence techniques in Chapter 5. 
The last chapter, Chapter 6, summarizes the results of the work and offers some 
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 The synthesis of peptides via the condensation of amino acids has been the focus of 
numerous studies for the past five or six decades1-7 and many approaches to accomplish this 
synthesis have been developed. The choice of a proper synthetic method depends on the 
amino acids that constitute the peptide. Some amino acids have side groups which can 
undergo unwanted reactions with the reagents used in the synthesis. Thus special attention 
must be paid to the structure of the amino acids used in the synthesis of a given peptide 
sequence. With the exception of proline which is a cyclic amino acid, all amino acids have 








Figure 2.1. Chemical structure of an amino acid 
 
 Nineteen of the twenty essential amino acids differ only by the R group that is 
attached to the central carbon atom. Common amino acids include glycine (R = CH3) and 
valine (R = isopropyl). Amino acids contain side groups which can have aromatic, basic, or 
acidic character. Out of the twenty essential amino acids, only proline has a secondary amine 







Figure 2.2. Chemical structure of proline. 
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 All natural amino acids are found in the L-configuration and have a chiral carbon 
except for glycine for which the substituent R in Figure 2.1 is hydrogen. In nature, peptide 
synthesis is accomplished by the condensation reaction of an amine with an acid shown in 
Figure 2.3 which results in the formation of an amide bond and a water molecule. By driving 
the water out of the system, the reaction can be thermodynamically driven to the right. 





















Figure 2.3. Amide bond formation between two amino acids 
 
Almost all coupling reactions between two amino acids involve the protection of the 
amine function of one amino acid and the activation of its carboxylic acid. Nevertheless these 
more efficient syntheses are not without drawbacks. Countless papers involving peptide 
synthesis report difficulties in maintaining the chiral purity of the protected/activated amino 
acids during synthesis.8 Unprotected amino acids are less prone to undergo racemization 
because the amine functionality hinders acidic catalysis and the carboxylic group hinders 
alkaline catalysis of racemization. 
Figure 2.4 represents a typical mechanism by which an amino acid bearing a 
protected amine and an activated acid can undergo racemization. The mechanism depicted in 
Figure 2.4 occurs to varying degrees with each amino acid, depending on the steric hindrance 
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and electronic effects provided by the various side chains. No synthetic method has been 











































Figure 2.4. Racemization through an azlactone route: R1 is the side chain for the amino acid, 
X is the activating/protecting group for the acid side of the amino acid and R is the alkyl 
group on the protecting group on the amino side of the amino acid. 
 
The azlactone formation shown in Figure 2.4 occurs via a resonance stabilized cyclic 
intermediate and is generally accepted as a major pathway for racemization.1 The cyclic 
intermediate is formed by the attack of the nucleophilic oxygen carboxyl carbon which has 
been made more electropositive by the presence of the activating group. In the presence of a 
base, de-protonation of the chiral center can take place. Re-protonation can occur on either 
side of the ring structure, thus resulting in a mixture of L- and D-isomers. The occurrence of 
D-isomers in a polypeptide must be minimized, because they can disrupt the secondary 
structure and thus the behavior of the polypeptide in solution. The uncontrolled incorporation 
of D-isomers in an otherwise all L-polypeptide complicates the characterization of the 
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polypeptide and weakens the conclusions drawn for the structure-property relations of a 
polypeptide. 
 
2.1.1. Coupling methods 
There are several factors, other than the sensitivity to side groups that need to be 
optimized when choosing a coupling method. These factors are the yield, the inertness of the 
protecting groups during the reaction, the minimization of side reactions and racemization, 
and the relative ease of synthesis. 
The majority of coupling methods gives satisfactory results with respect to the first 
three considerations but often yield racemic mixtures. Many of them are difficult to handle 
and some require that the synthesis be conducted under inert atmosphere. All of them involve 
the activation of the carboxyl acid through an electron withdrawing substituent to produce a 
more highly electrophilic center for acylation. These methods include the use of acid 
chlorides,9 acid azides10 and anhydrides,11 N-acyl derivatives12 as well as carbodiimide 
coupling agents and active esters.13 For example, coupling reactions involving acid chlorides 
require careful handling because they are very moisture sensitive and must be performed at 
low temperatures. Cyclic anhydride intermediates1 and difficult to remove by-products are 
produced during the reactions. The acid chloride method also leads to extensive 
racemization. 
 In the azide method, the protected methyl ester of an amino acid is transformed into a 
hydrazide, which is then converted into an acid azide.14 Although this procedure is still much 
in use, the major side reaction referred to as the Curtius rearrangement and shown in Figure 
2.5 produces a toxic isocyanate by-product. This by-product is very reactive, forms a urea 
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linkage with the free amino acid groups in solution, and generates compounds which are very 
difficult to separate from the mixture. The advantage of this method is the presence of very 
low amounts of racemates. Unfortunately the reaction also produces very toxic hydrozoic 
acid as a by product. 
 
R C N N N
O
R N C O N2 
 
Figure 2.5. Curtius rearrangement: Formation of an isocyanate. 
R C N N N
O




Figure 2.6. Formation of a peptide bond and hydrozoic acid. 
 
Peptides have also been synthesized using alkyl mixed anhydrides. These have the 
advantage of generating easily removable by-products such as carbon dioxide and alcohol. 
The acid anhydride method has been the method of choice of Urry and Tamburro in the 
synthesis of artificial elastin.15 
The reagent most commonly used by peptide chemists to create a mixed anhydride is 
isobutyl chloroformate.16 As an anhydride, it exhibits two electrophilic sites that can react 
with the nucleophile, typically an amine. The main advantage of the method is that the bulky 
isobutyl side group minimizes potential side reactions and the amine attacks preferentially 
the A carbonyl group, as depicted in Figure 2.7. The main disadvantage of the method arises 
when dealing with an amino acid bearing a side chain of size comparable to that of isobutyl. 
For amino acids with bulky side chains like phenylalanine, isoleucine or valine, the 
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nucleophilic amine can react at either carbonyl A or B. This results in a by−product which is 

















Figure 2.7. Mixed anhydride reactive sites: A is the preferred reaction site at the carboxyl of 
the amino acid, B is a sterically hindered second site by a t-Bu in this case. 
 
Two of the most widely used methods for coupling today are carbodiimide and 
activated ester coupling. Both methods activate the free C-terminal carboxyl group on one 
amino acid to allow for faster coupling with the free N-terminal group on the second amino 
acid. The carbodiimide method is performed by activating the carboxyl group, and coupling 
and purifying the coupled amino acids in a single step1 (Figure 2.8). The most commonly 
used carbodiimide in peptide synthesis is dicyclohexylcarbodiimide (DCC). It is fairly 
inexpensive and its by-product, dicyclohexyl urea (DCU) can be isolated and removed from 
the solution. However significant racemization can occur depending on the solvent used for 
coupling. The extent of racemization can be lowered by the addition of a catalyst, 
1−hydroxybenzotriazole (HOBt), and copper salts such as CuCl2.17 HOBt is an excellent 
acylating agent which is also a weak acid that minimizes the removal of the hydrogen from 

































































Figure 2.8. DCC/HOBt activation reaction 
 
 In the active ester method, DCC is used to activate the carboxyl group of an amino 
acid which is then reacted with HOBt, a strong electron withdrawing group that is easily 
crystallized and isolated before the addition of the next amino acid. Each electron 
withdrawing activating ester has different benefits and drawbacks. Three of the most widely 
used activating groups are p−nitrophenol (PNP),18 N−hydroxysuccinimide (HOSu),19 and 
pentachlorophenol (PCP).20,21 They are shown in Figure 2.9. PCP is known to be the most 
reactive activated ester, reacting approximately 20 times faster than PNP,22 but it also results 
in the largest steric hindrance as it contains many large chlorine groups close to the active 
site. HOSu is often used because it is water-soluble which makes it easily removable.1,23 
 There are many other coupling agents found in the literature that are reported to 
produce good yields and low racemization. They include 1−ethoxycarbonyl−2−ethoxy−1,2-
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dihydroquinoline (EEDQ), 1−isobutylcarbonyl−2−isobutyloxy−1,2−dihydroquinoline (HDQ) 
used for mixed anhydrides,24 benzotriazoyl N−oxytri-dimethyl-phophonium 
hexafluorophosphate chloride (BOP-Cl),25 O−benzotriazolyl-tetramethyl-isouronium 
hexafluorophosphate (HBTU) and 1−ethyl−3−(3−dimethylaminopropyl) carbodiimide (EDC)  












Pentachlorophenol (PCP) N-Hydroxysuccinimide (HOSu) p-Nitrophenol (PNP)
 
 
Figure 2.9. Common activating groups 
 
2.1.2. Protecting groups 
 Most amino acids exhibit more than two reactive functional groups which 
complicates the specific coupling reaction of two amino acids. Accordingly protecting groups 
are used to minimize or completely eliminate side reactions. In the present work, the 
synthesis of the polypeptides has been carried out using two amino acids, phenylalanine and 
aspartic acid, the former being bifunctional whereas the latter is trifunctional. The chemical 
structures of these amino acids are shown in Figure 2.10. Consequently, the discussion of 




















Figure 2.10. Chemical structure of trifunctional aspartic acid and bifunctional phenylalanine 
 
The most commonly used amino protecting groups in peptide synthesis are the 
carbobenzoxycarbonyl (Z or CBz), t-butoxycarbonyl (t-Boc), and 9-
fluorenylmethyloxycarbonyl (Fmoc), while t-butyl (t-Bu) and benzoxycarbonyl (Bz)26-28 are 





































Figure 2.11. Common protecting groups in peptide synthesis 
 59
A well thought-out synthetic strategy must be applied to deprotect the desired group 
while leaving the others untouched.29-31 Table 2.1 lists the conditions under which each group 
can be removed or remains stable. This list is by no means exhaustive, but accounts for those 
protecting groups most frequently used in peptide synthesis. 
 
Table 2.1 Stability of peptide protecting groups 
Protecting groups Stable conditions Removal conditions 
Z, CBz Basic Hydrogenation, Acidic 
t-Boc, t-Bu Basic Mild Acidic 
Bz Basic Acidic 
Methyl Ester Acidic Strong Basic 
Fmoc Acidic Mild Basic 
 
2.1.3. Polymerization 
 Polypeptides with well-defined repeating sequence can only be synthesized by 
preparing first a peptide referred to as a monomer which is then polymerized. To achieve 
high molecular weight polypeptides, the carboxyl group of the monomer must be activated 
using an active ester such as PCP, HOSu, or PNP. These active esters are more stable in 
solution than the intermediates produced using a coupling agent such as DCC, and thus live 
longer and continue to react over long periods of time to produce longer chain polypeptides.  
 After the required sequence has been synthesized, it is de-protected at the N-terminal 
of the monomer with a dilute solution of HCl or trifluroacetic acid (TFA) resulting in a 
chloride or trifluoroacetate ammonium salt. A hindered tertiary base such as triethylamine 
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(TEA) or N−methylmorpholine (NMM) is used to free the amine and begin the 
polymerization. Dimethylsulphoxide (DMSO) or N, N−dimethylformamide (DMF) are used 
as solvents for the polymerization reaction to ensure that the product remains soluble during 
the polymerization. Other common solvents such as ethyl acetate and methylene chloride 
commonly used during the monomer synthesis are unable to solubilize the growing chains. 
Also higher concentrations of monomer are used to produce higher molecular weight (MW) 
polypeptides. 
 Depending on the reactivity of the monomer and the desired MW, the polymerization 
reaction can go on for 1 to 14 days before completion. The workup of the polypeptides is 
carried out by successive washes with large portions of ether, water, and methanol to remove 
the solvent and any small molecules such as PCP and TFA as well as any undesirable low 
MW oligomeric material. These steps can be followed by dialysis, where the pore size of the 
dialysis tubing is chosen to remove low molecular weight polypeptides. 
 
2.1.4. Monomer synthesis 
In this work, the monomer refers to a sequence of 3-4 amino acids which will be 
polymerized to give a polypeptide with a well-defined repeating sequence. The strategy is 
followed to prepare five polypeptides made up of aspartic acid (Asp) and phenylalanine 
(Phe) in varying proportions, (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, (Asp1Phe2)n, and 
(Asp1Phe3)n, affording a range of hydrophilic and hydrophobic character. The synthesis was 
designed to use a minimal number of steps and to yield the greatest amount of pure 
polypeptide.  
 Solution phase synthesis was chosen to produce the monomer because it generates 
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large quantities (grams) of material. Alternate method would have been to produce the 
monomer using solid phase synthesis. However solid phase synthesis is more commonly 
used to generate small amounts of oligopeptides in quantitative yield and the cost involved in 
obtaining gram scale quantities of such materials is quite high. 
 Schemes 2.1 and 2.2 illustrate two of the synthetic routes that were tried and found to 
be unsuccessful. By convention, the left and right hand side represents the N- and C-terminal 
of the amino acids, respectively. The β-carboxylic side chain of the aspartic acid is projected 
into the page and is shown as being either protected (Bz or t-Bu) or a free acid (OH). A 
horizontal line between two amino acids is a peptide linkage, while the reaction conditions 
for their coupling is described directly above the line. 
 



































The route depicted in Scheme 2.1 was stopped due to the intermolecular cyclization 
of the dipeptide which occurred during the second step of the reaction scheme and whose 
mechanism is shown in Figure 2.12. This resulted in the removal of the Bzl protecting group 
 62
from the β−carboxylic acid on the aspartic acid as well as the desired elimination of the 
methyl group from the α−carboxylic acid of phenylalanine. Earlier studies have established 
that strong acidic or basic conditions induce cyclization when the β- or γ-carboxylic acid of, 



























Figure 2.12. Mechanism for the cyclization reaction of the dipeptide resulting in the removal 
of the Bzl protecting group. 
 
The second proposed route was discarded because of problems encountered with the 
hydrogenation of the monomer in the fifth step of Scheme 2.2. The activating group (PCP) 
was also being removed along with the CBz group which meant that low yields of the desired 














































 These unsuccessful synthetic schemes are examples of the difficulties encountered 




Materials and methods 
Tert−butyloxycarbonyl−L−phenylalanine and tert−butyloxycarbonyl−L−β−benzyl-
aspartic acid were obtained from Bachem. Phenylalanine and other chemicals used were 
purchased from Sigma-Aldrich. Solvents of spectrograde quality (acetone, ethyl acetate, 
methanol, THF, DMF, and diethyl ether) were bought from VWR or Caledon. All solvents 
were used as received unless otherwise stated. Milli−Q water, with a resistivity of over 18 
MΩ.cm, was used in all preparatory steps. 
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 All melting points are uncorrected and were taken on a Mel-Temp apparatus. The 
reactions were followed by chromatography and the solvent mixture used for TLC was 
chloroform:methanol:acetic acid (85:10:5). 1H NMR spectra were acquired on a 300 MHz, 
Bruker Instrument in deutrated DMSO. The NMR spectra of all peptides and polypeptides 
prepared during this work are presented in the Appendix. All spectra exhibit two peaks at 2.4 
and 3.3 ppm due to the presence of DMSO, the solvent, and residual water in the solvent, 
respectively. The NMR spectra show that some racemization does take place as indicated by 
the presence of extra NH peaks in the intermediates prepared during the synthesis of the 
monomer. There are extra NH peaks observed in the NMR spectra of the polypeptides which 
also indicate a small amount of racemization. Mass spectra were acquired on a 
Waters/Micromass QTOF Ultima Global mass spectrometer using positive ion 
nanoelectrospray (ESI) equipped with an electrospray ionizer and a quadrupole time-of-flight 
(QTOF) detector. Samples were infused at a rate of 2 μL/min in a 1:1 acetonitrile:water 
mixture. Typical operating conditions consisted of a source temperature of 80 oC, a capillary 
voltage of 3.5 kV, a cone voltage of 60-160 V, and a mass resolution of ~9000. 
 
2.3. Peptide synthesis 
2.3.1. Synthesis of  poly(Asp1Phe1) 
 For polymerization purposes, a tetrapeptide active ester was chosen as the monomer 
since a dipeptide active ester would be expected to yield the diketopiperazine1 in addition to 
the polymer, whereas the tripeptide would not give the desired alternating sequence. As 
shown in Scheme 2.3, the peptide was extended from its amino end by the reaction of the 
Boc-Asp(OBzl)-OSu ester with the free H-Phe-OH using NaHCO3 for the coupling reaction. 
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The Boc protecting group was removed by using trifluoroacetic acid (TFA). The tripeptide 
and the tetrapeptide were prepared similarly. Each amino acid addition goes through an 
activation, a coupling and a deprotection step. This procedure ensures minimum racemization 
throughout the synthesis because the unwanted cyclization of the activated amino acid is 
reduced thanks to the bulkiness of the Boc group and also by the use of N-hydroxy 
succinimide (HOSu) which acts both as the activating group and as an auxiliary nucleophile 
providing competition in the abstraction of the proton from the carbon atom of the 
intermediate activated with dicyclohexylcarbodiimide (DCC). The Boc tetrapeptide was then 
activated with HOSu and the Boc group removed before polymerization. The polymerization 
was carried out in DMSO using triethylamine (TEA) as the base. The benzyl protecting 
group was finally removed after completing the polymerization using methane sulphonic acid 
in the presence of thioanisole.  
 





































































 To a solution of tert-butyloxycarbonyl-L-β-benzyl-aspartic acid (Boc-Asp(OBzl)-
OH) (25 g, 0.077 mole) and N-hydroxy succinimide (HOSu, 9.8 g, 0.085 mole) in ethyl 
acetate (200 mL) at -5 oC, dicyclohexylcarbodiimide (DCC, 17.5 g, 0.085 mole) was added.32 
The mixture was stirred for 5 h at -5 oC and then left to stand overnight in a refrigerator. The 
excess DCC was decomposed by adding glacial acetic acid (3 mL). The dicyclohexyl urea 
thus produced was filtered off and the filtrate was concentrated under vacuum using a rotary 
evaporator. The viscous oil obtained was redissolved in ethyl acetate and more urea was 
filtered off. The ethyl acetate solution was successively washed with 40 mL of 0.5 M sodium 
carbonate, water, 0.5 M hydrochloric acid, and water.  After drying of the ethyl acetate layer 
over anhydrous sodium sulphate and removal of the solvent under reduced pressure, the 
white solid of 1 was obtained which was crystallized in isopropanol. 
Yield: 88 % (28.6 g), m.p. 98-99 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.34 (s, 9H, C(CH3)3-Boc), 2.76 (s, 4H, CH2-Su), 2.81-
3.0 (m, 2H, CH2-pendent), 4.70-4.77 (q, 1H, CH-backbone), 5.09 (s, 2H, CH2-Bzl), 7.32 (5H, 
Ar-H), 7.68-7.71 (d, 1H, NH) 
Boc-Asp(OBzl)-Phe-OH (2) 
 A solution of 1 (16 g, 0.038 mole) in tetrahydrofuran (THF, 200 mL) was added to a 
solution of phenylalanine (5.9 g, 0.036 mole) and sodium bicarbonate (6.0 g, 0.71 mole) in 
THF (200 mL) and water (200 mL).33 After the solution had been stirred at room temperature 
for 24 h, the reaction mixture was concentrated by removing THF with the rotary evaporator, 
acidified with 0.5 M hydrochloric acid, and extracted with ethyl acetate (500 mL). The 
organic layer was then washed with water three times (200 mL), dried over anhydrous 
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sodium sulphate, filtered, and the solvent was removed under reduced pressure. Addition of 
petroleum ether (bp 30-60 oC) to the oily concentrate resulted in the precipitation of the 
dipeptide 2 which was filtered. 
Yield: 92 % (15.5 g), m.p. 115-116.5 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.33 (s, 9H, C(CH3)3-Boc), 2.47-2.71 (m, 2H, CH2-
pendent), 2.77-3.03 (m, 2H, CH2-pendent), 4.29-4.38 (m, 2H, CH-backbone), 5.0-5.09 (s, 
2H, CH2-Bzl), 7.10-7.32 (m, 10H, Ar-H), 7.89-7.95 (d, 1H, NH) 
Boc-Phe-OSu (3) 
 To a solution of tert-butyloxycarbonyl-L-phenylalanine (Boc-Phe-OH) (15 g, 0.057 
mole) and HOSu (7.2 g, 0.062 mole) in methylene chloride (CH2Cl2, 120 mL) at -5 oC, DCC 
(12.8 g, 0.062 mole) was added. The mixture was stirred for 5 h at -5 oC and then left to stand 
overnight in a refrigerator. The reaction was worked up as mentioned above for 1. A white 
solid of 3 was obtained which was crystallized in isopropanol. 
Yield: 82 % (16.8 g), m.p. 138-138.5 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.27 (s, 9H, C(CH3)3-Boc), 2.78 (s, 4H, CH2-Su), 2.92-
3.17 (m, 2H, CH2-pendent), 4.48-4.56 (m, 1H, CH-backbone), 7.19-7.30 (m, 5H, Ar-H), 
7.61-7.64 (d, 1H, NH) 
H-Asp(OBzl)-Phe-OH.CF3COOH (4) 
The dipeptide 2 (5 g, 0.011 mole) was dissolved in trifluoroacetic acid, (TFA, 12 mL) 
and the reaction mixture was stirred for 45 min at room temperature.33 After removal of TFA 
under reduced pressure, anhydrous ether was added to the residue to obtain white crystals of 
4 in quantitative yield. 
m.p. 73-76 oC 
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300 MHz, 1H NMR: δ (dmso-d6) ppm 2.74-3.11 (m, 4H, CH2-pendent), 4.0-4.1 (m, 1H, CH-
backbone), 4.4-4.5 (m, 1H, CH-backbone), 5.08 -5.16 (t, 2H, CH2-Bzl), 7.20-7.36 (m, 10H, 
Ar-H), 8.19 (br, 3H, NH3), 8.7-8.8 (d, 1H, NH) 
Boc-Phe-Asp(OBzl)-Phe-OH (5) 
 Into a solution of 4 (5 g, 0.0103 mole) and sodium bicarbonate (2.6 g, 0.031 mole) in 
a mixture of THF (60 mL) and water (60 mL) was added a solution of 3 (4.5 g, 0.124 mole) 
in THF (65 mL). The solution was left to stir at room temperature for 24 h. The reaction 
mixture was concentrated by removing the THF with a rotary evaporator, acidified with 0.5 
M hydrochloric acid, and extracted with ethyl acetate (200 mL). The organic layer was then 
washed three times with water (50 mL), dried over anhydrous Na2SO4, and filtered. The 
solvent was removed under vacuum. Petroleum ether (bp 30-60 oC) was added and the 
precipitate thus formed was collected by filtration and dried to give the tripeptide. 
Yield: 95 % (6.05 g), m.p. 99-100 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.23 (s, 9H, C(CH3)3-Boc), 2.52-2.99 (m, 6H, CH2-
pendent), 4.05-4.18 (m, 1H, CH-backbone), 4.37-4.41 (m, 1H, CH-backbone), 4.6-4.75 (m, 
1H, CH-backbone), 5.05-5.08 (t, 2H, CH2-Bzl), 6.87-6.89 (d, 1H, NH), 7.11-7.34 (m, 15H, 
Ar-H), 8.08-8.10 (d, 1H, NH),  8.2-8.3 (d, 1H, NH) 
H-Phe-Asp(OBzl)-Phe-OH.CF3COOH (6) 
 A solution of 5 (6.0 g, 0.01 mole) in TFA (10 mL) was stirred for 45 min. After 
removing TFA with the rotary evaporator, the product was precipitated by adding anhydrous 
ether. The crystals obtained were filtered off. 
Yield: 83 % (5.1 g), m.p. 77-79 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.47-3.06 (m, 6H, CH2-pendent), 3.93-3.95 (m, 1H, 
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CH-backbone), 4.38-4.43 (m, 1H, CH-backbone), 4.65-4.75 (m, 1H, CH-backbone), 5.0-5.1 
(s, 2H, CH2-Bzl), 7.13-7.34 (m, 15H, Ar-H), 8.35-8.45 (d, 1H, NH), 8.8-8.9 (d, 1H, NH) 
Boc-Asp(OBzl)-Phe-Asp(OBzl)-Phe-OH (7) 
 A solution of 1, (5.6 g, 0.0133 mole) in THF (100 mL) was added to a solution of 6 
(7.0 g, 0.011 mole) in a mixture of THF (90 mL) and water (90 mL) containing NaHCO3 
(2.77 g, 0.033 mole). After the solution was stirred at room temperature for 24 h, the reaction 
mixture was concentrated, acidified with 0.5 M HCl and extracted with ethyl acetate (200 
mL). The organic layer was then washed with water three times (60 mL), dried over 
anhydrous Na2SO4, filtered and the solvent was removed under vacuum using a rotary 
evaporator. Upon addition of petroleum ether (bp 30-60 oC), a white precipitate of the 
tetrapeptide was formed which was collected. 
Yield: 95 % (8.7 g), m.p. 145-146.6 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.31 (s, 9H, C(CH3)3-Boc), 2.49-2.98 (m, 8H, CH2-
pendent), 4.28-4.42 (m, 3H, CH-backbone), 4.6-4.7 (m, 1H, CH-backbone), 4.95-5.1 (s, 4H, 
CH2-Bzl), 7.15-7.31 (m, 20H, Ar-H), 7.75-7.89 (d, 1H, NH), 8.01-8.15 (d, 1H, NH), 8.3-8.43 
(d, 1H, NH) 
Boc-Asp(OBzl)-Phe-Asp(OBzl)-Phe-OSu (8) 
 To a solution of 7 (8.0 g, 0.0097 mole) and HOSu (2.24 g, 0.0194 mole) in a 1:1 
mixture of ethyl acetate:dioxane (80 mL) at -5 oC, DCC (3.0 g, 0.015 mole) was added.  The 
mixture was stirred for 5 h at -5 oC and then left to stand overnight in a refrigerator. The 
excess DCC was decomposed by adding glacial acetic acid (2 mL). The dicyclohexyl urea 
thus produced was filtered off and the filtrate was concentrated under vacuum using a rotary 
evaporator. The viscous oil obtained was dissolved in ethyl acetate (100 mL) and more urea 
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was filtered off. The ethyl acetate solution was washed successively with 20 mL of 0.5 M 
sodium carbonate, water, 0.5 M hydrochloric acid, and water. After drying of the ethyl 
acetate layer over anhydrous Na2SO4 and removal of the solvent under reduced pressure, a 
white solid was obtained which was crystallized in isopropanol. 
Yield: 86 % (7.7 g), m.p. 74-78 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.31 (s, 9H, C(CH3)3-Boc), 2.50-3.16 (m, 8H, CH2-
pendent), 2.77 (s, 4H, CH2-Su), 4.25-4.32 (m, 1H, CH-backbone), 4.35-4.42 (m, 1H, CH-
backbone), 4.65-4.75 (m, 1H, CH-backbone), 4.82-4.90 (m, 1H, CH-backbone), 4.98-5.10 (s, 
4H, CH2-Bzl), 7.14-7.30 (m, 20H, Ar-H), 7.72-7.80 (d, 1H, NH), 8.35-8.45 (d, 1H, NH), 
8.65-8.75 (d, 1H, NH) 
H-Asp(OBzl)-Phe-Asp(OBzl)-Phe-OSu.CF3COOH (9) 
 The activated tetrapeptide 8 (7.5 g, 0.0082 mole) was dissolved in TFA (21 mL) and 
the reaction mixture was stirred for 45 min at room temperature to remove the BOC group. 
TFA was removed under reduced pressure. The solid was dissolved in anhydrous ether and 
white crystals of 9 were obtained. 
Yield: 95 % (7.2 g), m.p. 145-147 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.55-3.17 (m, 8H, CH2-pendent), 2.77 (s, 4H, CH2-
Su), 3.98-4.10 (m, 1H, CH-backbone), 4.45-4.55 (m, 1H, CH-backbone), 4.65-4.75 (m, 1H, 
CH-backbone), 4.8-4.9 (m, 1H, CH-backbone), 4.98-5.20 (m, 4H, CH2-Bzl), 7.14-7.36 (m, 
20H, Ar-H), 8.1-8.2 (br, 3H, NH3), 8.45-8.55 (d, 1H, NH), 8.55-8.65 (d, 1H, NH), 8.75-8.85 
(d, 1H, NH) 




 To a solution of 9 (7 g, 0.0075 mole) in DMSO (9.0 mL), triethyl amine (TEA, 2.1 
mL, 0.0145 mole) was added. The reaction mixture was stirred at room temperature and 
turned pale yellow and viscous within 2 days. After the mixture had been allowed to react at 
room temperature for 7 days, the mixture was triturated with ether. The precipitate was 
washed with water, methanol, and ether, and dried. 
Yield: 60 % (3.2 g).  
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.72 (br, 2H, CH2-pendent), 2.93 (br, 2H, CH2-
pendent), 4.42 (br, 1H, CH-backbone), 4.62 (br, 1H, CH-backbone), 4.98 (br, 2H, CH2-Bzl), 
7.12-7.40 (br, 10H, ArH), 7.90-8.3 (br, 2H, NH) 
Poly(Asp(OH)-Phe-Asp(OH)-Phe) (11) 
 The protected polymer 10 (1 g, 0.0014 mole) was treated with 9 mL of methane 
sulphonic acid (MSA) 31,33 in the presence of thioanisole (0.9 mL) at room temperature for 1 
hour and the mixture was triturated with ether to give a whitish precipitate. The solid was 
washed with methanol and ether and dried. 
Yield: 70 % (0.5 g)  
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.93 (br, 4H, CH2-pendent), 4.38 (br, 1H, CH-
backbone), 4.73 (br, 1H, CH-backbone), 7.15 (br, 5H, ArH), 8.55 (br, NH) 
 
2.3.2. Synthesis of poly(Asp3Phe1) 
 The sequence of this polypeptide required starting the synthesis with a tetrapeptide. 
The synthetic pathway of the tetrapeptide is illustrated in Scheme 2.4 and the synthetic steps 
are described below. Those steps which have already been described in the synthesis of the 
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alternating polypeptide have been omitted. 
 













































































 Into a solution of 4 (6.58 g, 0.0134 mole) and NaHCO3 (3.45 g, 0.041 mole) in a 
mixture of THF (75 mL) and water (75 mL) was added a solution of 1 (6.3 g, 0.015 mole) in 
THF (70 mL). The resulting solution was left to stir at room temperature for 24 h. The 
reaction mixture was concentrated, acidified with 0.5 M hydrochloric acid and extracted with 
ethyl acetate (200 mL). The organic layer was then washed three times with water (50 mL), 
dried over anhydrous Na2SO4, and filtered. The solvent was removed under vacuum. 
Petroleum ether (bp 30-60 oC) was added and the precipitate formed was collected by 
filtration and dried. 
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Yield: 93 % (8.5 g), m.p. 81.5-83 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.33 (s, 9H, C(CH3)3-Boc) 2.46-2.98 (m, 6H, CH2-
pendent), 4.25-4.40 (m, 2H, CH-backbone), 4.60-4.70 (m, 1H, CH-backbone), 4.98-5.15 (s, 
4H, CH2-Bzl), 7.13-7.45 (m, 15H, ArH), 7.90-8.10 (d, 1H, NH), 8.15-8.20 (d, 1H, NH) 
H-Asp(OBzl)-Asp(OBzl)-Phe-OH.CF3COOH (13) 
 The tripeptide 12 (5.5 g, 0.0081 mole) was dissolved in TFA (12 mL) and the reaction 
mixture was stirred for 45 min at room temperature. TFA was removed under reduced 
pressure and white crystals were obtained upon the addition of anhydrous ether. 
Yield: 75 % (4.2 g), m.p. 145.5-146.5 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.56-3.04 (m, 6H, CH2-pendent), 3.89-3.99 (m, 1H, 
CH-backbone), 4.3-4.4 (m, 1H, CH-backbone), 4.6-4.7 (m, 1H, CH-backbone), 5.00-5.15 (s, 
4H, CH2-Bzl), 7.11-7.35 (m, 15H, ArH), 8.15-8.21 (d, 1H, NH), 8.58-8.70 (br, 3H, NH3) 
Boc-Asp(OBzl)-Asp(OBzl)-Asp(OBzl)-Phe-OH (14) 
 A solution of 1 (3.7 g, 0.009 mole) in THF (45 mL) was added to a solution of 13 (3.1 
g, 0.0045 mole) in a mixture of THF (45 mL) and water (45 mL) containing NaHCO3 (1.13 
g, 0.0134 mole). After the solution was stirred at room temperature for 24 h, the reaction 
mixture was concentrated, acidified with 0.5 M hydrochloric acid, and extracted with ethyl 
acetate (200 mL). The organic layer was then washed three times with water (60 mL), dried 
over anhydrous Na2SO4, filtered and the solvent was removed under vacuum using a rotary 
evaporator. Upon addition of petroleum ether (bp 30-60 oC) a white precipitate of the 
tetrapeptide was formed which was collected. 
Yield: 95 % (3.8 g), m.p. 80.3-82 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.32 (s,  9H, C(CH3)3-Boc), 2.47-2.99 (m, 8H, CH2-
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pendent), 4.25-4.36 (m, 2H, CH-backbone), 4.55-4.68 (m, 2H, CH-backbone), 5.01-5.10 (m, 
6H, CH2-Bzl), 7.10-7.34 (m, 20H, ArH), 7.9 (d, 1H, NH), 8.1 (d, 1H, NH), 8.21 (d, 1H, NH) 
Boc-Asp(OBzl)-Asp(OBzl)-Asp(OBzl)-Phe-OSu (15) 
 N-methyl morpholine (NMM) (0.55 mL, 0.0051 mole) was added to a solution of 14 
(4.5 g, 0.0051 mole), HOSu (1.17 g, 0.0102 mole) and DCC (1.5 g, 0.0073 mole) in a 1:1 
ethyl acetate:dioxane mixture (50 mL) at -5 oC. The mixture was stirred for 5 h at -5 oC and 
then left to stand overnight in a refrigerator. The excess DCC was decomposed by adding 
glacial acetic acid (1 mL). DCU was filtered off and the filtrate was concentrated under 
vacuum. The solid obtained was dissolved in ethyl acetate and more urea was filtered off. 
The ethyl acetate solution was washed with 20 mL of water, 0.5 M HCl solution, and water 
successively. After drying of the ethyl acetate layer over anhydrous Na2SO4 and removal of 
the solvent under reduced pressure, a white solid was obtained which was crystallized in 
isopropanol. 
Yield: 80 %, (4.0 g) m.p. 99-101 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.31 (s, 9H, C(CH3)3-Boc), 2.51-3.17 (m, 8H, CH2-
pendent), 2.75 (s, 4H, CH2-Su), 4.25-4.35 (m, 1H, CH-backbone), 4.50-4.65 (m, 2H, CH-
backbone), 4.72-4.85 (m, 1H, CH-backbone), 4.95-5.05 (s, 6H, CH2-Bzl), 7.14-7.31 (m, 20H, 
ArH), 8.1-8.2 (br, 3H, NH), 8.48-8.55 (d, 1H, NH). 
H-Asp(OBzl)-Asp(OBzl)-Asp(OBzl)-Phe-OSu.CF3COOH (16) 
 A solution of 15 (4.0 g, 0.0041) in TFA (10 mL) was stirred for 45 min. After 
removing TFA, the product was precipitated by adding anhydrous ether. The crystals 
obtained were filtered off. 
Yield: 89 % (3.6 g), m.p. 105-107 oC 
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300 MHz, 1H NMR: δ (dmso-d6) ppm 2.51-3.15 (m, 8H, CH2-pendent), 2.76 (s, 4H, CH2-
Su), 4.02-4.12 (m, 1H, CH-backbone), 4.51-4.68 (m, 2H, CH-backbone), 4.71-4.81 (m, 1H, 
CH-backbone), 4.96-5.11 (s, 6H, CH2-Bzl), 7.13-7.34 (m, 20H, ArH), 8.18 (br, 3H, NH3), 
8.25-8.31 (d, 1H, NH), 8.59-8.65 (d, 1H, NH), 8.75-8.80 (d, 1H, NH) 
Mass: expected, 877, obtained: (ESI), 878 [M+1]+, -TFA group  
Poly(Asp(OBzl)-Asp)OBzl)-Asp(OBzl)-Phe) (17) 
 To a solution of tetrapeptide active ester 16 (3.6 g, 0.0036 mole) in dimethyl 
sulphoxide (3.6 mL), triethyl amine (TEA) (1.1 mL, 0.0072 mole) was added. The reaction 
mixture was stirred at room temperature and turned yellow and viscous within 2 days. After 
standing at room temperature for 7 days, the mixture was triturated with ether. The 
precipitate was washed with water, methanol, ether, and dried. 
Yield: 56.3 % (1.6 g) 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.55-3.4 (br, 8H, CH2-pendent), 4.30-5.30 (br, 1H, 
CH-backbone), 4.62-4.82 (br, 1H, CH-backbone), 5.00-5.10 (br, 6H, CH2-Bzl), 5.10-5.32 (br, 
1H, CH-backbone), 7.18-7.32 (br, 20H, ArH), 8.80 (br, NH) 
Poly(Asp(OH)-Asp)OH)-Asp(OH)-Phe) (18) 
 The protected polymer 17 (1 g, 0.0013 mole) was treated with 4.3 mL of methane 
sulphonic acid (MSA) in the presence of thioanisole (0.43 mL) at room temperature for 1 
hour and the mixture was triturated with ether to give a whitish precipitate. The solid was 
washed with methanol and ether and dried. 
Yield: 68 % (0.4 g) 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.63 (br, 4H, CH2-pendent), 2.99 (br, 4H, CH2-
pendent), 4.39 (br, 1H, CH-backbone), 4.71 (br, 1H, CH-backbone), 4.90-5.18 (br, 2H, CH-
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backbone), 7.12-7.25 (br, 5H, ArH), 8.79 (br, NH) 
 
2.3.3. Synthesis of poly(Asp2Phe1) 
 The desired polypeptide sequence required a tripeptide to be synthesized. The 
synthetic pathway is illustrated in Scheme 2.5 and the synthesis is described below. 
 
























































 To a solution of 12 (5.0 g, 0.0074 mole) and HOSu (1.28 g, 0.011 mole) in methylene 
chloride (30 mL) at -5 oC, DCC (1.83 g, 0.0089 mole) was added. The mixture was stirred for 
5 h at -5 oC and then left to stand overnight in a refrigerator. Glacial acetic acid (1 mL) was 
added to decompose the excess DCC. The solution was filtered and the filtrate was 
 77
concentrated under vacuum. The solid was dissolved in ethyl acetate (80 mL) and more urea 
was filtered off. The ethyl acetate solution was washed successively with (20 mL) water, a 
0.5 M HCl solution, and water.  After drying of the ethyl acetate layer over anhydrous 
Na2SO4 and removal of the solvent under reduced pressure, the white solid obtained was 
crystallized in isopropanol. 
Yield: 75.4 % (4.3 g), m.p. 95-98 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.33 (s, 9H, C(CH3)3-Boc), 2.52-2.73 (m, 4H, CH2-
pendent), 2.77 (s, 4H, CH2-Su), 3.01-3.20 (m, 2H, CH2-pendent), 4.28-4.35 (m, 1H, CH-
backbone), 4.59-4.70 (m, 1H, CH-backbone), 4.75-4.85 (m, 1H, CH-backbone), 4.98-5.09 (s, 
4H, CH2-Bzl), 7.10-7.33 (m, 15H, ArH), 8.1-8.2 (d, 1H, NH), 8.58-8.65 (d, H, NH) 
H-Asp(OBzl)-Asp(OBzl)-Phe-OSu.CF3COOH (20) 
 A solution of 19 (4.31 g, 0.0056 mole) in TFA (12 mL) was stirred for 45 min. After 
removing TFA with a rotary evaporator, the product was precipitated by adding anhydrous 
ether. The pale yellow crystals obtained were filtered off. 
Yield: 91 % (4.0 g), m.p. 143-146 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.53-3.38 (m, 6H, CH2-pendent), 2.77 (s, 4H, CH2-
Su), 4.00-4.12 (m, 1H, CH-backbone), 4.60-4.70 (m, 1H, CH-backbone), 4.80-4.90 (m, 1H, 
CH-backbone), 5.00-5.14 (s, 4H, CH2-Bzl), 7.16-7.36 (m, 15H, ArH), 8.10-8.30 (br, 3H, 
NH3), 8.75-8.97 (d, 2H, NH) 
Mass: expected 672, obtained: (ESI), 673 [M+1]+, -TFA group  
Poly(Asp(OBzl)-Asp(OBzl)-Phe) (21) 
 To a solution of the tripeptide active ester 20 (4.0 g, 0.0051 mole) in dimethyl 
sulphoxide (3.8 mL), triethyl amine (TEA) (1.2 mL, 0.0078 mole) was added. The reaction 
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mixture turned yellow immediately and was stirred at room temperature for 7 days. The 
mixture was triturated with ether and the precipitate was washed with water, methanol, and 
ether. 
Yield: 58.3 % (1.7 g)  
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.98 (br, 6H, CH2-pendent), 4.50 (br, 1H, CH-
backbone), 4.62-4.85 (br, 1H, CH-backbone), 5.03 (br, 4H, CH2-Bzl), 5.13 (br, 1H, CH-
backbone), 7.16-7.48 (15H, ArH), 8.66-8.80 (br, NH) 
Poly(Asp(OH)-Asp(OH)-Phe) (22) 
 The protected polymer 21 (0.8 g, 0.0014 mole) was treated with 4.7 mL of methane 
sulphonic acid (MSA) in the presence of thioanisole (0.47 mL) at room temperature for 1 
hour and the mixture was triturated with ether to give a whitish precipitate. The solid was 
washed with methanol and ether and dried. 
Yield: 64.8 % (0.4 g)  
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.98 (br, 6H, CH2-pendent), 4.50 (br, 1H, CH-
backbone), 4.76 (br, 1H, CH-backbone), 5.04-5.14 (br, 1H, CH-backbone), 7.1-7.23 (br, 5H, 
ArH), 8.60 (br, NH) 
 
2.3.4. Synthesis of poly(Asp1Phe2) 
 A tripeptide was prepared to synthesize this polypeptide. The synthetic pathway is 

















































 A solution of 3 (8.0 g, 0.022 mole) in THF (100 mL) was added to phenylalanine 
(3.32 g, 0.02 mole) dissolved in a mixture of THF (90 mL) and water (90 mL) containing 
sodium bicarbonate (3.38 g, 0.04 mole). After the solution was stirred at room temperature 
for 24 h, the reaction mixture was concentrated, acidified with 0.5 M hydrochloric acid and 
extracted with ethyl acetate (500 mL). The organic layer was then washed three times with 
water (200 mL), dried over anhydrous sodium sulphate, filtered, and the solvent was 
removed under vacuum using a rotary evaporator. Addition of petroleum ether (bp 30-60 oC) 
to the viscous oil resulted in the precipitation of the dipeptide 23 which was filtered.  
Yield: 95 % (7.9 g), m.p. 124-125.3 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.24 (s, 9H, C(CH3)3-Boc), 2.58-3.07 (m, 4H, CH2-
pendent), 4.05-4.18 (m, 1H, CH-backbone), 4.35-4.48 (m, 1H, CH-backbone), 6.82-6.85 (d, 
1H, NH), 7.13-7.27 (m, 10H, ArH), 8.07-8.09 (d, 1H, NH) 
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H-Phe-Phe-OH.CF3COOH (24) 
 The Boc group was removed by stirring a solution of 23 (7.0 g, 0.017 mole) in TFA 
(14 mL) for 45 min at room temperature. After removal of TFA under vacuum, the product 
was precipitated by the addition of anhydrous ether. The white crystals were collected in a 
quantitative yield. 
m.p. 77-78.5 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.87-3.12 (m, 4H, CH2-pendent), 3.9-4.0 (m, 1H, CH-
backbone), 4.42-4.50 (m, 1H, CH-backbone), 7.2-7.5 (m, 10H, ArH), 7.9-8.15 (br, 3H, NH3), 
8.83-8.86 (d, 1H, NH) 
Boc-Asp(OBzl)-Phe-Phe-OH (25) 
 To a solution of 24 (3 g, 0.007 mole) and NaHCO3 (1.77 g, 0.021 mole) in a mixture 
of THF (30 mL) and water (30 mL), a solution of 1 (3.25 g, 0.00774 mole) in THF (40 mL) 
was added. The reaction mixture was stirred for 24 h at room temperature.  The solution was 
concentrated under vacuum and acidified with 0.5 N HCl solution (40 mL), extracted in ethyl 
acetate (150 mL) and washed 3 times with water (50 mL). After drying the organic layer over 
anhydrous Na2SO4, the solvent was removed and the solid was obtained by adding petroleum 
ether.  
Yield: 92 % (4.0 g), m.p. 81-83.6 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.31 (s, 9H, C(CH3)3-Boc), 2.55-3.04 (m, 6H, CH2-
pendent), 4.2-4.3 (m, 1H, CH-backbone), 4.35-4.55 (m, 2H, CH-backbone), 5.03-5.06 (s, 2H, 
CH2-Bzl), 7.08-7.32 (m, 15H, ArH), 7.65-7.75 (d, 1H, NH), 8.25-8.35 (d, 1H, NH) 
Boc-Asp(OBzl)-Phe-Phe-OSu (26) 
 DCC (1.4 g, 0.0068 mole) was added to a solution of 25 (3.5 g, 0.0057 mole) and 
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HOSu (0.98 g, 0.0085 mole) in methylene dichloride (35 mL) at -5 oC. The reaction mixture 
was stirred at -5 oC for 5 h and then left overnight in a refrigerator. The reaction was worked 
up as mentioned above for 19. The active ester was obtained as a white solid.  
Yield: 84 % (3.4 g), m.p. 72-75 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.23 (s, 9H, C(CH3)3-Boc), 2.52-3.21 (m, 6H, CH2-
pendent), 2.73 (s, 4H, CH2-Su), 4.12 (m, 1H, CH-backbone), 4.71 (m, 1H, CH-backbone), 
4.8 (m, 1H, CH-backbone), 4.99-5.10 (s, 2H, CH2-Bzl), 6.8 (d, 1H, NH), 7.16-7.32 (m, 15H, 
ArH), 8.25 (d, 1H, NH), 8.71-8.73 (d, 1H, NH) 
H-Asp(OBzl)-Phe-Phe-OSu.CF3COOH (27) 
 A solution of 26 (3.4 g, 0.0048 mole) in TFA (10 mL) was stirred for 45 min. After 
removing TFA, the product was precipitated by adding anhydrous ether and filtered.  
Yield: 85 % (3.0 g), m.p. 85-87 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.55-3.19 (m, 6H, CH2-pendent), 2.77 (s, 4H, CH2-
Su), 4.01 (m, 1H, CH-backbone), 4.53 (m, 1H, CH-backbone), 4.88 (m, 1H, CH-backbone), 
5.07-5.17 (s, 2H, CH2-Bzl), 7.17-7.37 (m, 15H, ArH), 8.01 (br, 3H, NH3), 8.60-8.66 (d, 1H, 
NH), 8.90-8.96 (d, 1H, NH) 
Mass: expected, 614, obtained: (ESI), 615 [M+1]+, -TFA group 
Poly(Asp(OBzl)-Phe-Phe) (28) 
 To a solution of tripeptide active ester 27 (2.95 g, 0.0041 mole) in DMSO (4 mL), 
TEA (1.2 mL, 0.0078 mole) was added. The reaction mixture turned pale yellow 
immediately and was stirred at room temperature for 7 days.  The mixture was triturated with 
ether and the precipitate was washed with water, methanol, and ether. 
Yield: 72.7% (1.5 g)  
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300 MHz, 1H NMR: δ (dmso-d6) ppm 2.69 (br, 4H, CH2-pendent), 2.88 (br, 2H, CH2-
pendent), 4.45-4.61 (br, 3H, CH-backbone), 4.95-5.05 (br, 2H, CH2-Bzl), 7.09-7.29 (br, 15H, 
ArH), 7.86 (br, 1H, NH), 8.10 (br, 1H, NH), 8.30 (br,1H, NH) 
Poly(Asp(OH)-Phe-Phe) (29) 
 The protected polymer 28 (0.8 g, 0.0016 mole) was treated with 5.3 mL of MSA in 
the presence of thioanisole (0.53 mL) at room temperature for 1h and the mixture was 
triturated with ether to give a whitish precipitate. The solid was washed with methanol and 
ether and dried. 
Yield: 63.0 % (0.4 g) 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.69 (br, 2H, CH2-pendent), 2.88 (br, 4H, CH2-
pendent), 4.47 (br, 3H, CH-backbone), 7.16 (br, 10H, ArH), 7.68 (br, 1H, NH), 8.07 (br, 1H, 
NH), 8.22 (br, 1H, NH) 
 
2.3.5. Synthesis of poly(Asp1Phe3) 
A tetrapeptide was prepared for this polypeptide. The synthetic pathway is illustrated 



































































 A solution of 3 (6.7 g, 0.0185 mole) in THF (97 mL) was added to a solution of 24 
(7.24 g, 0.017 mole) and NaHCO3 (4.28 g, 0.051 mole) in a mixture of THF (97 mL) and 
water (97 mL). After the reaction mixture had been stirred for 24 h, it was concentrated under 
vacuum, acidified with 0.5 M HCl (30 mL), and extracted with ethyl acetate (200 mL). The 
organic layer was washed three times with water (50 mL) and then dried over anhydrous 
Na2SO4. The tripeptide was obtained as a white solid after removal of the solvent and 
precipitation in petroleum ether.  
Yield: 85 % (8.1 g), m.p. 168-170.3 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.22 (s, 9H, C(CH3)3-Boc), 2.50-3.02 (m, 6H, CH2-
pendent), 4.05 (m, 1H, CH-backbone), 4.44 (m, 1H, CH-backbone), 4.55 (m, 1H, CH-
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backbone), 6.81-6.84 (d, 1H, NH), 7.10-7.25 (m, 15H, ArH), 7.86-7.88 (d, 1H, NH), 8.33-
8.36 (d, 1H, NH) 
H-Phe-Phe-Phe-OH.CF3COOH (31) 
 A mixture of 30 (7 g, 0.0125 mole) in TFA (20 mL) was stirred at room temperature 
for 45 min. The solvent was removed under pressure and the product was precipitated after 
the addition of anhydrous ether.  
Yield: 89 % (6.4 g), m.p. 125.0-126.5 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.72-3.09 (m, 6H, CH2-pendent), 3.9-4.0 (m, 1H, CH-
backbone), 4.4-4.5 (m, 1H, CH-backbone), 4.55-4.65 (m, 1H, CH-backbone), 7.10-7.22 (m, 
15H, ArH), 7.85-8.05 (br, 3H, NH3), 8.45-8.55 (d, 1H, NH), 8.65-8.75 (d, 1H, NH) 
Boc-Asp(OBzl)-Phe-Phe-Phe-OH (32) 
To a solution of 31 (6.4 g, 0.011 mole) and NaHCO3 (2.8 g, 0.033 mole) in a mixture 
of THF (85 mL) and water (85 mL) at room temperature, a solution of 1 (7.2 g, 0.017 mole) 
in THF (85 mL) was added. The reaction was worked up as mentioned for 30 to obtain the 
tetrapeptide. 
Yield: 85 % (7.3 g), m.p. 147.4-150.0 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.30 (s, 9H, C(CH3)3-Boc), 2.53-3.06 (m, 8H, CH2-
pendent), 4.2-4.3 (m, 1H, CH-backbone), 4.35-4.52 (m, 2H, CH-backbone), 5.02 (s, 2H, 
CH2-Bzl), 7.09-7.30 (m, 20H, ArH), 7.6-7.7 (d, 1H, NH), 8.09-8.18 (d, 1H, NH), 8.28-8.38 
(d, 1H, NH) 
Boc-Asp(OBzl)-Phe-Phe-Phe-OSu (33) 
 To a solution of 32 (4.56 g, 0.0060 mole) and HOSu (1.37 g, 0.012 mole) in a 1:2 
mixture of ethyl acetate:dioxane (110 mL) at -5 oC, DCC (1.84 g, 0.009 mole) and 4-methyl 
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morpholine (NMM) (0.65 mL, 0.006 mole) was added. The mixture was stirred for 5 h at 
−5 oC and then left to stand overnight in a refrigerator. The excess DCC was decomposed by 
adding glacial acetic acid (1 mL). DCU was filtered off and the filtrate was concentrated 
under vacuum. The solid obtained was dissolved in ethyl acetate (70 mL) and more urea was 
filtered off. The ethyl acetate solution was washed successively with 0.5 M NaHCO3 (25 
mL), water, 0.5 M HCl, and water. After drying of the ethyl acetate layer over anhydrous 
Na2SO4, and removal of the solvent under reduced pressure, a white solid was obtained which 
was crystallized in isopropanol. 
Yield: 85 % (4.4 g), m.p. 127-128 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 1.30 (s, 9H, C(CH3)3-Boc), 2.55-3.24 (m, 8H, CH2-
pendent), 2.79 (s, 4H, CH2-Su), 4.15-4.25 (m, 1H, CH-backbone), 4.30-4.45 (m, 1H, CH-
backbone), 4.45-4.60 (m, 1H, CH-backbone), 4.80-4.98 (m, 1H, CH-backbone), 5.02 (s, 2H, 
CH2-Bzl), 7.05-7.35 (m, 20H, ArH), 7.55-7.65 (d, 1H, NH), 8.25-8.35 (d, 1H, NH), 8.8-8.9 
(d, 1H, NH) 
H-Asp(OBzl)-Phe-Phe-Phe-OSu.CF3COOH (34) 
The activated tetrapeptide 33 (6.5g, 0.0082 mole) was dissolved in TFA (21 mL) and 
the reaction mixture was stirred for 45 min at room temperature. After removal of TFA under 
reduced pressure, anhydrous ether was added to obtain the product as a white crystal. 
Yield: 90 % (6.0 g), m.p. 86-89 oC 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.55-3.20 (m, 8H, CH2-pendent), 2.79 (s, 4H, CH2-
Su), 3.92-4.05 (m, 1H, CH-backbone), 4.4-4.6 (m, 2H, CH-backbone), 4.80-4.92 (m, 1H, 
CH-backbone), 5.11 (t, 2H, CH2-Bzl), 7.09-7.35 (m, 20H, ArH), 8.0-8.2 (br, 3H, NH3), 8.3-
8.4 (d, 1H, NH), 8.5-8.6 (d, 1H, NH), 8.85-8.98 (d, 1H, NH) 
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Mass: expected 761, obtained: (ESI), 762 [M+1]+, -TFA group 
Poly(Asp(OBzl)-Phe-Phe-Phe) (35) 
 To a solution of the tripeptide active ester 34 (6.0 g, 0.0069 mole) in DMSO (7.0 
mL), TEA (2.0 mL, 0.013 mole) was added. The reaction mixture turned pale yellow 
immediately and was stirred at room temperature for 7 days. The mixture was triturated with 
ether and the precipitate was washed with water, methanol, and ether. 
Yield: 74.5% (3.3 g) 
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.68 (br, 2H, CH2-pendent), 2.90 (br, 2H, CH2-
pendent), 4.3-4.7 (br, 4H, CH-backbone), 5.00 (br, 2H, CH2-Bzl), 7.06-7.28 (br, 20H, ArH), 
7.85-8.30 (br, NH) 
Poly(Asp(OH)-Phe-Phe-Phe) (36) 
 The protected polymer 35 (2.0 g, 0.0016 mole) was treated with 10.3 mL of MSA in 
the presence of thioanisole (1.03 mL) at room temperature for 1 hour and the mixture was 
triturated with ether to give a whitish precipitate. The solid was washed with methanol and 
ether and dried. 
Yield: 74.3 % (1.3 g)  
300 MHz, 1H NMR: δ (dmso-d6) ppm 2.68 (br, 2H, CH2-pendent), 2.89 (br, 2H, CH2-
pendent), 4.50 (br, 4H, CH-backbone), 7.00-7.25 (br, 15H, ArH), 7.72-8.26 (br, NH) 
 
2.4. Results and Discussion 
 Each of the five peptide monomers was prepared in a similar manner in THF/water 
mixtures where NaHCO3 had been added. A Boc protected amino acid activated with 
N−hydroxysuccinimide is added to phenylalanine with a free α-carboxylic acid to insure 
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minimum racemization. DCC has been used to synthesize N-hydroxysuccinimide active 
esters, which are white/colourless crystalline compounds with good stability.19,23 The β-
carboxylic acid of the aspartic acid was protected with the benzyl group. The Boc group was 
removed selectively by using TFA and the benzyl group was eliminated after polymerization 
of the polypeptide by treatment with MSA in the presence of thioanisole.31,33 The 
polypeptides were obtained in their protonated form. 
 The polymerization of polypeptides having a well-defined sequence of repeat units of 
amino acids is typically achieved by a self-condensation of monomer peptide active esters. 
For polymerization purposes, the peptide monomers were activated at the C-terminal by 
conversion of the carboxylic acid to its succinimide ester. All of the intermediates and the 
peptide monomers were generally obtained in good yield and purity as shown by a sharp 
melting point and single spots in chromatography. Chemical shift values obtained from 1H 
NMR spectra for each intermediate and the peptide monomers agreed well with those 
expected suggesting a purity of at least 95 % for all intermediates since NMR spectroscopy 
gives a purity within a ± 5 %. The molecular weight values of the peptide monomers 
obtained by mass spectrometry were also those expected. These results indicated that all 
monomer were sufficiently pure to proceed with the polymerization. 
 The polymerization was carried out in DMSO in the presence of triethylamine after 
removing the Boc group of the activated esters using TFA. After the completion of 
polycondensation, the resulting polypeptides were isolated by precipitation from the reaction 
upon addition of diethyl ether. All signals of the 1H NMR spectra of the polypeptides 
broadened due to slower tumbling of the molecules after polymerization. The Bzl groups of 
the protected polypeptides were removed by MSA in the presence of thioanisole. The 1H 
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NMR confirmed the disappearance of the signals assigned to the protecting group after the 
cleavage reaction. Extra peaks for the NH protons observed for both the intermediates and 
the polypetides in the 1H NMRs are a direct indication that racemic forms of these 
compounds are also present. The extent of racemization was found to be too little for most of 
intermediates to determine accurately through integration of the 1H NMR spectra whereas for 
some it was found to be in the range of 10-15 %.  
Appendix A contains the 1H NMR spectra of all the intermediates, the monomer 
peptides, and the polypeptides. It also contains the mass spectra obtained for the monomer 
peptides before polymerization. Characterization of the behavior of these polypeptides in 
basic aqueous solutions is carried out in the following chapters. 
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1H NMR Spectra of intermediates, monomer peptides and polypeptides 











Boc-Asp(OBzl)-Phe-OH (2)  
BocAsp(OBzl)-OSu (1) 
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 Boc-Phe-OSu (3) 
H-Asp(OBzl)-Phe-OH.CF3COOH (4) 
 94






 H-Asp(OBzl)-Phe-Asp(OBzl)-Phe-OSu.CF3COOH (9) 
Poly(Asp(OBzl)-Phe-Asp(OBzl)-Phe) (10) 
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 Poly(Asp(OH)-Phe-Asp(OH)-Phe) (11) 
Boc-Asp(OBzl)-Asp(OBzl)-Phe-OH (12) 
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 Boc-Asp(OBzl)-Asp(OBzl)-Phe-OSu (19) 
H-Asp(OBz  l)-Asp(OBzl)-Phe-OSu.CF3COOH (20)
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 Poly(Asp(OBzl)-Asp(OBzl)-Phe) (21) 
Poly(Asp(OH)-Asp(OH)-Phe) (22) 
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 Boc-Phe-Phe-OH (23) 
H-Phe-Phe-OH.CF3COOH (24) 
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 Boc-  (25) Asp(OBzl)-Phe-Phe-OH
Boc-Asp(OBz  l)-Phe-Phe-OSu (26)
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 H-Phe-Phe-Phe-OH.CF ) 3COOH (31




B  oc-Asp(OBzl)-Phe-Phe-Phe-OSu (33)













































































































































































































































































































































































































































































































































































































 Five polypeptides were synthesized and their photophysical properties in solution were 
studied. These polypeptides had a well-defined uence and their composition was 
(AspxPhey)n with all combinations of x=1-3 and y=1 or x=1 and y=1-3. All experiments 
aiming at characterizing the photophysical properties of the polypeptides were carried out at 
pH 9.0 to ensure that they would be fully ionized. The photophysical properties of the 
polypeptides were found to depend on their phenylalanine (Phe) content. Increasing the Phe 
content led to a linear increase of the extinction coefficient, fluorescence emission intensity, 
and fluorescence average lifetime of the polyp ptides. The fine structure of the fluorescence 
spectra of Phe is lost for the polypeptides, and the emission is shifted to higher wavelength 
suggesting the formation of Phe excim te dimers. Circular dichroism spectra 
suggest that all p wn structure in 





olypeptides except (Asp1Phe3)n did not adopt any kno




lock. A water-soluble block copolymer made of a PEO and poly(glutamic acid) (PGA) has 
also been modified into a HMWSP by attaching a hydrophobic drug such as doxorubicin 
onto the PGA moiety which induces PGA to turn hydrophobic upon sufficient drug 
attachment.9 The modified PEO-b-PGA block copolymer can then self-assemble into block 
copolymer micelles where the hydrophobic core hosts the drug and the assembly is stabilized 
by the PEO chain. 
 HMWSPs where the hydrophobes are distributed throughout the polymer backbone 
are much less common examples of HMWSPs studied for drug delivery applications. The 
final structure of these copolymers falls into two main categories depending on the level of 
control achieved over the distribution of the hydrophobes along the chain. Random 
 Hydrophobically modified water-soluble polymers (HMWSPs) can generate 
hydrophobic microdomains in aqueous solution which can host hydrophobic drugs. For this 
reason, their use as drug delivery systems (DDSs) has been under intense scrutiny,1-5 
contributing another chapter to the use of polymers in drug delivery applications and leading 
some to suggest that present times are The Dawning Era of Polymer Therapeutics.6 In the 
majority of cases, block copolymer-type HMWSPs have been considered for DDSs.1,2,5,7 
Block copolymers used for DDS consist of a hydrophilic and hydrophobic block joined 
together at one end. These block copolymers self-assemble into polymeric micelles1,2,5,7 or 
vesicles8 whose hydrophobic core is stabilized by the hydrophilic corona. Poly(ethylene 
oxide) (PEO) is the hydrophilic block of choice because of its high water-solubility, low 
toxicity, and “stealth” properties towards the reticuloendothelial system.1 Poly(benzyl-L-
aspartate) or poly(caprolactone) are examples of apolar polymers used as the h
b
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incorporation of the hydrophobes along the chain can be achieved by covalently linking a 
adjust the hydrophobic-to-hydrophilic ratio, five polypeptides were 
hydrophobic pendant onto a water-soluble polymer substrate10,11 or random copolymerization 
of a hydrophobic monomer with a hydrophilic monomer.12,13 Incorporation of a hydrophobe 
at specific positions along the backbone, say every 3 monomer units, can only be achieved 
with polypeptides. Such polypeptides can be synthesized chemically by preparing a well-
defined peptide sequence of a few amino acids which is then polymerized,14,15 or via DNA 
recombinant technology.16,17 
 The ability of alternating styrene-maleic anhydride copolymers (SMA) to form small 
micelles ~2 nm in diameter that host large amounts of hydrophobic molecules and deliver 
them in a controlled manner by adjusting the ionization level of the polymer18 triggered the 
interest of this laboratory to search for biocompatible SMA analogs that might be used for 
drug delivery applications. Alternating SMAs fall into the family of HMWSPs where the 
hydrophobes are distributed in a controlled manner along the chain. The requirement of 
biocompatibility combined with the alternating structure and chemical motives of SMAs led 
to the synthesis of polypeptides made of phenylalanine (Phe) and aspartic acid (Asp). The 
benzene ring of Phe and the acid functionality of Asp were expected to mimic the structural 
motives of the styrene and maleic acid monomers found in SMA, respectively. In these 
polypeptides, Phe and Asp play the part of the hydrophobic and hydrophilic monomers, 
respectively. To 
synthesized where the Phe content was increased according to the composition sequence 
(Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n. This report describes 
the solution properties of the (AspxPhey)n polypeptides. Their associative properties are 
presented in Chapters 4 and 5. 
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3.3. Experimental 
Reagents. Poly(aspartic acid) was purchased from Sigma-Aldrich with a Mw of 24 kg.mol−1. 
NaOH (BDH) and HCl (reagent ACS grade) were supplied by Fischer and sodium carbonate 
anhydrous (ACS grade) was obtained from EMD.  Milli-Q water with a resistivity of over 18 
MΩ.cm was used to make all the aqueous solutions. Spectra/Por® 7 regenerated cellulose 
dialysis membranes having a cut-off value of 3,500 g/mol were used for dialysis. 
Preparation of the polypeptide aqueous solutions. All polypeptide solutions were prepared in 
a 0.01 M Na2CO3 solution at pH 9. Due to the poor solubility of the polypeptides in aqueous 
solution, the samples could not be prepared by directly dissolving the polypeptides into the 
0.01 M Na2CO3 solution at pH 9. Therefore, all aqueous solutions of the polypeptides were 
prepared according to the following protocol.19 A known amount of the polypeptide (~ 50 
mg) was dissolved in 10 mL of DMF. To this an aqueous solution of 0.1 M NaOH was added 
at a rate of one drop every 4 s with vigorous stirring. The solution turned cloudy as the 
polypeptide precipitated into stable aggregates. The addition of the NaOH solution was 
continued until the solution contained 30 wt% of the NaOH solution. The NaOH solution 
was used to ensure that all aspartic acids in the polypeptide were ionized. The resulting 
solution was dialyzed against a solution of 0.01 M Na2CO3 at pH 9 for 2 days. The 0.01 M 
Na2CO3 solution at pH 9 was renewed every 8 hours to remove the DMF.  
UV-Vis absorption. All UV-Vis absorption spectra were obtained with a Hewlett Packard 
8452A diode array spectrophotometer using a spectrometer cell with a 1 cm path length. The 




Massic extinction coefficients of polypeptides. To determine the actual polypeptide 
es of water, 
ugh dialysis.  
scattering. The absolute weight-average molecular weight, Mw, of the five 
olypeptides was determined using static light scattering. The refractive index increments 
concentration in the 0.01 M Na2CO3 aqueous solution at pH 9 prepared through dialysis, the 
massic extinction coefficient of the polypeptides was determined. The concentration of a 
polypeptide stock solution was determined by weighing three aliquots of the polypeptide 
stock solution and three similar aliquots of the 0.01 M Na2CO3 solution at pH 9. These 
samples were dried under a gentle flow of nitrogen. To remove any residual trac
the vials were left overnight in a vacuum oven at 60 oC. The vials were weighed and the 
average masses of the dried samples were obtained. The concentration of the polypeptide 
solution was determined by taking the difference between the solid contents of the 
polypeptide solution and that of the Na2CO3 solution. 
 Several samples were prepared by diluting the polypeptide stock solution of known 
concentration in g/L and their absorption spectrum was obtained. These spectra were baseline 
corrected for light scattering. The part of the absorption spectrum where Phe did not absorb 
(284-500 nm) was fitted with a quadratic polynomial equation which was substracted from 
the polypeptide UV-Vis spectrum. The massic extinction coefficient of each polypeptide 
expressed in g−1.L.cm−1 was retrieved from the slope of the straight line drawn by plotting the 
absorption at 260 nm versus the polypeptide concentration. These were then used to 
determine the concentration of any new polypeptide solutions prepared thro
Circular dichroism. CD spectra were acquired on a J 715 CD spectropolarimeter (Jasco) at 
25 oC with a 0.1 cm path length cell, a 100 nm/min scan rate, and a 2 nm bandwidth. Spectra 




(dn/dc) were measured at room temperature using a Brice-Phoenix differential refractometer 
equipped with a 510 nm band-pass interference filter. A Brookhaven BI-200 SM light 
scattering goniometer equipped with a Lexel 2 W argon ion laser operating at 514.5 nm was 
used for the static light scattering measurements. All light scattering experiments were done 
in DMF except for (Asp3Phe1)n for which acetone was used. The SLS tubes (VWR) were 
flamed beforehand to remove eventual scratches in the glass and then washed for 30 minutes 
in an acetone fountain to remove dust. The weight-average molecular weight was determined 
by Zimm extrapolation to zero angle and zero concentration for a series of measurements for 
8-9 solutions between 0.5 and 5.0 g/L at angles ranging from 45o to 145o. The samples were 




th /dc values used to obtain the Mw, and the second virial coefficients, A2, of the 
polypeptides by static light scattering. 
 
Table 3.1. Values for dn/dc, Mw, and A2 obtained for the polypeptides. All SLS experiments 





A   
cm3 mol/gm2 
(Asp3Phe1)n 0.142 8,500 0.0116 
(Asp2Phe1)n 0.119 9,500 -0.00441 
(Asp1Phe1)n 0.117 11,400 0.00711 
(Asp1Phe2)n 0.124 10,200 0.00779 
(Asp1Phe3)n 0.144 8,300 0.0119 
 
Steady-state fluorescence measurements. The steady-state fluorescence spectra were obtained 
using a Photon Technology International LS-100 steady-state fluorometer with a continuous 
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xenon lamp. A fluorescence cell (VWR) with an inner cross section of 10×10 mm2 was used 
in the right angle geometry and the samples were not deoxygenated. The emission spectra 
were acquired by exciting the polypeptide solutions at 245 nm. 
Time-resolved fluorescence measurements. The fluorescence decay profiles were obtained by 
a time-correlated single photon counter manufactured by IBH Ltd. using a 5000F coaxial 
nanosecond flash lamp filled with H2 gas. Samples were excited at 245 nm and the emission 
wavelength was set at 290 nm. The samples were placed in a 10×10 mm2 fluorescence cell 
(VWR). All decays were collected with the right angle geometry over 200-800 channels with 
a minimum of 20,000 counts taken at the decay maximum to ensure a high signal-to-noise 
ratio. A light scattering standard was used for the lamp profile. Analysis of the decays was 
performed by convoluting the lamp profile with a sum of typically 3 exponentials (Equation 
3.1) and comparing the convolution result with the experimental decay. 
he parameters in Equation 3.1 were optimized using the Marquardt-Levenberg algorithm. 
The quality of the fits was establ  the χ2 v 1.30) and stribution 
around zero of the residuals and o tocorrelatio tion of the res
 
3.4. Results and Discussion 
Th f the po apter 2. It involves the 
elongation of an oligopeptide made of n (n ≥ 1) amino acids (aa ) by one amino acid (a.a.) at 
the time according to the following sequence of synthetic steps: 1) activation with 
 
ix (t) = a1exp(-t/τ1) + a2exp(-t/τ2) + a3exp(-t/τ3)            (3.1) 
 
T
ished from alues (<  the random di
f the au n func iduals. 
e synthesis o lypeptides was described in Ch
n
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hydroxysuccinimide of one a.a. protected at the N-terminal with a t-BOC group, 2) coupling 
of the activated a.a. with aan to yield an oligopeptide of length n + 1 (aan+1), and 3) 
deprotection of the N-terminal of aan+1. The oligopeptide aan+1 can then be extended by 
arger charge than the 
enter of the macromolecule because the monomer density being lower towards the ends is 
less disfavorab
oes the conformation of the polyacid. In the case where the polyacid contains some 
ackbone, the 
olymer adopts a pearl-necklace conformation where collapsed neutral stretches of the 
 stretches of charged monomers. When the polyelectrolyte is 
fully c
another a.a. by iterating steps 1-3. Polymerization of the oligopeptide activated with 
hydroxysuccinimide was conducted over several days yielding polypeptides with Mw in the 
8-12 kg.mol−1 range (Table 3.1). These Mw values were determined by static light scattering 
with polypeptide solutions in DMF, except for (Asp3Phe1)n which was studied in acetone. 
The solution behavior of weak polyelectrolytes or polyacids such as the polypeptides, 
poly(L-glutamic acid), poly(L-aspartic acid) is controlled by the solution pH.20 Polyacids 
dissociate over a limited pH range.21 As a result, the total charge of the chain can be tuned by 
adjusting the pH of the solution. In turn, this effect leads to an inhomogeneous charge 
distribution along the backbone. The chain ends are predicted to bear a l
c
le from an energy point of view.21 As the charge density evolves with pH, so 
d
hydrophobic monomers such as the (AspxPhey)n polypeptides, the following sequence of 
conformations is expected as a function of pH.22 When the backbone exhibits few charges, 
the polymer coil is a collapsed globule. As more charges are added onto the b
p
polyelectrolyte are separated by
harged and if the electrostatic repulsion overcomes the van der Waals associations 
between the hydrophobic monomers, the polyacid adopts a stretched rod-like conformation. 
In view of this, all experiments were performed at pH 9 to ensure that the polypeptides of 
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(AspxPhey)n series would be all in the same fully ionized conditions.20 
 Although the small extinction coefficient (εPhe = 200 M−1.cm−1 at 258 nm)23,24 and 
low quantum yield (φF(Phe) = 0.04)24 of Phe make it almost impossible to detect by 
fluorescence in proteins that contain other aromatic amino acids,25 the large Phe content of 
the (AspxPhey)n polypeptides implies that their photophysical properties reflect those of the 
Phe residues. Consequently the absorption and fluorescence of (AspxPhey)n solutions were 
characterized. The absorption spectra of polypeptides in 0.01 M Na2CO3 solution at pH 9 
were a
 
cquired for 10 polypeptide concentrations ranging from 0.1 to 1.2 g/L. Typical 
absorption spectra of the polypeptide solutions are shown in Figure 3.1 for a polypeptide 
concentration of 0.5 g/L.  As the Phe content of the polypeptide increases, so does its 
absorption. This result is reasonable since the Phe monomer absorbs at 260 nm, but not the 
Asp residue. Interestingly, the general features of the absorption spectrum of Phe are also 
observed for the polypeptides, but shifted by about 2 nm (also the resolution of the 
spectrophotometer). Phe exhibits absorption maxima at 252, 258, and 264 nm whereas the 
polypeptide solutions have absorption maxima at 254, 260, and 266 nm. At wavelengths 
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Figure 3.1. Absorption spectra of the 0.05 g/L polypeptide solutions in 0.01 M Na2CO3 






solution at pH 9. Solid lines from bottom to top: (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, 
A plot of the absorption at 260 nm as a function of polypeptide concentration in g.L  
for a given polypeptide resulted in a straight line passing through the origin. The slope of this 
straight line yielded the massic extinction coefficient of the polypeptides, εm, expressed in 
L.g .cm . As the Phe content of the polypeptide increased in the sequence (Asp3Phe1)n, 
(Asp Phe ) , (Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n, εm increased taking values of 0.52, 
−1, respectively. If x represents the mole fraction of Phe in the 
ven in Equation 3.2 is expected to hold between the massic, 
εm, and molar, εM, extinction coefficients. 
 
  
0.59, 0.91, 1.07, and 1.25 g.L








            (3.2) 
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In Equation 3.2, ξ represents the Phe content of the polypeptides expressed in moles of Phe 
per grams of polypeptide. A plot of εm as a function of ξ is shown in Figure 3.2. A straight 
line is obtained whose slope yields the molar extinction coefficient equal to 230 ± 15 
L.mol−1.cm−1. This extinction coefficient is in the range expected for Phe found to equal 
202 L.mol−1.cm−1 in a 0.1 M NaCl solution.23 The difference in extinction coefficient might 
be due to the presence of ground-state Phe dimers in the polypeptide aqueous solutions 
induced by the high local concentration of hydrophobic Phe residues. The εM value of 
230 ± 15 L.mol−1.cm−1 agrees with that of 224 L.mol−1.cm−1 found for random copolymers of 
of the polypeptides as a function of phenylalanine content, ξ. 
 
lthough the polypeptide solutions absorb most strongly at 260 nm, the fluorescence 
 by exciting the solutions at 245 nm. This absorptio  
wavelength was selected to minimize light scattering leaking into the fluorescence signal 
rough the slits of the monochromator when the solutions were excited at 260 nm. The 
Phe and Glu.13 
 































spectra and decays were acquired n
th
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fluorescence spectra are shown in Figure 3.3 for 0.05 g/L polypeptide samples in 0.01 M 
Na2CO3 solution at pH 9. The low polypeptide concentration ensured that the inner filter 
effect could be neglected (OD < 0.07). 
The data shown in Figure 3.3 indicate that as the Phe content of the polypeptide 
increases, so does the fluorescence intensity at 290 nm. The fluorescence spectra of the 
polypeptides have lost the fine resolution of the fluorescence spectrum of Phe with peaks at 
275, 281, and 288 nm. They also appear to have shifted to higher wavelengths with a 
maximum around 290 nm compared to 281 nm for Phe. At wavelengths larger than 340 nm 
where Phe does not emit, all polypeptides emit. These observations suggest that a Phe 
er or ground-state dimer is present in solution. The excimer of an aromatic molecule 
emits usually at wavelengths longer than those of the monomer fluorescence.26 




















Figure 3.3. Solid lines: fluorescence spectra of 0.05 g/L polypeptide solutions in 0.01 M 
Na CO  solution at pH 9. From bottom to top: (Asp Phe ) , (Asp Phe ) , (Asp Phe ) , 
(Asp1Phe2)n, and (Asp1Phe3)n.  Dashed line is for L-phenylalanine ([Phe] = 2.8 × 10−3 
mol.L ). ex = 245 nm. 
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 The intensity of the polypeptide fluorescence spectra shown in Figure 3.3 was 
integrated over 287-289 nm. If the increase in the fluorescence intensity, IF, is the result of 
the increased Phe content, then IF is expected to increase linearly with the molar 
concentration of Phe. If m is the polypeptide concentration in g/L, then IF should be 
proportional to [Phe] in mol.L−1 with a proportionality constant α according to Equation 3.3: 
 






][   (3.3) 
 
ξ is the Phe content of the polypeptide expressed in mol.g−1. A plot of IF versus ξ is given in 
Figure 3.2. According to Figure 3.2, both the extinction coefficient and the
F
 fluorescence 
intensity of the polypeptides increase linearly with the Phe content of the polypeptides. 
 The fluorescence decays of 0.5 g/L polypeptide samples in 0.01 M Na2CO3 solution 
at pH 9 were acquired using excitation and emission wavelengths of 245 and 290 nm, 
respectively. The decays of (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, (Asp1Phe2)n, and Phe are 
shown in Figure 3.4. The inset of Figure 3.4 shows the decays of (Asp1Phe1)n, (Asp1Phe2)n, 
and (Asp1Phe3)n.  Phe in 0.01 M Na2CO3 solution at pH 9 exhibits a biexponential decay with 
a number-average lifetime of 4.8 ns. Phe is shorter-lived than any of the polypeptides. All 
polypeptides display a multiexponential decay which required three exponentials to fit. The 
decay times, pre-exponential factors, and χ2 obtained from the analysis of the decays are 
listed in Table 3.2. The early part of the polypeptide decay is similar to that of Phe 
suggesting that some Phe monomers remain isolated on the polypeptide. However the 
fluorescence decays of all polypeptides indicate that a longer-lived species is present in 
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solution, and that the contribution of that species increases with Phe content up to 
(Asp1Phe2)n. (Asp1Phe3) exhibits a fluorescence decay which is slightly shorter-lived than 
(Asp1Phe2)n (see inset in Figure 3.4), but still longer-lived than (Asp1Phe1)n and the 
polypeptides with a smaller Phe content. This longer-lived species is attributed to the 
presence of a Phe excimer or ground-state dimer. 
 
Figure 3.4. Solid lines: Fluorescence decays of 0.5 g/L polypeptide solutions in 0.01 M 
Na2CO3 solution at pH 9.  From bottom to top: (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, and 
−3 −1





































Table 3.2. Pre-exponential factors, decaytimes, and χ2 values obtained from the fit of the 











L-Phe 2.6 0.29 5.8 0.71 − − 4.8 1.20 
(Asp3Phe1)n 1.0 0.32 5.6 0.39 13.2 0.28 6.2 1.06 
(Asp2Phe1)n 1.4 0.23 5.6 0.41 13.1 0.36 7.3 1.16 
(Asp1Phe1)n 1.5 0.26 6.0 0.42 14.8 0.33 7.8 1.16 
(Asp1Phe2)n 1.5 0.32 6.4 0.32 17.6 0.36 8.8 1.30 
(Asp1Phe3)n 1.8 0.27 7.2 0.38 16.9 0.34 9.0 1.20 
 
 
 A plot of the number-average lifetime of the polypeptides, <τ>, versus Phe content is 
shown in Figure 3.5. As expected from Figure 3.4, <τ> increases with increasing ξ. It 
intercepts the Y-axis at a <τ> value of 4.8 ± 0.3 ns. This value is the number-average lifetime 
of the Phe monomer found to equal 4.8 ns. As expected, the polypeptides with lower Phe 
ontent reflect the behavior of the Phe monomer. c
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Figure 3.5. Number-average lifetime of the polypeptides in 0.01 M Na2CO3 solution at pH 9 
 
 The CD spectra of the polypeptide solutions were acquired from 195 to 250 nm. The 
CD spectra of the (Asp Phe ) , (Asp Phe ) , (Asp1Phe1)n, (Asp1Phe2)n polypeptides did not 
yield any of the characteristic features of a β−sheet (minimum at 220 nm)27 or α−helix 
(minima at 208 and 222 nm, maximum at 192 nm).28 They did not exhibit the features of a 
random coil conformation (small maximum at 215 nm, minimum at 197 nm).27 At this stage, 
the structure of these polypeptides in solution remains unknown. On the other hand, the CD 
spectrum of (Asp1Phe3)n displays the features of an α−helix with minima at 205 and 217 nm. 
Poly(aspartic acid) which should adopt a random coil conformation at pH 920 had a minimum 
at 203 nm. 
as a function of Phe content. 



























































Figure 3.6. Circular dichroism spectra of the polypeptides in 0.01 M Na2CO3 solution at pH 
3 n 2 1 n 1 1 n 1 2 n
(Asp Phe ) . Dashed line: Poly(Asp). 
 
 Whereas contiguous stretches of Phe induce α−helix formation,29-31 poly(Asp) adopts 
a random coil conformation in basic aqueous solution.20 The incorporation of Phe and Asp 
inside a same polypeptide provides a means to compare the strength of Phe to induce α−helix 
formation against the strength of Asp to induce a random coil formation. According to the 
CD spectra shown in Figure 3.6, a Phe to Asp ratio of 3:1 is necessary to induce α−helix 
formation. 
9. Thin solid lines: (Asp Phe1) , (Asp Phe ) , (Asp Phe ) , (Asp Phe ) . Thick solid line: 
1 3 n
Lower Phe:Asp ratios result in CD responses which demonstrate the absence of 
 133
α−helix. The study of polypeptides having a larger Phe:Asp ratio is complicated by the 
increased hydrophobicity of the polypeptide which limits its solubility in aqueous solution. 
 
3.5. Conclusions 
 The synthesis (in Chapter 2) and the solution properties of a series of polypeptides 
have been presented. The polypeptides consist of well defined repeating sequences of Phe 
and Asp with Phe:Asp ratios of 0.33, 0.5, 1.0, 2.0, and 3.0. Phe being hydrophobic and Asp 
being hydrophilic in basic aqueous solutions, these polypeptides are amphiphilic polymers 
and their associative properties in basic aqueous solutions will be described in Chapters 4 and 
5. In Chapter 3, the photophysical properties of the polypeptides were investigated. They 
were found to depend strongly on the Phe content of the polypeptide. Molar extinction 
coefficient (Figure 3.2), fluorescence emission intensity (Figure 3.2), and fluorescence 
average lifetime (Figure 3.5) increased linearly with the Phe content of the polypeptides. The 
uorescence spectra of the polypeptides were shifted to the red when compared to the 
duces the formation of Phe ground-state dimers. CD was used to infer the conformation 
fl
fluorescence spectrum of Phe. The polypeptides were longer-lived than Phe. These 
observations suggest that the high local Phe concentration inside the polypeptide coils 
in
adopted by the polypeptides. For Phe:Asp ratios lower than 3, the polypeptides displayed no 
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The behavior of an alternating polypeptide of aspartic acid and phenylalanine 
(Asp1Phe1)n was studied in solution by performing quenching and non-radiative energy 
transfer (NRET) fluorescence experiments. Dynamic light scattering (DLS) was used to 
complement the results obtained by fluorescence. The fluorescence quenching experiments 
where the chromophore pyrene was either covalently attached onto the polypeptide or 
physically bound to the polypeptide via hydrophobic interactions demonstrated that the 
chromophore was less accessible to its surrounding. Restricted accessibility of pyrene to the 
solvent was most pronounced when pyrene was not attached to the polypeptide since the 
fluorescence quenching experiments showed protective quenching. The absence of NRET 
be e 
conclusion that (Asp1Phe1)n generates cular polymeric micelles. The small 
ount of polypeptide aggregation was further confirmed from the substantial reduction in 
e light scattered by the filtered polypeptide solutions. The filtration experiments also 
emonstrated that molecular pyrene targets the hydrophobic domains generated by the few 
olypeptide aggregates present in solution. 
.2. Introduction 
Amphiphilic polymers (APs) are polymers made up of hydrophilic and hydrophobic 
arts, which can self-assemble into objects which often have sizes in the nanometer range, 
ch as micelles,1,2 vesicles,3 and fibers4 in organic solvents or aqueous solutions. The self-
ssembly of APs into large polymeric structures has led to their use in numerous applications 
ch as associative thickeners in paints,5 crosslinking agents in smart gels,6 or the building 














blocks of polymeric micelles whose interior can be loaded with drugs.7 Most of the studies 
on self-
 large number of fluorescence techniques which 
ave been designed to probe almost all aspects of polymeric systems.20,21 A variety of probes 
has been coined as being “by far the most frequently used dye in 
assembling systems and their applications have focused on hydrophobically modified 
polymers (HMPs).8-12 The synthesis of these amphiphilic polymers can be achieved either by 
block copolymerization where one block is water−soluble poly(ethylene oxide) (PEO) and 
the other is not such as polystyrene (PS), poly(propylene oxide) (PPO), or poly(L-amino 
acids)1,13 by grafting onto the water-soluble polymer backbone bulky hydrophobes such as 
long alkyl chains,14 cholesteryl pendants,15 or cholic acid,16,17 or by random copolymerization 
of a water soluble monomer with a hydrophobic comonomer.18,19 
 The characterization of polymeric aggregates in solution is usually accomplished by a 
combination of several techniques such as fluorescence,20,21 dynamic light scattering,22 small 
angle X-ray scattering,23 small angle neutron scattering,24,25 electron microscopy,4,26 and 
NMR.27,28 Among these, fluorescence has been used extensively to gain structural 
information on polymeric aggregates at the molecular level.20,21 This is due to the high 
sensitivity of fluorescence, the small size of the fluorescent probe which can report on 
molecular sized domains, the strong structural dependence of most fluorophores on their 
local environment, and the availability of a
h
can be used, but pyrene 
fluorescence studies of labeled polymers”.29 Pyrene has been used to study amphiphilic 
polymers in aqueous solution by taking advantage of its hydrophobicity which enables its 
favourable partition in the hydrophobic domains generated by the APs, or by covalent 
labeling of the AP. 
 In comparison to the extensive research performed on APs, very little attention has 
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been paid to the self-assembly of APs having well defined repeat units of hydrophobic and 
hydrophilic monomer residues. This situation results certainly from the more demanding 
synthetic skills required to prepare such APs. One such study was carried out on the self-
assembly of copolymers of styrene and maleic anhydride (SMA).30 The alternating SMA 
copolymers were shown to associate in aqueous alkaline solutions into small spherical 
polymeric aggregates 3.4 nm in diameter. These aggregates exhibit hydrophobic 
microdomains made of the styrene monomers, which are stabilized by the carboxylate anions 
generated by the hydrolyzed maleic anhydride.  
 The interior of the SMA aggregates can solublize large quantities of hydrophobic 
compounds such as pyrene, anthracene, or phenanthrene.30 The rate of release of these 
hydrophobic compounds from the hydrophobic microdomains of SMA is very slow, 103-104 
times slower than that from typical surfactant micelles such as those of sodium dodecyl 
sulfate (SDS). The hydrophobic interior of the SMA aggregates was shown to be extremely 
rigid. The slow rates of release exhibited by the SMA aggregates would have made them 
ideal candidates as carriers for drug delivery applications had it not been for their lack of 
biocompatibility, which prevents their use in physiological environments. If the slow, 
controllable rate of release of hydrophobic compounds from the hydrophobic interior of 
SMA aggregates were due to the sequence of alternating hydrophobic and hydrophilic 
monomers, it would be worthwhile to undertake the synthesis of a biocompatible amphiphilic 
polymer where the hydrophobic and hydrophilic monomers could be incorporated into the 
backbone in a controlled manner. Such polymers could become a valuable addition to the 
arsenal of carriers used for drug delivery applications.31 
In view of the inherent biocompatibility of polypeptides and the ability to control 
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their sequence via synthetic routes,32-34 the structure of a polypeptide was designed with an 
alternating sequence of amino acids having a chemical structure that would mimic that of the 
styrene and maleic acid monomers constituting the SMA backbone. Phenylalanine (Phe) was 
chosen to replace styrene since both contain an aryl pendant. Maleic acid was substituted 
with an aspartic acid (Asp). The structure of the alternating polypeptide (Asp1Phe1)n is shown 
in Figure 4.1 together with that of SMA. 
 
 
  SMA       Polypeptide 
Figure 4.1. Comparison of the structure of SMA and (Asp1Phe1)n. 
 
 Under basic conditions, (Asp1Phe1)n is negatively charged and is water-soluble. The 
ability of the hydrophobic Phe residues to induce the formation of hydrophobic domains 
intra- or intermolecularly was investigated by fluorescence quenching and non-radiative 
energy transfer (NRET). The fluorescence study was complemented by dynamic light 
scattering (DLS) experiments. The results obtained by the combination of these techniques 
suggest that (Asp1Phe1)n forms essentially unimolecular micelles generated through intra-
























UV-Vis absorption. All UV-Vis absorption spectra were obtained with a Hewlett Packard 
8452A diode array spectrophotometer using an absorption cell with a 1 cm path length. The 
resolution of the spectrophotometer equals ± 2 nm. 
Circular dichroism. CD spectra were acquired on a J 715 CD spectropolarimeter (Jasco) at 
25 oC with a 0.1 cm path length cell, a 100 nm/min scan rate, and a 2 nm bandwidth. Spectra 
ere an average of 10 scans from 190 to 250 nm. 
Dynamic light scattering.  Dynamic light scattering measurements were carried out on a Zeta 
Sizer, NanoZS (Malvern Instrument, England). The analysis was performed at a laser 
wavelength of 633 nm, a scattering angle of 173o, and at a temperature of 25 oC. Solutions 
were filtered prior to data acquisition through a 0.2 μm pore size Supor® Membrane (Life 
Science) filter. For each sample, the mean diameter and standard deviation of the particles 
on spectra were obtained 
sing a Photon Technology International LS-100 steady-state fluorometer with a continuous 
peak at 385 nm (slit 
idth = 1 nm). Polypeptides labeled with naphthalene for the energy transfer experiments 
w
present in solution were calculated by applying the multimodal analysis.  
Steady-state fluorescence measurements. The steady-state emissi
u
xenon lamp. A fluorescence cell (VWR) with an inner cross section of 10×10 mm2 was used 
in the right angle geometry and the samples were not deoxygenated. The emission spectra of 
the samples containing pyrene were acquired by exciting the solutions at their maximum 
absorption, either 338 nm when pyrene was present as a free probe or 346 nm when pyrene 
was covalently attached to the polypeptides. The intensity of the first peak of the pyrene 
monomer, I1, was taken to be the intensity of the peak at 374 nm. The intensity of the third 
peak of the pyrene monomer, I3, was taken to be the intensity of the 
w
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were excited at 290 nm where pyrene absorbs little. 
nce measurements. The fluorescence decay profiles were obtained by 
whether pyrene was used as a free probe 
ngth at 370 nm and 495 nm were used to 
 references for the 
Time-resolved fluoresce
a time-correlated single photon counter manufactured by IBH Ltd. using a 5000F coaxial 
nanosecond flash lamp filled with H2 gas. Samples were excited at either 338 nm or 344 nm, 
respectively (maximum absorption), depending on 
or covalently attached to the polypeptide. The emission wavelength was set at 374 and 510 
nm for the pyrene monomer and excimer, respectively. To reduce the noise stemming from 
stray scattered light, filters with a cut off wavele
acquire the monomer and excimer decays, respectively. All samples were placed in a 10×10 
mm2 fluorescence cell (VWR). All decays were collected with the right angle geometry over 
200-800 channels with a minimum of 20,000 counts taken at the maximum of both the 
monomer and excimer decays to ensure a high signal-to-noise ratio. Deoxygenated solutions 
of PPO [2,5−diphenyloxazole] in cyclohexane (τ = 1.42 ns) and BBOT [2,5−bis(5−tert-
butyl−2−benzoxazolyl)thiophene] in ethanol (τ = 1.47 ns) were used as
monomer and excimer, respectively. The references were necessary to determine the true 
instrument response function of the IBH fluorometer according to the MIMIC method.35 All 
measured decays were deconvoluted from the lamp profile and were fitted with a sum of 
three exponentials according to Equation 4.1 where the index x represents either the 
monomer (M) or the excimer (E).  
 
ix (t) = ax1exp(-t/τx1) + ax2exp(-t/τx2) + ax3exp(-t/τx3) x = M, E            (4.1) 
 
The parameters of the fits were optimized using the Marquardt-Levenberg algorithm.36 The 
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quality of the fits was established from the χ2 values (< 1.30) and the random distribution 
around zero of the residuals and of the autocorrelation function of the residuals. 
4
1 1 n  
2
mole) was added and the reaction was carried out under vigorous stirring for 5 hours.  The 
reaction mixture was transferred to a dialysis bag having a molecular weight cut-off of 3,500 
MW and dialyzed against slightly acidic, basic, and neutral water in successive steps for 2 
days each. The dialyzed solution was removed from the dialysis bag and water was removed 
under a stream of nitrogen. The solid obtaine
diethyl ether and collected. This procedure was repeated 3-4 times and the solid obtained was 
Reagents. Pyrene, 1-pyrenemethylamine hydrochloride, 1−pyrenebutyric acid N−hydroxy 
succinimide ester, 1−naphthalenemethylamine, (1−ethyl−3−(3−dimethylaminopropyl) 
carbodiimide hydrochloride (EDC), and nitromethane were all purchased from Sigma-
Aldrich. THF and DMF (distilled in glass, Caledon), NaOH (BDH), HCl (reagent ACS 
grade, Fischer), methanol, anhydrous diethyl ether and acetone (all HPLC grade, EMD) were 
used as received. Milli-Q water with a resistivity of over 18 MΩ.cm was used to make all the 
aqueous solutions. Spectra/Por® 7 regenerated cellulose dialysis membranes having a cut-off 
value of 3,500 g/mol were used for dialysis. Pyrene was purified by recrystallization from 
ethanol three times, whereas 1−pyrenemethylamine (PyMeNH2) was obtained from the 
neutralization of 1−pyrenemethylamine hydrochloride with NH OH in water, extraction into 
hexane, and washing and drying over NaOH pellets prior to use.37 
Random labeling of polypeptides.  A small amount of (Asp Phe )  (40 mg, 1.53 × 10−4 mole
of Asp) was weighed in a 20 mL vial in which 8 mL of DMF was added. The solution was 
stirred. To this solution, 1.77 mg (7.65 × 10−6 mole) of PyMeNH  was added and stirred 
vigorously for approximately 10 min. An equivalent amount of EDC (1.47 mg, 7.65 × 10−6 
28
d was dissolved in DMF and precipitated in 
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dried under vacuum yielding a sample of (Asp1Phe1)n randomly labeled with pyrene 
(RPy−(Asp1Phe1)n).  
 Poly(aspartic acid) was also randomly labeled with pyrene to yield RPy−Aspn−229 
Figure 4.2. Random labeling of pyrene along the polypeptide chain 
using a slightly modified procedure. After dialysis, the polypeptide is obtained in its salt 
form. Whereas the salt of (Asp1Phe1)n was soluble in DMF thanks to the hydrophobic Phe, 
poly(aspartic acid) was not. Consequently, poly(aspartic acid) was acidified with 1 M HCL 
before disolution in DMF and precipitation with diethyl ether. The same procedure used for 
pyrene labeling was followed to randomly label (Asp1Phe1)n and poly(aspartic acid) with 1-
naphthalenemethylamine. 
End labeling of the polypeptides. A solution of (Asp1Phe1)n (40 mg, 3.1 × 10−6 mole of chain 
ends as calculated from Mw given in Table 3.1), 1-pyrenebutyric acid N-hydroxy succinimide 
ester (3.6 mg, 9.3 × 10−6 mole) and NaHCO3 (1.6 mg, 0.019 mole) in 8 mL of DMF was 

































dialysis bag with a 3500 MW cut-off and was dialyzed and purified as mentioned for the 
random labeling reaction to yield the pyrene end-labeled polypeptide (EPy−(Asp1Phe1)n). 
Determination of the pyrene and naphthalene contents. The pyrene content (λpy) of the 
1−pyrenebutyric acid N-hydroxy succinimide ester in DMF (εPy = 38,000 mol−1.L.cm−1 at 344 
nm)40 were used for RPy−(Asp1Phe1)n and EPy−(Asp1Phe1)n, respectively. 
 
 Absorbance = εPy [Py] L    (4.2) 
 
In Equation 4.2, L is the cell path length which equals 1 cm. The pyrene content, λPy, was 
calculated using Equation 4.3, 
 
pyrene-labeled polypeptide was determined by measuring the absorbance of a carefully 
weighed amount of the labeled polypeptide in a known volume (V) of DMF. As DMF is a 
good solvent for pyrene, no significant pyrene-pyrene interactions are expected, resulting in 
negligible distortion of the pyrene absorbance. The pyrene concentration [Py] in mol.L−1 was 
calculated using the Beer-Lambert law given in Equation 4.2. The extinction coefficient of 





=λ      (4.3) 
 
 (mol.g−1). To determine 
 the ex
−1 −1 40
where λPy is expressed in moles of pyrene per gram of polypeptide
the naphthalene content (λNp) of RNp−(Asp1Phe1)n, tinction coefficient of 
1−naphthalenemethylacetamide in DMF was used (εNp = 6,500 mol .L.cm at 284 nm).  
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 The chromophore content (λPy or λNp) of the polypeptide can be used to determine the 
fractions of labeled amino acids (XTotal) and aspartic acids (XAsp). 
 
    
[ ]
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In Equations 4.4 and 4.5, x and y represent the molar fractions of Asp and Phe constituting 
the polypeptide, λ  represents the chromophore content expressed in mol.g−1, M  and 
M  are the molar mass of Phe (147 g.mol−1) and chromophore-labeled Asp (328 g.mol−1 
and 254 g.mol−1 for pyrene and naphthalene labeled Asp) incorporated in the polypeptide. 
The two values of 115 and 137 g.mol−1 for MAsp were used depending on whether the 
polypeptide taken to measure the chromophore content was originally in its acid or salt form. 
More precisely, poly(aspartic acid) was used in its acid form whereas (Asp1Phe1)n was used 
in its salt form. 
 For the samples where pyrene was used as a non-covalent probe, the pyrene 
concentration was determined by adding a 0.1 M SDS solution to the polypeptide solution 
loaded with pyrene, measuring the absorbance of the solution, and applying Beer-Lambert 
law (Equation 4.2) knowing that the extinction 
ol−1.L.cm−1 at 338 nm.40 Table 4.1 gives the dye content of the labeled polypeptides.  
 
   (4.5) 
D Phe
Asp−D




Table 4.1. Pyrene and naphthalene contents (λPy, λNp) in moles of chromophore per gram of 
polymer and the molar fraction of labeled aspartic acids (XAsp) and of amino acids (XTotal) in 




λ (μmol/g) XTotal mole% XAsp mole% 
RPy−(Asp)n−229* 229 2.8 2.8 
RPy−(Asp1Phe1)n−70 70 2.0 1.0 
RPy−(Asp1Phe1)n−132 132 1.9 3.8 
RPy−(Asp1Phe1)n−221 221 3.3 6.6 
EPy−(Asp1Phe1)n−44 44 − 1.2 
RNp−(Asp) −180* 180 2.1 2.1 n
RNp−(Asp Phe ) −195 195 5.7 1 1 n 2.8 
RNp−(Asp1Phe1)n−313 313 4.6 9.2 
 
* For (Asp)n, XTotal = XAsp since all amino acids are aspartic acid. 
 
Preparation of the aqueous solutions of polypeptides. Polypeptide samples were prepared 
indirectly using DMF as the solvent for the solubilization of the polypeptides after which 
0.01 M NaOH was added dropwise up to 30 w % with vigorous stirring to induce the 
formation of the polypeptide aggregates.41 The polypeptide solutions were transferred to 
dialysis bags and dialyzed against 0.01 M Na2CO3 solution at pH 9 for 2 days to remove all 
traces of DMF. P
t
yrene was added to the unlabeled polypeptide solution in DMF when pyrene 
 
was used as a free probe before being dialyzed against a 0.01 M Na2CO3 solution at pH 9 
saturated with pyrene. Figure 4.3 shows the three different types of samples prepared with 
(Asp1Phe1)n and pyrene.  
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A-Molecular pyrene used as a probe 
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C-Polypeptide end-labeled with pyrene: EPy−(Asp1Phe1)n 
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4.4. Results and Discussion 
Most proteins and polypeptides have an intrinsic fluorescence caused by the presence 
f aromatic side chains. Out of the 20 naturally occurring amino acids, three bear aromatic 
, and phenylalanine. Tryptophan and tyrosine have very 
similar quantum yields, whereas the fluorescence of phenylalanine is so weak that it can only 
be observed in polypeptides lacking both tryptophan and tyrosine.42 However the alternating 
polypeptide (Asp1Phe1)n has such a high phenylalanine content that it exhibits substantial 
fluorescence. Its photophysical properties and those of other polypeptides have been 
described in Chapter 3. 
circular dichroism (CD) since CD can assess whether a polypeptide exists as an α-helix, a β-
 coil. The CD spectra of (Asp1Phe1)n, RPy−(Asp1Phe1)n−132, (Asp)n, and 
Py−(Asp)n−229 were acquired in a 0.01 M Na2CO3 solution at pH 9, to determine the 
condary structure of the polypeptides (Figure 4.4). The comparison was done to ensure that 
yrene does not induce any drastic conformational change of the polypeptide. 
Negatively charged poly(aspartic acid) at pH 9 is known to adopt a random coil 
onformation,43 and a right handed α-helical conformation is observed for phenylalanine 
locks present in copolymers of aspartic acid and phenylalanine in alkaline solutions.44-46  
lalanine to the conformation of a 
polypeptide make it difficult to predict the conformation of (Asp1Phe1)n where both amino 
acids alternate. The CD spectra of the unlabeled and pyrene-labeled (Asp1Phe1)n are shown in 
Figure 4.4A. They are noisy and do not exhibit the expected features of an α-helix, a β-sheet, 
or a random coil (Figure 1.13) which suggests that the labeled and unlabeled (Asp1Phe1)n 
o
groups. They are tryptophan, tyrosine
The conformations of polypeptides in solution have been studied extensively by 






The opposite effects conferred by aspartic acid and pheny
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adopt no well defined conformation in aqueous solution. The CD spectrum of poly(L-aspartic 
acid) exhibits a minimum at 205 nm in Figure 4.4B, suggesting a random coil conformation. 
In both Figures 4.4A and B, the CD spectra of the pyrene-labeled polypeptides resemble that 
of the naked polypeptides, indicating that the pyrene label does not induce the formation of 
undesirable secondary structures for both (Asp1Phe1)n and (Asp)n  
F
[Polypeptide] = 0.1 g/L and (Asp) , [Polypeptide] = 0.25 g/L. The labeled samples were 
 
Since Dynamic Light Scattering (DLS) yields the hydrodynamic diameters of 
particles in solution, DLS experiments were conducted on the polypeptide solutions to 
investigate whether (Asp1Phe1)n would aggregate in solution. DLS experiments were carried 
 
igure 4.4. CD spectra of unlabeled ( ) and labeled ( ) (Asp1Phe1)n (A) and 
(Asp)n (B) in a 0.01 M Na2CO3 solution at pH 9 in a 0.1 cm path length cell. (Asp1Phe1)n, 
n




















































































































out on 0.05 g/L and 0.5 g/L solutions of (Asp1Phe1)n, EPy−(Asp1Phe1)n, RPy−(Asp1Phe1)n, 
and (Asp1Phe1)n with molecular pyrene. The size distribution of the species present in the 
polypeptide solutions are represented in Figure 4.5A, B, and C using, respectively, the light 
scattering intensity, the number of particles, and the particle volume to determine the 
contribution of each species to the histograms. A summary of the peak diameters and 
 The difference observed between the size distribution profiles obtained by numbers, 
volumes, and intensities can be rationalized by the fact that smaller particles scatter much 
less light than larger ones. Thus if a population of particles contains a small fraction of large 
particles, these large particles contribute a large fraction of the total light scattered by the 
solution. Consequently the presence of the large particles is detected from their contribution 
to the total light scattered, although they are present in too small a number to appear in a size 
histogram generated by either numbers or volumes. The DLS results
standard deviations is provided in Table 4.2. The size distribution profile determined from 
the scattering intensities for (Asp1Phe1)n, EPy−(Asp1Phe1)n, and RPy−(Asp1Phe1)n exhibit 
two contributions: one peak in the 4-8 nm range attributed to individual polypeptide chains 
and a second peak centered around 130-160 nm depending on the polypeptide solution 
attributed to larger interchain polypeptide aggregates. In the presence of molecular pyrene, an 
additional peak centered around 20 nm is observed in the histograms. Unimodal size 
distributions are obtained for all samples when the histograms are calculated using numbers 
and volumes instead of scattering intensities, suggesting that a single species is present in 
solution. The diameter of this species is in the 3-7 nm range from the analysis based on the 
particle numbers, similar to the size expected from individual polypeptide chains. 
 suggest that (Asp1Phe1)n 
 present essentially as single chains and that a very small percentage of them form is
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(C) of (Asp ) −132 
 
 
Figure 4.5. Particle size distribution determined by intensity (A), number (B), and volume 
1 n
( ), and (Asp1Phe1)n with molecular pyrene ( ) in 0.01 M Na2CO3 at pH 9 and at 
a polypeptide concentration of 0.05 g/L. 
interpolymeric/multichain aggregates. 
 
























































 P di eter and their s da eviations for the alternating polypeptide samples.  
Particle size (nm) 
eak am tan rd d
Sa le Conc. 





5.0 ± 1.2 
 
5.1 ± 1.1 
7.7 ± 1.9 (31 %), 128.0 ± 67.1 (68 %) 
 
7.3 ± 0.8 (18 %), 105.2 ± 22.5 (21 %), 309.7 ± 51.  
Phe n 05 
 
.5 
5.8 ± 1.3 
 





4.4 ± 4.1 
 
3.6 ± 2.6 
4.3 ± 1.0 (17 %), 20.5 ± 6.8 (21 %), 130.1 ± 58.1 %
 






3.4 ± 0.7 
 
2.9 ± 0.6 
(61 ) 
(59 ) 
EPy−(Asp 1 44 0.05 
0
3.6 ± 1.1 
 
4.2 ± 1.2 
4.5 ± 0.9 (5 %), 153.6 ± 50.2 (95 %) 
 




3.7 ± 0.7 
 
3.8 ± 0.7 (86 ) 
RPy−(Asp1Phe1 70 0.05 
0
5.0 ± 1.0 
 
5.4 ± 1.2 
5.8 ± 1.2 (10 %), 154.0 ± 62.3 (90 %) 
 




4.6 ± 1.0 
 
4.5 ± 0.8 
RPy−(Asp1Phe1) 132 0.05 
0
4.9 ± 1.2 
 
5.1 ± 1.1 
5.8 ± 0.9 (14 %), 134.2 ± 69.6 (86 %) 
 




5.0 ± 0.9 
 
4.4 ± 0.5 (60 ) 
 
Table 4.2.
RPy−(Asp1Phe1) 221 0.05 
0
4.6 ± 1.5 
 
4.3 ± 1.0 
4.8 ± 0.8 (9 %), 32.2 ± 6.3 (15 %), 142.5 ± 41.5 %
 




4.2 ± 0.7 
 
3.6 ± 1.0 
(75 ) 
To further support the conclusion reached by DLS that (Asp1Phe1)n is predominantly 
present as unimolecular micelles in 0.01 M Na2CO3 solutions at pH 9, fluorescence energy 
transfer experiments were carried out using the polypeptides labeled with pyrene 
Py−(Asp1Phe1)n−70) and naphthalene (RNp−(Asp1Phe1)n−313). The process of non-
radiative energy transfer (NRET) involves the transfer of energy between an excited donor, 
naphthalene (Np), and a ground state acceptor, pyrene (Py),47 as shown in Scheme 4.1. For 
energy transfer to take place, the emission of the donor must overlap with the absorption of 
the acceptor. Figure 4.6 shows the absorption and emission spectra of both naphthalene and 
pyrene and how the actual energy transfer takes place. 
 
Scheme 4.1. Energy transfer between naphthalene and pyrene chromophores. 
 
 
NRET occurs as a result of dipole-dipole interactions between the donor and the 
acceptor without emission of a photon.47 The rate constant of energy transfer, kET, depends 
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ure 4. bsorption and emission spectra of pyrene (top) and naphthalene (bottom) for 
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−           (4.7) 
ons were excited at 290 nm and their 
eady-state fluorescence emission spectra were recorded. The solution for the NRET 
1Phe1)n−70 in 
DMF followed by dialysis in aqueous solution and adjusting the polypeptide concentration so 
that the OD at 290 nm takes a value lower than 0.05. The fluorescence spectrum of the 
mixture was recorded upon excitation of the solution at 290 nm. Similarly, solutions of 
labeled poly(L-aspartic acid) were prepared and their fluorescence emission spectra were 
cquired by exciting the solution at 290 nm. The fluorescence spectra of 
Np−(Asp1Phe1)n−313 (a), RPy−(Asp1Phe1)n−70 (b), and the RNp−(Asp1Phe1)n−313 + 
RPy−(A 1 1 n
n− n
The following precautions were taken when performing the NRET experiments. To 
avoid the inner-filter effect,47 all experiments were conducted under conditions where the 
absorption did not exceed 0.1 across the abso tio spectr m. Th  solut n abs  
lower than 0.05 at 290 nm, the excitation wavelength. Since the accuracy of the 
 
Here INp in mixture and oNpI  represent the fluorescence intensity of the donor in the presence and 
absence of the acceptor, respectively. In a NRET experiment, the donor is excited at a 
wavelength where the acceptor shows little or no absorption. In this study, naphthalene was 
selectively excited at 290 nm, where pyrene absorbs little. A 0.025 g/L solution of 
RNp−(Asp1Phe1)n−313 and a 0.017 g/L solution of RPy−(Asp1Phe1)n−70 were prepared with 
an optical density less than 0.05 at 290 nm. The soluti
st
experiment was prepared by mixing RNp−(Asp1Phe1)n−313 with RPy−(Asp
a
R
sp Phe ) −70 mixture (d) are shown in Figure 4.7. The inset depicts the same 
experiment performed with RNp−(Asp) 180 and RPy−(Asp) −229. 
rp n u e io orption was
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spectrophotometer is poor for absorptions below 0.1, concentrated solutions of the labeled 
olypeptides were prepared at a higher concentration and their absorption was recorded. The 
lutions were then diluted and the dilution factor was used to determine the absorption of 
e diluted polypeptide solution at 290 nm. Then the fluorescence spectrum of the diluted 
lution was acquired. 
To obtain Figure 4.7, the absorptions of the chromophores needed to be taken into 
ccount. The solution of the Np−labeled polypeptide was taken as reference, spectrum a) in 
igure 4.7. As shown in Figure 4.6, the absorption of pyrene at 346 nm can be easily 
etermined since it is separated from the absorption of naphthalene. This is not the case for 
aphthalene whose absorption at 290 nm overlaps with that of pyrene.  The absorption of the 
p−labeled polypeptide in the mixture of Py− and Np−labeled polypeptides was obtained by 
btracting the normalized absorption spectrum of the Py−labeled polypeptide from the 
bsorption spectrum of the mixture. To obtain spectrum d) in Figure 4.7, the fluorescence 
ectrum of the solution containing the mixture of the Np− and Py−labeled polypeptides was 




















=     (4.8) 
 
In Equation 4.8, the quantities Abs(Np, 290 nm) and Abs(Np-mix, 290 nm) represent the 
naphthalene absorption at 290 nm of the solution containing the Np-labeled polypeptide only 
and that of the solution containing the mixture, respectively. The fluorescence spectrum of 
the solution containing only the Py-labeled polypeptide (spectrum b) needed also to be 
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adjusted for changes in concentrations. It was multiplied by the factor q given in Equation 






)346,(       (4.9) 
 
In Equation 4.9, the quantities Abs(Py, 346 nm) and Abs(Py-mix, 346 nm) represent the 
pyrene absorption at 346 nm of the solution containing the Py-labeled polypeptide only and 
that of the solution containing the mixture, respectively. The normalized fluorescence spectra 
a) and b) were then added to yield spectrum c) which was compared to the fluorescence 
spectrum of the mixture d). 
In Figure 4.7, the fluorescence emission of naphthalene in the 320-330 nm range is 
the same for the Np-labeled polypeptide, alone or in the mixture. According to Equation 4.7, 
the resulting NRET efficiency equals zero implying that no energy transfer is taking place. 
Comparison of the fluorescence spectra c) and d) shows a small increase in the pyrene 
fluorescence in spectrum d) suggesting that residual energy transfer is occurring. From the 
inset of Figure 4.7, it can be seen that no energy transfer occurs for the labeled poly(aspartic 
acid) as there is no change in the fluorescence of either naphthalene or pyrene. (Asp)n being 
more hydrophilic than (Asp1Phe1)n, the complete absence of NRET from RNp−(Asp)n−180 to 
RPy−(Asp)n−229 is reasonable since (Asp)n is expected to be present as individual polymer 






RNp−(Asp1Phe1)n−313, [Polypeptide] = 0.025 g/L; b) RPy−(Asp1Phe1)n−70, [Polypeptide] = 
s, RNp−(Asp1Phe1)n−313, [Polypeptide] = 
0.025 g/L, RPy−(Asp1Phe1)n−70, [Polypeptide] = 0.017 g/L; Inset: a) RNp−(Asp)n−180, 
] = 0.042 g/L; b) RPy−(Asp)n−229, [Polypeptide] = 0.004 g/L; c) sum of the two 
precedent spectra; d) fluorescence spectrum of a m
poly(aspartic acid)s, RNp−(Asp)n−180, [Polypeptide] = 0.042 g/L, RPy−(Asp)n−229, 
] = 0.004 g/L. λex = 290 nm, O.D ≤ 0.05 at 290 nm. 
1 1 n
1 1 n 1 1 n
Figure 4.7. Fluorescence emission spectra of aqueous solutions of labeled polypeptides: a) 
0.017 g/L; c) sum of the two preceding spectra; and d) fluorescence emission spectrum of a 
mixture of the two singly labeled polypeptide
[Polypeptide
ixture of the two singly labeled 
[Polypeptide
 
Since the Förster radius is around 3 nm for the Np/Py pair,49 the quasi-absence of 
energy transfer observed for (Asp Phe )  in Figure 4.7 indicates that the naphthalene and 
pyrene chromophores in the RNp−(Asp Phe )  + RPy−(Asp Phe )  mixture are located at 
100









































































distances larger than 2 × Ro ~ 6 nm, or larger than the average size of a single polypeptide 
estimated by DLS to range from 3 to 8 nm in Figure 4.5B. Consequently, the NRET 
experiments suggest that few interpolymeric aggregates are being formed, in agreement with 
e light scattering results. 
es using pyrene as a hydrop
have frequently been used to determine the polarity of its surrounding environment in 
icellar and polymeric systems.50,51 In this study, pyrene has been used both as a probe and a 
1 1 n
1 3 1 3







results indicate that pyrene whether free in solution or covalently attached 
 the polypeptide is located in an apolar environment and that the polypeptide does generate 
th
Fluorescence techniqu hobic fluorescent chromophore 
m
hydrophobic label to characterize the hydrophobic microdomains generated by (Asp Phe ) . 
The I /I ratio, where I  and I  are, respectively, the fluorescence intensities of the first and 
third peaks of the fluorescence spectrum of molecular pyrene, gives information about the 
polarity of the environment where pyrene is located. This ratio has been found to equal 1.66-
1.80 for pyrene in water50,51
s less polar (I /I  = 1.10 for molecular pyrene in SDS micelles). A similar effect has 
been reported for pyrene labels although the dependence of the I /I  ratio with the 
environment polarity is somewhat reduced when compared to the pyrene molecule.21 
Recently the I /I  ratio of a poly(ethylene oxide) labeled at one end with a pyrenyl group (Py-
PEO) has been found to equal 1.69 in a 0.1 M Na CO  solution at pH 9 and 1.38 when large 
quantities of sodium dodecyl sulphate (SDS) are added to the solution.52 As the pyrenyl 
pendant of Py-PEO is being incorporated inside the SDS micelles, the I /I  ratio decreases. 
For the alternating polypeptide, the I /I ratio was found to be 1.24 when pyrene was used as 




hydrophobic microdomains. The higher values of the I1/I3 ratios obtained for the labeled 
pyrenes is a direct result of the restriction in their mobilities which lowers their ability to 
target the hydrophobic microdomains generated by the polypeptide. Figure 4.8 shows the 
steady-state fluorescence emission spectra of the different polypeptide solutions. Very little 
pyrene excimer is observed for the end-labeled polypeptide and the sample where pyrene is 
used as a probe. The I1/I3 ratio of EPy−(Asp1Phe1)n−44 was not taken into account since it 
has been reported that the pyrene label loses its sensitivity to the environment when it is 
connected to a polymer with a butyl linker.21 All randomly labeled polypeptides show 




Figure 4.8. Steady-state emission spectra normalized at 375 nm: 1) [EPy−(Asp Phe ) −44] = 



























0.32 g/L, λex = 346 nm; 2) (Asp1Phe1)n + Py, [(Asp1Phe1)n] = 1.5 g/L, [Py] = 1.7×10−5 M, λex 
= 338 nm; 3) [RPy−(Asp1Phe1)n−70] = 0.14 g/L, λex = 346 nm; 4) [RPy−(Asp1Phe1)n−132] = 
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The fluorescence decays of the pyrene monomer and excimer (Figure 4.9) were 
acquired for the solutions used in Figure 4.8. The decays could be fitted by a sum of three 
exponentials whose pre-exponential factors and decay times are listed in Tables 4.3 and 4.4 
for the pyrene monomer and excimer, respectively.  
 
Table 4.3. Summary of the pyrene monomer decay times and pre-exponential factors 
obtained for the polypeptide solutions 
Sample τM1 
(ns) 
aM1 τM2  
(ns) 





(Asp1Phe1)n + Py 8.6 0.26 118 0.35 299 0.38 157 1.10 
EPy−(Asp Phe ) −44 10.7 0.13 92 0.30 150 0.56 113 1.15 1 1 n
RPy−(Asp Phe ) −70 78 0.16 176 0.68 135 1.18 1 1 n 17.5 0.16 
RPy−(Asp1Phe1)n−132 13.3 0.25 73 0.21 176 0.54 114 0.94 
RPy−(Asp1Phe1)n−221 10.0 0.26 57 0.23 172 0.51 104 1.00 
RPy−(Asp)n−229 7.1 0.09 53 0.16 128 0.75 105 1.08 
 
The first entry of Table 4.3 indicates that when pyrene is used as a probe in the 
polypeptide solution, 38 % of all pyrene monomers emit with a 299 ns decay time.  A decay 
time of 299 ns observed for pyrene in aerated polypeptide solution is rather long since pyrene 
dissolved in an aerated 0.01 M Na2CO3 pH 9 aqueous solution has a lifetime of 128 ns. Since 
the I1/I3 ratio suggests that pyrene is located in an environment less polar than water, these 
long-lived pyrenes are located inside the hydrophobic domains generated by the polypeptide 
chains. While inside these hydrophobic domains, pyrene is protected from the quenching of 
oxygen dissolved in the aqueous solution. Similarly long decay times were also observed for 
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pyrene dissolved in SMA aggregates.30 






































Figure 4.9. Monomer (left) and excimer (right) fluorescence decays of 
RPy−(Asp1Phe1)n−132 in 0.01 M Na2CO3 solution at pH 9, [Polypeptide] = 0.54 g/L. The 
samples were excited at 346 nm. The monomer and excimer decays were acquired at 374 and 
510 nm, respectively. The decays were fitted with a sum of exponentials. The χ2 were 0.94 
and 1.14 for the monomer and the excimer, respectively. 
 
The fact that a hydrophobic organic molecule like pyrene can be incorporated inside 
and protected by the polypeptide suggests that (Asp1Phe1)n could be used as a potential 
 
rene in water 
carrier of hydrophobic drugs. Unfortunately only a small amount of pyrene (1.7×10−5 M) 
could dissolve molecularly in the 1.5 g/L polypeptide solution. Nevertheless, a pyrene 
concentration of 1.7×10−5 M is 24 times larger than the concentration of py
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(0.7×10
pyrene aggregates might be occurring 
ading to shorter decay times. 
als. Poly(aspartic acid) being less hydrophobic than 
(Asp1Ph  expected to pr  l rotection f the ent. This is indeed 
observed since all (Asp1Phe mples lab ith 1-pyre thylamine (i.e. the “R” series 
in Table 4.3) have a substantially larger τ  decaytime (175 ns) than RPy−(Asp)n−229 (τ = 
128 ns).  The pyrene derivative bearing a butyl linker in EPy−(Asp Phe1)n−44 has a shorter 
natural lifetime and can not be compared with the polypeptides randomly labeled with 
longer-lived 1-pyrenemethylamine.
 er can form via diffusional encounters between an excited pyrene 
and a ground-state pyrene, or by the di
ggregates.20,21,53 In order to determine how the excimer of the pyrene-labeled polypeptides 
is form
−6 M)54 so that the decay times τ1 and τ2 obtained with substantial pre-exponential 
factors aM1 and aM2 can not be attributed to pyrene in the aqueous solution. These shorter 
decaytimes are certainly due to pyrenes associated with the polypeptides but more exposed to 
the solvent. Also residual pyrene association into 
le
The fluorescence decays of the pyrene monomer of all pyrene-labeled polypeptides 
were also fitted with three exponenti
e1)n, it is ovide ess p rom  solv





rect excitation of ground-state pyrene 
a
ed, time-resolved fluorescence decays of the excimer of the randomly labeled 
polypeptides were acquired, since these are the only ones which give rise to excimer 
formation (Figure 4.8). A rise time is observed in the excimer decay if excimer formation 
occurs via diffusion whereas the rise time is absent when the excimer is formed from direct 
excitation of the pyrene ground-state aggregates. Figure 4.9 shows the excimer decay of 
RPy−(Asp1Phe1)n−132. A very small rise time is visible at the beginning of the decays. 
Similarly short rise times were observed for the other two randomly labeled polypeptides. 
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The magnitude of the rise time is calculated using the pre-exponential factors obtained from 
the fits of the fluorescence decays. The negative pre-exponential factors are associated with 
the rise time and the positive ones with the decay. The ξ parameter being the ratio of the sum 
of the negative pre-exponential factors over the sum of the positive ones yields information 
about the process by which the excimer is formed. When excimer formation occurs via 
diffusional encounters only, ξ equals −1.0. ξ becomes more positive as more ground-state 
dimers are present.  The ξ values listed in Table 4.4 suggest that excimer formation occurs 
mainly via direct excitation of pyrene ground-state dimers. The ξ ratio in Table 4.4 becomes 
less positive as the labeling level increases. The decrease of ξ with increasing pyrene content 
is certainly an analysis problem due to the second decaytime τ2 becoming too close to the 
risetime τ1. Nevertheless, for RPy−(Asp1Phe1)n−70 and RPy−(Asp1Phe1)n−132 where τE1 and 
τE2 are sufficiently well separated, a small rise time is observed indicating the formation of 
excimer by diffusion. Excimer formation by diffusion is enabled by the hydrophobic 







aE3 ξ χ2 
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Table 4.4. Summary of the excimer decay times and the rise time calculated for the 
randomly labeled polypeptides. 
 
Sample τ  a  τ  a  
RPy−(Asp1Phe1)n−70 13 −0.23 50 0.88 84 0.35 −0.19 1.15 
RPy−(Asp1Phe1)n−132 18 −0.37 32 0.54 68 0.82 −0.27 1.14 
RPy−(Asp1Phe1)n−221 22 −0.75 29 0.98 70 0.77 −0.43 1.25 
RPy−(Asp)n−229 4.3 0.15 26 0.41 58 0.44 0.00 1.04 
 166
 No rise time could be detected in the excimer decay of RPy−(Asp)n−229 indicating 
that all pyrene excimer is generated via direct excitation of pyrene aggregates.  The absence 
of hydrophobic aryl side chains in (Asp)n is certainly responsible for preventing the partial 
solubilization of the pyrenyl pendants achieved by the RPy−(Asp1Phe1)n samples. 
Consequently the formation of ground-state pyrene aggregates is favored with 
RPy−(A
pyrene. Upon the addition of the quencher, the 
sp)n−229 and no excimer is formed by diffusion. The same result has been reported 
for poly(L-glutamic acid) randomly labeled with 1-pyrenemethylamine.56 
 Steady-state and time-resolved fluorescence quenching experiments were carried out 
on the different types of pyrene solutions to further investigate the hydrophobic 
microdomains generated by the polypeptide. The polypeptide concentration for these 
solutions was approximately 0.15 g/L for the labeled polypeptides and 1.5 g/L for the 
solution where pyrene was molecularly dissolved. Nitromethane, CH3NO2, was used as a 
neutral water-soluble quencher of 
fluorescence intensity of the pyrene monomer decreases and the number-average lifetime 
shortens as shown in Figure 4.10 for the solution in which pyrene is molecularly dissolved.  
The fluorescence spectra and decays shown in Figure 4.10 allow one to plot the ratios 
I0/I and <τ0>/<τ> as a function of quencher concentration, [Q]. I0 and I represent the 
fluorescence intensity of pyrene in the absence and presence of quencher, respectively. 
Similarly, <τ0> and <τ> are the number-average lifetime of pyrene in the absence and 
presence of quencher, respectively.  Quenching of pyrene results in a decrease of I and <τ>. 
A plot of the I0/I and <τ0>/<τ> ratios as a function of quencher concentration, [Q], (equation 
1.5 Chapter 1), is referred to as a Stern-Volmer plot.47 These plots are shown in Figure 4.11.  
The Io/I and <τo>/<τ> ratios do not overlap. This is a clear indication that static 
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quenching is occurring.47 Static quenching occurs when a ground-state complex is formed 
between the chromophore and the quencher. Upon excitation of the chromophore, those 
chromophores which are complexed do not emit whereas those which are not complexed 
with the quencher can emit. Consequently, a steady-state fluorescence experiment reports on 
all chromophores present in solution, whereas a time-resolved fluorescence experiment 
reports only on those chromophores that can emit, i.e. are not complexed. The Io/I ratio 
increases more steeply with [Q] than the <τo>/<τ> ratio when static quenching is occurring, 
as observed in Figure 4.11. Since the <τo>/<τ> ratio increases with [Q], it indicates that 
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pyrenes which are not complexed with nitromethane can not be quenched when larger 



















solution at pH 9. λex = 338 nm, λem = 374 nm. 
rate co
 4.11. Stern-Volmer plot obtained by steady-state ( ) and time-resolved ( ) 
fluorescence with 1.7×10−5 M pyrene dissolved in 1.5 g/L of polypeptide in 0.01 M Na2CO3 
 
The data shown in Figure 4.11 indicate that static, dynamic, and protective quenching 
are occurring concurrently. They are represented by Scheme 4.2 where α1 and α2 are the 
molar fractions of pyrenes which are protected and quenched diffusionally, respectively. The 
fraction 1 − α1 − α2 represents those pyrenes which are complexed with nitromethane. The 
nstant for dynamic quenching is kQ whereas KS is the equilibrium constant for the 
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formation of the complex between pyrene and nitromethane. Since no model could be found 
in the literature to analyze the data shown in Figure 4.11 according to Scheme 4.2, Equations 
4.10 and 4.11 were derived as shown in the Appendix located in section 4.7, to yield the 
parameters fa =α2/(α1 + α2), kQ, and KS. Equations 4.10 and 4.11 were used to fit the trends 
shown in Figure 4.11. 
 
Scheme 4.2. Pathways for dynamic, static, and protective quenching 
KS 




























  (4.10) 
 










   (4.11) 
quenched diffusionally by nitromethane. The quantity Δ<τ> represents the difference <το> − 






 In Equations 4.10 and 4.11, fa represents the fraction of accessible pyrenes that are 
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<τ>. The brackets for <το> and <τ> indicate that the number-average lifetime is being used. 
First the data obtained by time-resolved fluorescence were used to plot the ratio 
<το>/Δ<τ> as a function of 1/[Q]. Fit of this plot with a straight line according to Equation 
4.11 yielded fa and kQ. These parameters where used in Equation 4.10 with the Io/I ratios 
obtained by steady-state fluorescence to yield KS. As very often done when the pyrene 
monomer with no quencher exhibits a multiexponential decay, the lifetime of pyrene, τPy, in 
Equations 4.10 and 4.11 was approximated by <το>.30 
When this analysis was applied to the data shown in Figure 4.11, fa, kQ, and KS were 
found to equal 0.60, 0.92 × 109 M−1.s−1, and 15.8 M−1, respectively. An  fa value of 0.60 
implies that 40 % of all non-complexed pyrenes are not accessible to the quenchers in the 
solution. This result agrees with the fact that 38 % of all non-complexed pyrenes emit with a 
lifetime of 299 ns (see aM3 for the “(Asp1Phe1)n + Py” entry in Table 4.3), much longer than 
the 128 ns lifetime of pyrene in the 0.01 M Na2CO3 pH 9 solution. The quenching rate 
constant, kQ, for the solution of (Asp1Phe1)n and pyrene is 10 times smaller than that of 
pyrene by nitromethane in the 0.01 M Na2CO3 solution at pH 9 found experimentally to 
qual 9.5 × 109 Μ−1.s−1.  
le
me-resolved fluorescence measurements. The results are reported in the form of Stern-
Volmer
e
Quenching studies were also carried out for the end-labe d and the randomly labeled 
(Asp1Phe1)n, and for the randomly labeled poly(aspartic acid) using both steady-state and 
ti
 plots shown in Figure 4.12. A striking difference is observed for the labeled 
(Asp1Phe1)n samples which do not exhibit the protective quenching found when pyrene is 
used as a molecular probe (fa = 1.0). All the plots are linear, indicating that efficient 
quenching of pyrene takes place and the main process of quenching is via diffusional 
 171
encounters of pyrene with nitromethane. As a result the data shown in Figure 4.12 were fitted 
according to the classic Stern-Volmer Equations 4.12 and 4.13.47 A small amount of static 
quenching also takes place as slight differences are observed between the slopes of the 
straight lines obtained by steady-state and time-resolved fluorescence. A linear Stern-Volmer 
plot is also observed for the labeled poly(aspartic acid) which means that diffusional 
quenching is taking place. 
 
][1 Qk











    (4.13) 
 
The quenching param kQ and fa listed in Table 4.5 ind t the quenching of 
pyrene is more efficient when pyrene is covalently attached to the p hen it is 
used as a free probe. It would seem that the polypeptide is able to generate a few 
hydrophobic microdomains that can accommodate some free pyrene molecules which are 
protected from quenching by nitromethane. However once the pyrene is attached onto the 
lf inside the microdomains generated
the I1/I3 ratio value of 1.42 lower than that of 1.69 found for Py−PEO in aqueous solution,52 
ains are unable to protect efficiently the pyrenyl pendants from 
bels are more exposed to the
is taking place. 




polypeptide, it also locates itse  by Phe, as suggested by 
but those hydrophobic dom
being quenched. The pyrene la  quencher and efficient quenching 
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third of its value obtained for the quenching of pyrene in aqueous solution. This reduction in 
kQ is due in part to a loss in mobility of the pyrenyl pendants upon attachment onto the 
polypeptide. The kQ values obtained for the pyrene-labeled (Asp1Phe1)n are about half that 
obtained for RPy−(Asp)n−229. It suggests that (Asp1Phe1)n provides some relative protection 
against quenching when compared to (Asp)n. Nevertheless, that protection is not sufficient to 
induce protective quenching as was observed for the (Asp1Phe1)n + Py solution. The similar 
kQ values found for the polypeptides labeled either at the end (EPy−(Asp1Phe1)n−44) or 
randomly suggest that the entire chain is similarly exposed to the solvent. 
e
(Asp1Phe1)n (Figures 4.5B, 4.5C, 4.7). The results observed by DLS 
and fluores
The different techniques used to describe the (Asp1Phe1)n species pres nt in solution 
fall into two main categories. They can be classified depending on whether they are biased 
toward observing large structures in solution or not. Experiments carried out by DLS and 
analyzed with scattering intensity are biased toward probing larger species (Figures 4.5A). 
The NRET experiments carried out with the fluorescently labeled polypeptides (Figure 4.7) 
as well as the DLS experiments analyzed by numbers or volumes (Figures 4.5B and C) 
provide a number-averaged representation of the species present in solution. If most 
macromolecules are not aggregated, these experiments report the absence of aggregation as 
found experimentally for 
cence are certainly consistent with a situation where residual polypeptide 
aggregation occurs in solution but where the majority of polypeptides are isolated. 
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Figure 4.12. Stern-Volmer plots obtained for the labeled polypeptides by steady-state ( ) 
= 1.41 × 10−5 M; B) RPy−(Asp1Phe1)n−70, [Polypeptide] = 0.14 g/L, [Py] = 9.52 × 10−6 M; 
C) RPy−(Asp1Phe1)n−132, [Polypeptide] = 0.54 g/L, [Py] = 7.18 × 10−5 M; D) 
1 1 n
RPy−P(Asp) −229, [Polypeptide] = 0.15 g/L, [Py] = 3.44 × 10−5 M in 0.01 M Na CO  
solution at pH 9,
and time-resolved ( ) fluorescence. A) EPy−(Asp1Phe1)n−44, [Polypeptide] = 0.32 g/L [Py] 
RPy−(Asp Phe ) −221, [Polypeptide] = 0.26 g/L, [Py] = 5.83 × 10−5 M; E) 
n 2 3



















































































































Table 4.5. Summary of parameters retrieved from the analysis with Equations 4.8-4.11 of the 







10−9 ×  kQ 
M−1s−1 (SS) 




Na2CO3 solution 128 n.a. 9.82 ± 0.05 n.a. n.a. 
(Asp1Phe1)n + Py 157 15.8 ± 0.3 n.a. 0.92 ± 0.05 0.61 ± 0.01 
RPy−(Asp)n−229 105 11.8 ± 1.1 6.23 ± 0.13 4.82 ± 0.06 1.00 
EPy−(Asp1Phe1)n−44 113 16.7 ± 2.1 2.91 ± 0.03 2.19 ± 0.18 1.00 
RPy−(Asp Phe ) −70 135 6.5 ± 1.0 2.80 ± 0.05 2.51 ± 0.09 1 1 n 1.00 
RPy−( 1 1 nAsp Phe ) −132 113 12.5 ± 1.9 3.81 ± 0.06 2.82 ± 0.04 1.00 
RPy−(Asp1Phe1)n−221 104 1.8 ± 0.7 3.34 ± 0.04 3.18 ± 0.05 1.00 
 
To further test the validity of these conclusions, the following experiment was 
conducted. A 0.05 g/L solution of (Asp1Phe1)n was prepared and the light scattering and 
fluorescence intensities of the solution were determined before and after the solution was 
filtered through 20 nm pores. The scattering and fluorescence intensities obtained before and 
after filtration are shown in Figure 4.13. Filtering the (Asp1Phe1)n solution had a major effect 
on the scattering intensity which was reduced by 75 %. It indicates that the large polypeptide 
aggregates were filtered out. On the other hand, filtering did not affect much the intrinsic 
fluorescence intensity of the polypeptide, demonstrating that the aggregates involve a small 




Figure 4.13. (A) Light scattering intensity (λex = λem = 450 nm) and (B) fluorescence 
emission spectra (λex = 255 nm) of (Asp1Phe1)n  before ( ) and after ( ) 
filtration of 0.05 g/L solutions (Asp1Phe1)n; (C) Light scattering intensity (λex = λem = 450 
nm) and (D) fluorescence emission spectra (λex = 338 nm) before ( ) and after 
( ) filtration of 0.05 g/L solutions (Asp1Phe1)n + Py in 0.01 M Na2CO3. 
 suggests that molecular pyrene targets the 
 
A similar experiment helps rationalize why the results of the fluorescence quenching 
experiments obtained with (Asp1Phe1)n and molecular pyrene are so different from those 
obtained with the pyrene-labeled (Asp1Phe1)n (cf. Figures 4.11 and 4.12). Filtering the 
(Asp1Phe1)n + Py solutions results in a substantial decrease of light scattering (Figure 4.13C) 






















































































































hydrophobic pockets provided by the polypeptide aggregates. The situation is different for 
the pyrene-labeled polypeptides where the pyrene label is confined to a single chain since the 
polypeptides have shown little tendency to aggregate (Figures 4.5B and C, Figure 4.7).  
There the pyrene labels are not free to target the ic do erated by e few 
polypeptide aggregates. They are m cessib en ctive qu nching 
is observed (Figure 4.12). 
 using e olecular probe provides information about the 
polypeptide aggregates (Figure 4. s D  w tering ities 
(Figure 4.5A). Covalently attaching a chro ophore onto the polypeptide enables the study of 
the overall polypeptide population, as do NRET (Figure 4.7) and DLS analyzed with particle 
volum bers (Figures 4.5B and C). ined use of different types of 
uorescence and DLS experiments results in a detailed description of the (Asp1Phe1)n 
solutio
.01 M Na2CO3 solution at pH 9 as shown by DLS which 
etects the presence of particles 3-7 nm in diameter (Figures 4.5B and C). The quasi-absence 
of fluorescence NRET between the Np- and Py-labeled polypeptides also supports the 
 hydrophob
le to the solv
mains gen
t and no prote
 th
ore ac e
In summary,  pyr ne as a m
11), as doe LS analyzed ith light scat intens
m





 CD, DLS, and various fluorescence techniques have been employed to investigate the 
solution properties of the amphiphilic polypeptide (Asp1Phe1)n. Those were compared to the 
solution properties of (Asp)n. CD spectra (Figure 4.4) show that (Asp1Phe1)n exhibits no 
defined secondary structure and that labeling of (Asp1Phe1)n or (Asp)n with a chromophore 
does not affect the CD spectra of the polypeptides. (Asp1Phe1)n forms predominantly 
unimolecular micelles in the 0
d
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formation of unimolecular micelles (Figure 4.7). The presence of some hydrophobic 
microdomains was revealed by both the low value of the I1/I3 ratio and the long decay time of 
pyrene. Molecular pyrene in solution targets those hydrophobic domains generated by the 
few polypeptide aggregates which are compact enough to lead to protective quenching 
(Figure 4.11). Quenching experiments carried out on the labeled polypeptides show no 
evidence of protective quenching (Figure 4.12). Instead the quenching process appears to be 
diffusion controlled. This is expected from individual polymer coils which do not offer 
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Schem raction (1 − α1 − α2) of chromophores D associate with the 
 are not 
quenching rate constant kQ. According to Scheme A1, the following equations can be 
Appendix 
Scheme A1: Photophysical processes undergone by a chromophore D subject to static,








e A1 states that a f
quencher Q with an association constant KS, a fraction α1 of the chromophores D





















1][ 21DQK αα −−==    (A3) 
D + Q (DQ) 
KS 









=f     (A4) 
In Equations A1 and A2, Io represents the concentration of chromophores D absorbing a 
photon per unit time.  If the solution is excited with a short pulse of light as done during a 

























+ ][QkQ   (A6)   
 
Integration of Equations A5 and A6 over time yields Equations A7 and A8, respectively. 




*][DfInt Dτ=    (A8) 
nd A8 can 
no quencher is present in solution. 
In Equations A7 and A8, D* represents the chromophores which do not form a complex with 
the quencher and can be detected by time-resolved fluorescence.  Equations A7 a



























ITRo/ΔITR as a function of [Q]−1 yields a straight line with 
 
According to Equation A9, a plot of 
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a slope (fakQτD)−1 and an intercept (fa)−1. Since the lifetime of the chromophore τD can be 
ophores fa and the rate constant for diffusion quenching kQ. 
Experimentally, the fluorescence decays of the chromophore with and without 
uencher are acquired  with a sum entials. Integration of the fluorescence 
ecays yields the quantities ITR and ITRo which can be used in Equation A9. 
 
Under steady-state irradiation of the solution, the deriva s with respect to time in 
quations A1 and A2 equal 0 leading to Equations A10 an
 
   (A10) 
determined independently, Equation A9 allows one to estimate the fraction of accessible 
chrom
q and fitted of expon
d
tive
E d A11. 
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me-resolved fluorescence experiments using Equation A9. Plotting the left-hand side of 
Equation A14 as a function of quencher concentration  slope 
equals KS. 
 
Table A-1. Pre-exponential factors and decay times of the fluorescence decays of 1.5 g/L of 
1 1 n
[Q], M τM1 (ns) aM1 τM2 (ns) aM2 τ a τ 2
 
In Equation A14, the quantities ISSo and ISS represent the fluorescence intensity of the solution 
without and with quencher. The parameters fa and kQ have been determined by conduc
ti
 resulted in a straight line whose
(Asp Phe )  solution with 1.7 × 10-5 M pyrene quenched by nitromethane. 
 
M3 (ns) M3 < 0> (ns) χ  
0.0000 8.6 0.26 118.15 0.35 299.4 0.38 157.3 1.10 
0.003978 18.2 0.39 93.6 0.28 271.6 0.33 123.0 1.22 
0.008607 13.0 0.45 87.9 0.26 257.9 0.29 103.5 1.07 
0.01436 9.7 0.47 81.6 0.27 249.8 0.25 89.0 1.15 
0.018549 9.2 0.47 78.0 0.28 243.1 0.25 87.0 1.07 
0.024091 9.0 0.46 76.5 0.29 238.3 0.24 83.5 1.27 
0.030059 8.0 0.45 68.6 0.30 231.0 0.24 79.6 1.19 
0.035262 7.4 0.47 69.0 0.30 229.34 0.23 76.9 1.17 
0.039896 9.0 0.45 72.5 0.32 230.22 0.23 80.1 1.14 







Table A-2. Pre-exponential factors and ecay times of the fluorescence decays of 0.15 g/L of 
EPy−(Asp1Phe1)n−44 quenched by nitromethane. 
[Q], M τM1 (ns) aM1 τM2 (ns) aM2 τM3 (ns) a
d
 
M3 <τ0> (ns) χ2 
0.00000 10.7 0.13 91.8 0.30 150.0 0.56 113.0 1.15 
0.00312 12.5 0.10 56.4 0.78 122.6 0.12 60.1 1.16 
0.00620 19.1 0.22 42.0 0.70 114.0 0.08 42.5 1.04 
0.00931 22.0 0.56 40.8 0.39 113.4 0.05 34.1 1.17 
0.01238 15.7 0.50 31.7 0.49 110.0 0.05 28.0 0.88 
0.01543 14.7 0.67 33.2 0.28 109.8 0.04 23.3 1.19 
0.01843 13.0 0.73 30.7 0.23 102.4 0.04 20.2 1.07 
0.02150 12.0 0.78 31.1 0.18 102.7 0.03 18.1 1.18 
 
Table A-3. Pre-exponential factors and deca  0.15 g/L of 
RPy−(Asp1Phe1)n−70 quenched by nitromethane. 
 
[Q], M τM1 (ns) aM1 τM2 (ns) aM2 τM3 (ns) aM3 <τ0> (ns) χ2 
y times of the fluorescence decays of
0.00000 17.5 0.16 77.6 0.16 175.7 0.68 134.6 1.18 
0.00330 11.8 0.16 59.1 0.48 105.0 0.36 68.0 1.25 
0.01035 10.4 0.21 29.0 0.71 69.0 0.08 28.3 1.01 
0.01380 8.0 0.26 22.8 0.68 59.0 0.06 21.1 1.25 
0.02480 3.5 0.23 15.5 0.69 42.7 0.08 15.0 1.22 
0.03470 5.2 0.38 12.6 0.56 0.06 11.0 1.04 35.2 










Table A-4. Pre-expone orescence decaysntial factors and decay times of the flu  of 0.15 g/L of 
RPy−(Asp1Phe1)n−132 quenched by nitromethane. 
[Q], M τM1 (ns) aM1 τM2 (ns) aM2 τM3 (ns) aM3 <τ0> (ns) χ2 
 
0.00000 13.3 0.25 73.1 0.21 175.9 0.54 113.4 0.94 
0.00396 9.6 0.25 49.8 0.54 95.6 0.21 49.4 1.01 
0.00758 10.2 0.25 39.5 0.61 81.2 0.14 38.0 1.05 
0.01240 8.0 0.27 25.0 0.65 61.0 0.08 23.3 1.03 
0.01610 7.5 0.28 22.7 0.64 56.5 0.081 21.2 1.11 
0.02220 5.9 0.36 16.5 0.59 45.1 0.05 14.1 0.98 
0.03020 4.0 0.32 11.2 0.59 30.0 0.09 10.6 1.2 
0.03900 3.1 0.38 9.8 0.56 28.8 0.06 8.3 1.09 
0.04540 3.3 0.50 10.0 0.47 31.3 0.03 7.2 1.26 
 
Table A-5. Pre-exponential factors and decay times of the fluorescence decays of 0.15 g/L of 
RP Phe u d methane. 
 
τM  s) τ  < ) 
y−(Asp1 1)n−221 q enche  by nitro
[Q], M 1 (ns) aM1 τM2 (n aM2 M3 (ns) aM3 τ0> (ns χ2 
0.00000 10.0 0.26 57.4 0.23 172.2 0.51 103.6 1.00 
0.00392 9.4 0.26 46.7 0.47 91.3 0.27 49.0 1.00 
0.00813 7.8 0.28 28.5 0.60 60.9 0.12 26.6 1.10 
0.01320 9.5 0.33 21.8 0.57 47.5 0.10 20.1 1.10 
0.01800 9.6 0.46 19.4 0.49 47.2 0.05 16.0 0.98 
0.0233 2.6 0.28 11.3 0.60 27.7 0.13 11.1 1.02 
0.02708 2.4 0.27 9.4 0.62 24.4 0.11 9.2 1.11 
0.03610 2.6 0.32 8.8 0.59 22.9 0.09 8.1 1.34 
0.04290 1.7 0.33 7.4 0.58 20.2 0.10 6.8 1.29 
0.02290 2.1 0.28 11.7 0.57 29.5 0.14 11.4 1.06 
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generation of hydrophobic microdomains.1-4 These hydrophobic interactions are affected by 
hanges in the polymer concentration, temperature, ionic strength, or pH.  
The hydrophobic domains thus created are capable of encapsulating by hydrophobic 
ssociation hydrophobic cargos such as ink pigments or hydrophobic drugs which are then 
rotected from their surroundings. These modified polymers are used in various 
chnological formulations such as associative thickeners in paints and coatings,5-7 colloidal 
abilizers in food products, and drug carriers.8-10 
The hydrophobic groups of these water-soluble polymers can be incorporated in 
ifferent manners, either during the polymerization resulting in the blocky or random 
incorporation of the hydrophobes or after the polymerization by covalent attachment onto the 
water-soluble polymer backbone us ailable functional groups or after 
functionali ed to as 
hydrophobically modified water-so Ps).1-3 
The hydrophilic backbone of HMWSPs can be either neutral such as poly(ethylene 
oxide) (PEO),12,13 poly(N−vinylcaprolactam) (PVCL),14,15 and poly(N−isopropylacrylamide) 
(PNIPAM),16-19 or charged such as poly(sodium−2−(acrylamido)−2-
methylpropanesulphonate) (PAMPS).20-24 Apart from those already mentioned, a wide range 
of water-soluble biopolymers such as hydroxycellulose (HEC)25 or poly(aspartic acid)26,27 
can be hydrophobically modified by attaching alkyl chains23,26-28 and cholestryl 
pendants24,29,30 either along the backbone or at the polymer chain ends.13,18  
 The solution properties of the HMWSPs depend on the hydrophobic microdomains 
produced through the association of their hydrophobic parts. These interactions depend on 














rigidity and bulkiness of the hydrophobic groups.20 The hydrophobic microdomains 
generat
he3)n. Phe and Asp 
ere chosen since they bear, respectively, a phenyl pendent and a carboxylic acid, chemical 
se found in the SMAs. Furthermore the synthetic procedure used to 
ed by HMWSPs can occur via intra− or intermolecular association. Intramolecular 
associations result in the formation of unimolecular polymeric micelles whereas polymeric 
aggregates are obtained via intermolecular associations.24,30,33,34  
 One much less studied feature is the effect that the position of the hydrophobes along 
the chain has on the association of the HMWSP.35 Recently Duhamel et al.36 have 
investigated the hydrophobic microdomains generated by a series of copolymers of styrene 
and maleic anhydride (SMAs) using several fluorescence techniques. The reactivity ratios of 
styrene and maleic anhydride are such that these two monomers tend to copolymerize in a 
strongly alternating fashion.37 The hydrophobic character of the SMAs could be increased 
either by increasing the content of the styrene monomer or by lowering the degree of 
ionization of the copolymers. The ability of these SMAs to encapsulate large amounts of 
hydrophobic compounds such as pyrene, phenanthrene, anthracene, and dipyme and release 
them in a controlled manner by adjusting the SMA degree of ionization would have made 
them very attractive as carriers of hydrophobic drugs were it not for their non-
biocompatibility. 
 To circumvent the non-biocompatibility issue, a series of polypeptides built with 
well-defined sequences of phenylalanine (Phe) and aspartic acid (Asp) were prepared, 
namely (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, (Asp1Phe2)n, and (Asp1P
w
features which mimic tho
prepare the (AspxPhey)n polypeptides ensures that the hydrophobic (Phe) and hydrophilic 
(Asp) monomers are incorporated in a controlled manner in the polypeptide, as found in the 
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strongly alternating SMAs.38-40 In this work, self-association of these polypeptides in a 
0.01 M Na2CO3 solution at pH 9 was studied using dynamic light scattering and several 
lution of ± 2 nm, using an absorption cell 
as performed at a laser 





UV-Vis absorption. All UV-Vis absorption spectra were recorded on a Hewlett Packard 
8452A diode array spectrophotometer with a reso
with a 1 cm path length. 
Circular dichroism. CD spectra were acquired at 25 oC on a J 715 CD spectropolarimeter 
(Jasco) with a 0.1 cm path length cell, a 100 nm/min scan rate, and a 2 nm bandwidth. 
Spectra were averaged over 10 scans from 190 to 250 nm. 
Dynamic light scattering. Dynamic light scattering measurements were carried out on a Zeta 
Sizer, NanoZS (Malvern Instrument, England). The analysis w
wavelength of 633 nm, a scattering angle of 173o, and at a temperature of 25 oC. For each 
sample, the mean diameter and standard deviation of the particles present in solution were 
calculated by applying the multimodal analysis. Solutions were filtered prior to data 
acquisition through a 0.2 μm pore size Supor® Membrane (Life Science) filter. 
Steady-state fluorescence measurements. The steady-state emission spectra were obtained 
using a Photon Technology International LS-100 steady-state fluorometer with a continuous 
xenon lamp using a square fluorescence cell (VWR) with an inner cross 
m he samples were not deoxygenated. The emission spectra of the samples were 
acquired by exciting the solutions at 338 nm when pyrene was present as a free probe and at 
346 nm when pyrene was covalently attached to the polypeptides. To determine the I1/I3 ratio 
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used to evaluate the polarity of the local environment surrounding pyrene, the intensity of the 
first peak of the pyrene monomer, I1, was taken to be the intensity of the peak at 374 nm. The 
intensity of the third peak of the pyrene monomer, I3, was taken to be the intensity of the 
peak at 385 nm. Polypeptides labeled with naphthalene for the energy transfer experiments 
ing to the MIMIC method.41 All acquired decays were fitted with a sum of 
were excited at 290 nm where pyrene absorption is low and phenylalanine does not absorb 
(Figure 3.1). 
Time-resolved fluorescence measurements. The fluorescence decay profiles were acquired on 
a time-correlated single photon counter manufactured by IBH Ltd. using a 5000F coaxial 
nanosecond flash lamp filled with H2 gas. The excitation and the emission wavelengths were 
338 nm and 374 nm, respectively, for pyrene used as a free probe and 344 nm and 374 nm, 
respectively, when covalently attached. The emission wavelength for the excimer decays was 
set at 510 nm. Cut off filters of 370 nm and 495 nm were used to reduce the noise from stray 
scattered light for the monomer and excimer decays, respectively. Reference decay curves of 
deoxygenated solutions of PPO in cyclohexane and BBOT in ethanol were also obtained for 
the monomer and excimer, respectively, in order to determine the actual response of the IBH 
fluorometer accord
three exponentials according to Equation 5.1 where x represents either the monomer (M) or 
the excimer (E). 
 
ix (t) = ax1exp(-t/τx1) + ax2exp(-t/τx2) + ax3exp(-t/τx3) x = M, E  (5.1) 
 
The Marquardt-Levenberg algorithm42 was used to optimize the parameters of the fits. The 
quality of the fits was determined from the χ2 values (< 1.30) and the random distribution 
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around zero of the residuals and of the autocorrelation function of the residuals. 
Reagents. Pyrene, 1-pyrenemethylamine hydrochloride, 1−pyrenebutyric acid N−hydroxy 
succinimide ester, 1−naphthalenemethylamine, (1−ethyl−3−(3−dimethylaminopropyl) 
arbodiimide hydrochloride (EDC), and nitromethane were all purchased from Sigma-
ch F (distilled in glass, Caledon), NaOH (BDH), HCl (reagent ACS 
ra/Por membranes having a cut-off value of 3,500 g/mol were used 
s has been described in Chapter 2. 
SDS solution 
c
Aldri . THF and DM
grade, Fischer), methanol, anhydrous diethyl ether and acetone (all HPLC grade, EMD) were 
used as received. Milli-Q water with a resistivity of over 18 MΩ.cm was used to make all the 
aqueous solutions. Spect
for dialysis. Both pyrene and 1−pyrenemethylamine (PyMeNH2) were purified prior to usage 
as mentioned in Chapter 4. 
Labeling of polypeptides: The synthesis of the polypeptide
The polypeptides were labeled randomly with either 1-pyrenemethylamine or 1-
naphthalenemethylamine. The end-labeling of the polypeptides was carried out by using 
1−pyrenebutyric acid N−hydroxy succinimide ester. The labeling procedure and purification 
procedure is outlined in Chapter 4. The chromophore content of the polypeptides, given in 
Table 5.1, was determined by UV−Vis absorption. Pyrene concentrations for samples 
containing pyrene as a non-covalent probe were obtained through a 0.1 M 
where the extinction coefficient of pyrene in SDS micelles was experimentally found to be 
42,600 mol−1.L.cm−1 at 338 nm. 
 As done in Chapter 4, the fractions of labeled amino acids (XTotal) and aspartic acids 
(XAsp) for a given polypeptide were determined with Equations 5.2 and 5.3. 
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e unlabeled polypeptides were referred to as (AspxPhey)n, where Asp and 
he stand for aspartic acid and phenylalanine, respectively, and x and y represent the 
number  
olypeptides RPy(Np)−(AspxPhey)n−Ν and EPy−(AspxPhey)n−Ν, R and E refer to a random 
   (5.3) 
 
In Equations 5.2 and 5.3, the chromophore content is given by λD (D = Py or Np for pyrene 
or naphthalene, respectively) and is expressed in mol.g , x and y represent the molar 
fractions of, respectively, Asp and Phe in the polypeptide of sequence (AspxPhey)n, and the 
molar masses MPhe, MAsp-P,y, and MAsp-Np were taken equal to 147 g.mol−1, 328 g.mol−1, and  
254 g.mol−1 for Phe, the pyrene labeled Asp, and the naphthalene labeled Asp, respectively. 
Depending on whether the polypeptide was weighed in its acid or salt form for the 
characterization of the chromophore content, a value of 115 or 137 g.mol−1 was used for 
MAsp. In practice, the polypeptides (Asp3Phe1)n and (Asp2Phe1)n were acidified before 
chromophore content determination, whereas the polypeptides (Asp1Phe1)n, (Asp1Phe2)n, and 
(Asp1Phe3)n were used in their salt form. 
 The description of the polypeptides was done according to the following 
nomenclature. Th
P
s of each amino acid in the particular polypeptide sequence. For the labeled
p
or an end-chain incorporation of the chromophore and N represents the chromophore content 
of the labeled polypeptide expressed in μmol of chromophore per gram of polypeptide. Py 
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and Np stand for the pyrene and naphthalene chromophores, respectively. 
Table 5.1. Pyrene (λPy) and naphthalene contents (λNp) in μmoles of chromophore per gram 
of polymer and the total molar fraction XTotal of labeled (AspxPhey)n and (Asp)n determined 
 
Chromophore Chromophore 












RPy−(Asp) −229 229 2.8 RNp−(Asp Phe ) −232 232 2.9 n 3 1 n
RPy−(Asp3Phe1)n−195 195 2.5 RNp−(Asp3Phe1)n−335 335 4.3 
RPy−(Asp3Phe1)n−245 245 3.2 RNp−(Asp2Phe1)n−115 115 1.5 
RPy−(Asp Phe ) −56 56 0.7 RNp−(Asp2Phe1)n−120 120 1.5 2 1 n
RPy−(Asp2Phe1)n−176 176 2.3 RNp−(Asp1Phe1)n−195 195 2.8 
RPy−(Asp2Phe1)n−322 322 4.3 RNp−(Asp1Phe1)n−313 313 4.6 
RPy−(Asp Phe ) −70 70 1.0 RNp−(Asp Phe ) −149 149 2.2 1 1 n 1 2 n
RPy−(Asp1Phe1)n−132 132 1.9 RNp−(Asp1Phe2)n−223 223 3.3 
RPy−(Asp1Phe1)n−221 221 3.3 RNp−(Asp1Phe3)n−103 103 1.5 
RPy−(Asp1Phe2)n−45 45 0.7 RNp−(Asp1Phe3)n−155 155 2.3 
RPy−(Asp1Phe2)n−97 97 1.4 EPy−(Asp3Phe1)n−26 26 0.3 
RPy−(Asp1Phe2)n−131 131 1.9 EPy−(Asp2Phe1)n−15 15 0.2 
RPy−(Asp1Phe3)n−72 72 1.1 EPy−(Asp1Phe1)n−44 44 0.6 
RPy−(Asp1Phe3)n−104 104 1.5 EPy−(Asp1Phe2)n−13 13 0.2 
RNp−(Asp)n−180 180 2.1 EPy−(Asp1Phe3)n−91 91 1.3 
 
Preparation of the aqueous polypeptide solutions. The aqueous solutions of all the 
polypeptide  unlabe ed, labeled, s l and those using molecular pyrene as a probe were prepared 
 
in a solution of 0.01 M Na2CO3 at pH 9 through dialysis by an indirect method as explained 
in Chapters 3 and 4. 
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5.4. Results and Discussion 
 The conformation of polypeptides containing residues of L-aspartic acid and L-
henylalanine have been examined in Chapter 3, where it was established from the CD 
 (Asp3Phe1)n, (Asp2Phe1)n, (As
they do not show any well-defined conformation. The polypeptide sequence having the most 
1Phe3)n, adopts an α-helical conformation.43 The polypeptides 
were then labeled randomly with pyrene, a hydrophobic chromophore, in order to study their 
 solution. Polymeric aggregates have been widely 
p
spectra of the four sequences p1Phe1)n, and (Asp1Phe2)n that 
hydrophobic character, (Asp
solution properties by fluorescence. The CD spectra of the randomly labeled polypeptides 
were also obtained in order to determine whether any conformational change takes place 
after this modification. Figure 5.1 A and B illustrate the effect if any that pyrene labeling has 
on the secondary structure of the polypeptides. It is easily discernable that these polypeptides 
undergo no noticeable conformational change after this modification, which suggests that 
labeling the polypeptides with small amounts of the hydrophobic chromophore pyrene does 
not affect substantially the behavior of the polypeptides in aqueous solution. 
 The (AspxPhey)n polypeptides are HMWSPs. As such they are expected to associate and 
form polypeptide aggregates in aqueous
characterized using dynamic light scattering which provides the hydrodynamic diameters and 
the relative amounts of the various species present in solution. Hence DLS experiments were 
performed on the (AspxPhey)n polypeptides to investigate their ability to associate via 
hydrophobic interactions. It was already shown in Chapter 4 that the alternating polypeptide 
(Asp1Phe1)n is primarily present as unimolecular micelles in solution. It is therefore expected 
that out of the five polypeptide sequences, those with a lower hydrophobic character i.e. 
(Asp3Phe1)n and (Asp2Phe1)n where the phenylalanine content is less than 50 mol% would 
 197
also exist as single chains in solution and generate intramolecular hydrophobic domains. 
p1Phe2)n and (Asp1Phe3)n. The increased number of hydrophobic 
pendants along with the decreased solubility of these sequences both favors the formation of 
large interpolymeric particles. The DLS experiments were carried out for the different 
polypeptide sequences, in their unlabeled form as well as the labele d  
solution  of solutions with 
an  g/
3 1 n
was 0.1 g/L. For the labeled polypeptides 
3 1 n 195,  RPy⎯(Asp2Phe1)n⎯176,  RPy⎯(Asp1Phe1)n⎯132, 
Py⎯(Asp1Phe2)n⎯131, and RPy⎯(Asp1Phe3)n⎯104, the polypeptide concentrations were 
08 g/L respectively. All polypeptide solutions 
ere prepared in a 0.01 M Na2CO3 solution at pH 9 in a 0.1 cm cell. 
Intermolecular association, resulting in polymeric aggregates is more likely for the 
polypeptide sequences having a larger percentage of the hydrophobic monomer 
henylalanine, i.e. (Asp
d form an  for the
s where pyrene was present as a molecular p e. Two setsrob
polypeptide concentrations 0.05 g/L d 0.5 L were investigated. 
 
Figure 5.1. CD spectra of (A) unlabeled and (B) labeled polypeptides. ( ) (Asp Phe ) , 
(Asp2Phe1)n ( ), (Asp1Phe1)n ( ), (Asp1Phe2)n ( ), (Asp1Phe3)n ( ). The 
concentration of the unlabeled polypeptide 
















































































































 he size distribution of thT e species observed in the solutions of the two extreme 
aggregates. The 
polypeptide sequences, namely the most hydrophilic sequence (Asp3Phe1)n and the most 
hydrophobic sequence (Asp1Phe3)n, are represented in Figure 5.2 using, respectively, light 
scattering intensity (A and D), the number of particles (B and E), and the particle volume (C 
and F). The contribution of each species is given by these histograms and a summary of the 
peak diameters and standard deviations is given in Table A-1 in the Appendix. 
 The size distribution profiles obtained with light scattering intensity (Figures 5.2 A and 
D) confirm that more than one species is present in solution for both polypeptide sequences. 
This result indicates the coexistence of single chains as well as polymeric aggregates in 
solution. For the hydrophilic sequence (Asp3Phe1)n, two contributions are observed in the 
size distribution profile of the labeled polypeptides whereas a third peak is present for the 
unlabeled sample. The first peak to the left which is attributed to the individual polymeric 
chains is in the 3-5 nm range and the second and more intense peak in the 95-150 nm range 
depending on the polypeptide sample indicates the presence of polymeric 
unlabeled polypeptide solution has an additional peak centered at 16 nm. For the 
hydrophobic sequence (Asp1Phe3)n, the diameters range between 9-10 nm and 100-190 nm 
for the peaks representing single chains and polymeric aggregates, respectively. Despite 
some differences in the size distribution profiles, all profiles exhibit similar features for all 
polypeptides (see Table A-1). The profiles obtained with the scattering intensity exhibit two 
major peaks, one in the 3-10 nm range and a second one in the 100-200 nm range. The 
profiles obtained by number and volume exhibit a single peak in the 2-8 nm range. The 
different outlook of the size distribution profiles obtained by using on the one hand scattering 
intensity, and on the other hand number and volume is due to the extreme sensitivity of light 
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scattering to the presence of large objects. As a result, a small concentration of large particles 
can be probed by light scattering (Figures 5.2 A and D), although these particles constitute a 
negligible fraction of the overall population (Figures 5.2 B, C, E and F). Subtle differences in 
the particle size listed in Table A-6 are difficult to assess accurately since changes in the 
hydrodynamic volume can be due to a variety of effects ranging from electrostatic repulsion 
of the negatively charged backbone leading to coil expansion, a hydrophobic collapse of the 
coil due to the Phe content, a conformational change from random coil to extended α-helix. 
However, the DLS experiments do confirm the existence of a small concentration of 
polypeptide aggregates regardless of the polypeptide sequence. 
 The DLS experiments showed that all (AspxPhey)n polypeptides are capable of forming 
aggregates regardless of the polypeptide sequence. This result was somewhat surprising 
because the ability of these polypeptides to form aggregates was expected to depend on the 
hydrophobic character of the polypeptide. However the extreme sensitivity of DLS towards 
large particles led us to suspect that DLS would not be sensitive enough to determine the 
effect that subtle changes in the polypeptide hydrophobic content would have on the relative 
ability of each polypeptide sequence to generate polypeptide aggregates. To obtain this 























Figure 5.2. Particle size distribution by intensity (A), number (B), and volume (C) for 
unlabeled polypeptides, ( ) end-labeled polypeptides and ( ) randomly labeled 
polypeptides. [Polypeptide] = 0.05 g/L in 0.01 M Na2CO3 solution at pH 9. 
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 Fluorescence energy transfer is a simple but powerful tool for detecting the presence 
or absence of polymeric aggregates.17,20,22,23,25 It has been frequently used for this purpose by 
utilizing naphthalene and pyrene as donor/acceptor pair.44 The process of non radiative 
energy transfer (NRET) takes place as a result of dipole-dipole interactions between the 
excited donor, naphthalene (Np), and the ground-state acceptor, pyrene (Py), and hence does 
not involve photon emission. The emission of the donor molecule (Np) must overlap the 
absorption of the acceptor molecule (Py) in order for energy transfer to actually take place. 
Also, the acceptor should show little or no absorption at the wavelength where the donor is 
excited. 
The efficiency of energy transfer EET is strongly dependent on the distance between 
the donor and the acceptor molecules (dDA). Its expression was given in Equation 4.7 in 
Chapter 4. The strong dependency of EET with dDA means that energy transfer occurs only if 
the donor and acceptor molecules are close to each other. Fluorescence energy transfer 
experiments were performed using the polypeptides labeled with pyrene RPy−(AspxPhey)n 
and naphthalene RNp−(AspxPhey)n. Those polypeptides which exist predominantly as 
individual chains should exhibit no energy transfer from naphthalene to pyrene whereas those 
which are able to form polymeric aggregates would have the two molecules Np and Py close 
nough for NRET to occur.45 
NRET experiments were carried out for solutions of all the polypeptide sequences 
with the naphthalene (RNp−(AspxPhey)n) and pyrene (RPy−(AspxPhey)n) labeled 
polypeptides by selectively exciting naphthalene at 290 nm where pyrene and phenylalanine 
have little to no absorption. The polypeptide solutions were prepared with polypeptide 
concentrations in the 0.04−0.07 g/L range and with optical density (OD) of less than 0.05. 
e
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The solutions for the NRET experiment were prepared by mixing RNp−(AspxPhey)n and 
Py−(AspxPhey)n in DMF followed by dialysis and then adjusting the polypeptide 
oncentrations so that the OD be below 0.05 for each solution. The steady-state fluorescence 
mission spectra of all solutions were recorded by exciting at 290 nm. Table 5.2 lists the 
mples used for the NRET experiments along with the polypeptide concentrations and the 
aphthalene and pyrene contents for each solution. 
able 5.2. Polypeptide samples used for NRET 
Sample Polypeptide 
conc. (g/L) 









RNp−(Asp3Phe1)n−232 0.049 232 11.4 
RPy−(Asp3Phe1)n−195 0.004 195 0.9 
RNp−(Asp2Phe1)n−115 0.052 115 5.9 
RPy−(Asp2Phe1)n−176 0.008 176 1.5 
RNp−(Asp1Phe1)n−313 0.025 313 7.8 
RPy−(Asp1Phe1)n−70 0.017 70 1.2 
RNp−(Asp1Phe2)n−149 0.047 149 7.0 
RPy−(Asp1Phe2)n−97 0.012 97 1.3 
RNp−(Asp1Phe3)n−103 0.048 103 4.9 
RPy−(Asp1Phe3)n−72 0.017 72 1.3 
 
Figure 5.3 shows the NRET experiments which were conducted with (Asp3Phe1)n and 
sp1Phe3)n. The same procedure used to obtain Figure 4.7 in Chapter 4 was applied. In 
Figure 5.3, the fluorescence emission spectrum c) was obtained by summing the fluorescence 
ectra o
y−(As
hthalene concentration in the RNp−(AspxPhey)n solution and the 
(A
spectra a) and b). The spectra a) and b) are, respectively, the fluorescence sp f 
RNp−(AspxPhey)n and RP pxPhey)n whose intensities were scaled to account for the 
differences of the nap
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m  of RNp−(AspxPhey)n and RPy−(AspxPhey)n and the differences of the pyrene 
concentration in the RPy−(AspxPhe )  solution and the mixture of RNp−(AspxPhey)n and 
RPy−(AspxPhey)n. The fluorescence spectrum c) was the  compared to d) which is the 
fluorescence spectrum of the RPy−(AspxPhey)n and RNp−(AspxPhey)n mixture. Whereas 
spectra c) and d) overlap in Figure 5.3A, they do not in Figure 5.3B. In Figure 5.3B, the 
fluorescence intensity of naphthalene and pyrene in the mixture are decreased and increased, 
respectively. This result is a hallmark that intermolecular NRET is taking place.  





y (EET) which can be calculated with Equation 4.5. To do so, the fluorescence 
intensit
ET
3 1 n 2 1 n 1 1 n
1 2 n 1 3 n ET
e to 16 % and 34 % for the (Asp1Phe2)n and (Asp1Phe3)n 
sequen
y of naphthalene for both the Np−labeled polypeptide alone or in the mixture is 
integrated between 320 and 330 nm.  E  was measured for each polypeptide sequence and is 
listed in Table 5.3. The efficiency of NRET was found to equal zero for the more hydrophilic 
sequences (Asp Phe ) , (Asp Phe ) , and (Asp Phe ) . However the more hydrophobic 
sequences (Asp Phe ) , and (Asp Phe )  had non zero E . The NRET efficiencies listed in 
Table 5.3 indicate that as the content of the hydrophobic monomer (Phe) increases in the 
polypeptide sequence, the ability of the polypeptide to generate polymeric aggregates is 
enhanced. The energy transfer efficiency given in Table 5.3 increases from zero for the first 





[Polyp  RPy−( e1)n−195, [Polypeptide] = 0.004 g/L; c) sum of 
the tw d d) fluorescence emission spectrum of a mixture of the two 
singly labeled polypeptides, RNp− 1)n−232, peptide] = 0.049 g/L and 
RPy−(Asp ] = 0.004 g/L; and (B) a) RNp−(Asp Phe3)n−103, 
[Polypeptide  RPy−(A 3)n−72, [Polypeptide] = 0.017 g/L; c) sum of the 
two precedent spectra; and d) fluorescence emission spec ixture of the two singly 
labeled polypeptides, RNp−(Asp −103, [Polypeptide] = 0.032 g/L and 
RPy− ] = 0.016 g/L. λex = 290 nm, O.D ≤ 0.05 at 290 nm. 
 
Table 5.3. Fluorescence energy transfer efficiency (EET) for the polypeptide sequences 
 
Figure 5.3. Fluorescence emission spectra obtained for (A) a) RNp−(Asp3Phe1
eptide] = 0.049 g/L; b) Asp3Ph
o precedent spectra; an
(Asp Phe3 [Poly
3Phe1)n 195, [Polypeptide− 1
] = 0.048 g/L; b) sp1Phe
trum of a m
1Phe3)n
(Asp1Phe3)n−72, [Polypeptide























































































































































































































The sensitivity of pyrene to the polarity of its microenvironment has led to its use to 
probe the hydrophobic microdomains generated by a wide variety of micellar and polymeric 
systems.5,26,37 Pyrene has been used both as a free probe and a hydrophobic label. The 
relative intensities of the monomer peaks I1 and I3 in the pyrene fluorescence emission 
spectrum vary with the polarity of the solvent.  Hence the ratio I1/I3 is a useful parameter 
in establishing the location of pyrene in a heterogeneous system. The I1/I3 ratio of pyrene 
takes a value of 1.66-1.80 in water  but this value decreases in an apolar enviro
46,47
46,47 nment such 
as in th
f 
sequences. In fact, the two most hydrophilic sequences only solubilized the same 
amount of pyrene as that found in a saturated 0.01 M Na2CO3 aqueous solution (~4.0 × 10−7 
M). Very little emission of pyrene excimer was observed for all polypeptides.  
e hydrophobic cores of SDS micelles where it takes a value of 1.10. Changes in the 
I1/I3 ratio are also observed for 1-pyrenemethyl derivatives, although the magnitude of these 
changes is smaller that that found for pyrene. The intra− and intermolecular hydrophobic 
associations leading to the generation o the hydrophobic microdomains with the polypeptide 
sequences (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n were 
characterized using pyrene both as a free probe and as a hydrophobic label. The steady-state 
emission spectra of pyrene used as a free probe in the three hydrophobic polypeptide 
sequences (Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n is shown in Figure 5.4. The I1/I3 ratios 
were found to be 1.24, 1.20, and 1.24 for, respectively, (Asp1Phe1)n, (Asp1Phe2)n, and 
(Asp1Phe3)n, clearly indicative of pyrene being located in an apolar environment. It was not 




Figure 5.4. Steady-state emission spectra obtained for pyrene as a free probe. ( ) 
(Asp1Phe1)n, [Polypeptide] = 1.50 g/L, [Py] = 1.75 × 10−5 M, ( ) (Asp1Phe2)n, 
[Polypeptide] = 1.44 g/L, [Py] = 2.22 × 10−6 M, and ( ) (Asp1Phe3)n, [Polypeptide] = 































 A representative steady-state fluorescence emission spectrum obtained for each of the 
beled 
olypeptides, the I1/I3 ratio increases from 1.29 to 1.66 as the polypeptide sequence becomes 
richer in the aspartic acid, the hydrophilic monomer (see inset in Figure 5.5). These values 
are similar to the I1/I3 ratios of 1.69 and 1.38 found for a poly(ethylene oxide) labeled at one 
end with 1-pyrenemethanol in basic aqueous solution and 3.5 mM SDS basic aqueous 
solution, respectively.5 This result suggests that pyren  located inside the hydrophobic 
microdomains generated by the polypeptides having a re hydrophobic sequence but is 







































RPy (Asp1Phe2)n 97, [Polypeptide] = 0.09 g/L, ex = 346 nm; 6) RPy (Asp1Phe3)n 72, 
2 3
  
The results obtained with the I1/I3 ratios indicate that for the (Asp1Phe1)n, 
(Asp1Phe2)n, and (Asp1Phe3)n polypeptides, pyrene is located in an apolar environment 
xposed to the polar aqueous phase for the more hydrophilic polypeptides.48 For the 
end-labeled polypeptides, the I1/I3 ratios were not taken into consideration since the pyrene 
label is known to lose its sensitivity to the polarity of its environment when it is connected to 
a polymer through a butyl linker.48 
 
Figure 5.5. Steady-state emission spectra obtained for randomly labeled polypeptides. 1) 
[Polypeptide] = 0.14 g/L, λex = 344 nm; 3) Py−(Asp2Phe1)n−56, [Polypeptide] = 0.30 g/L, λex 
= 344 nm; 4) Py−(Asp1Phe1)n−70, [Polypeptide] = 0.14 g/L, λex = 346 nm; 5) 
− − λ − −
[Polypeptide] = 0.29 g/L, λex = 346 nm. Inset: Change in I1/I3 ratio as a function of Phe 
content in the polypeptides for the polypeptides randomly labeled with pyrene listed in Table 












































RPy−(Asp)n−229, [Polypeptide] = 0.12 g/L, λex = 344 nm; 2) RPy−(Asp3Phe1)n−195, 
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whether it is introduced as a free probe in the solution or covalently attached to the 
polypeptide. These sequences have the ability to form hydrophobic microdomains and 
interpolymeric aggregates, as indicated by DLS and NRET especially for those sequences 
having the highest Phe content.  
The extent of excimer formation for a pyrene-labeled polymer is reflected by the IE/IM 
ratio, the ratio of the excimer fluorescence intensity over that of the monomer. The IE/IM ratio 
of the polypeptides randomly labeled with pyrene was calculated and is plotted in Figure 
5.6A as a function of pyrene content. As the pyrene content of a labeled polypeptide 
increases, so does the IE/IM ratio. However the magnitude of that increase depends strongly 
on the polypeptide sequence. This statement is illustrated by fitting arbitrarily the IE/IM ratios 
lotted as a function of pyrene content in Figure 5.6A with a straight line and plotting the 
e tides 
er Phe content. These results can be rationalized by invoking the coiling index.49 The 
/IM ratio has been referred to as the coiling index as it decreases as the polymer switches 
sequence, namely (Aps Phe )  and (Asp Phe ) , adopt an extended conformation due to 
electrostatic repulsion along the negatively charged polypeptide backbone and their I /I  
e P
polypeptide decreases and stronger hydrophobic interactions take place resulting in a less 
of 50 mol%. As the Phe content is increased further, not only are the pyrene pendants 
p
slope of the line as a function of phenylalanine content in Figure 5.6B. Figure 5.6B shows a 
marked increase in excimer formation as the Phe content of th  polypep increases up to 
50 mol% followed by a marked decrease of excimer formation for polypeptides having a 
larg
IE
from a coiled to an extended conformation. At pH 9, the polypeptides with an Asp-rich 
3 1 n 2 1 n
E M
ratio is small. As th he content of the polypeptide increases, the charge density of the 
extended conformation of the polypeptide coil. The IE/IM ratio increases up to a Phe content 
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separated by longer stretches of Phe, but the polypeptide adopts an extended α−helical 
conformation (see CD signal for (Asp1Phe3)n in Figure 5.1B) resulting in a decrease of the 










Figure 5.6A. Pyrene IE/IM ratios calculated for the randomly labeled polypeptides ( ) 
(Asp3Phe1)n, ( ) (Asp2Phe1)n, ( ) (Asp1Phe1)n, ( ) (Asp1Phe2)n, and ( ) (Asp1Phe3)n. IM 
integrated between 373-377 nm and IE integrated between 500-530 nm. Polypeptides in 0.01 


























 5.6B. Slopes calculated from Figure 5.6A for the randomly labeled polypeptides as a 
function of phenylalanine content in mol%. Polypeptides in 0.01 M Na2CO3 solution at pH 9. 
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 To gain more insight into the nature of the hydrophobic microdomains generated by 
the polypeptides, the decays of pyrene either covalently attached to the polypeptides or 
physically bound to the polypeptides were acquired. The decay times for the pyrene 




polypeptides must be located inside the hydrophobic microdomains formed by the more 
n by fitting the fluorescence decays with a sum of three exponentials. The pre-
exponential factors and decay times retrieved from this analysis are listed in Tables 5.4 and 
5.5 for the pyrene monomer and excimer, respectively. 
 The decay times for pyrene used as a free probe are listed in the first three rows of 
Table 5.4 for the sequences having a phenylalanine content larger than or equal to 50 mol %. 
For these three polypeptides, a long decay time τM3 of 299 ns, 309 ns, and 314 ns is obtained. 
Those pyrenes emitting with a ~300 ns decay time can not be located in the aqueous solution 
since pyrene has a lifetime of 128 ns in aerated 0.01 M Na2CO3 aqueous solution at pH 9. 
Those long-lived pyrene monomers are located in the hydrophobic microdomains generated 
by the polypeptides where they are protected from oxygen quenching. A similar protection 
has been reported for numerous other polymeric systems,22,50 including SMA polymeric 
aggregates.36 The fraction of long-lived pyrenes increases from 0.38 to 0.60 as the Phe 
content of the polypeptide increases. The increase in the decay time τM3 as a function of Phe 
content was also observed for the randomly labeled polypeptides, for which the more 
hydrophobic sequence resulted in a τM3 decay time much larger than the one obtained for 
RPy−(Asp)n where the pyrene label is fully exposed to the aqueous solution (I1/I3 = 1.79 and 
τ = 128 ns). As found for the fluorescence experiments where pyrene is added to the 
polypeptide solution as a free probe, the long-lived pyrene found for the RPy−(Asp Phe )  
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hydrophobic polypeptide sequences. These pyrenes are thus protected from the quenching of 
the oxygen dissolved in the aqueous solutions. This is not the case for the Asp−rich 
polypeptides which show shorter decay times for pyrene resulting from its quenching by 
ither dissolved oxygen or the formation of pyrene excimer. 
The ability of these polypeptides, especially those with the more hydrophobic 
haracter, to encapsulate hydrophobic pyrene seems to suggest that they could be used as 
otential carriers for hydrophobic drugs. However as already mentioned above, only a small 
mount of free pyrene could be solubilized by the polypeptides having the sequences 
sp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n. If these polypeptides were used to carry 
ydrophobic drugs, one might consider attaching the hydrophobic drug covalently onto the 
olypeptides having a more hydrophobic sequence. 
Polypeptides end-labeled with 1−pyrenebutanoic acid had shorter decay times than 
hromophore.  However the same trend is shown by the EPy−(AspxPhey)n polypeptides in 
at the decay time τM3 increases with increasing phenylalanine content of the polypeptide 
quence. This again suggests that the pyrenes are able to incorporate themselves inside the 










their counterparts randomly labeled with 1-pyrenemethylamine. This is due to the 











Table 5.4. Summary of the pyrene monomer decay times and pre-exponential factors 











(Asp1Phe1)n + Py 9 0.26 118 0.35 299 0.38 157 1.10 
(Asp Phe )  + Py 11 0.17 122 0.40 309 0.42 181 1.13 1 2 n
(Asp Phe )  + Py 12 0.16 130 0.24 314 0.60 222 0.97 1 3 n
RPy−(Asp)n−229 7 0.09 53 0.16 128 0.75 105 1.08 
RPy−(Asp3Phe1)n−195 17 0.14 99 0.20 146 0.66 119 1.14 
RPy−(Asp2Phe1)n−56 − − 35 0.16 149 0.84 131 1.18 
RPy−(Asp Phe ) −70 17 0.16 78 0.16 176 0.68 135 1.18 1 1 n
RPy−(Asp Phe ) −97 20 0.14 104 0.30 240 0.56 168 1.05 1 2 n
RPy−(Asp1Phe3)n−72 26 0.11 117 0.34 226 0.56 169 1.05 
EPy−(Asp3Phe1)n−26 7 0.07 85 0.20 114 0.72 99 1.03 
EPy−(Asp2Phe1)n−15 6 0.10 63 0.05 114 0.85 101 1.03 
EPy−(Asp Phe ) −44 11 0.13 92 0.30 150 0.56 113 1.15 1 1 n
EPy−(Asp1Phe2)n−13 9 0.11 92 0.19 186 0.69 147 1.02 
EPy−(Asp1Phe3)n−91 6 0.12 85 0.22 180 0.66 138 1.04 
 
 The ability of pyrene to form an excimer has been used to characterize numerous 
polymeric systems.5,6,12,37,52-54 The formation of a pyrene excimer can occur either via 
diffusional encounters of an excited pyrene and a ground-state pyrene or by the direct 
excitation of ground-state pyrene aggregates.52 The former process results in the appearance 
f  rise time at the beginning of the excimer decay profile while the latter process yields no 
such rise time. The excimer decays were fitted with a sum of exponentials. The amount of 
excimer formed either via diffusion or by direct excitation of ground-state pyrene aggregates 
o  a
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can be evaluated from the value of the ratio ξ of the sum of the negative pre-exponential 
factors to the sum of the positive pre-exponential factors. This ratio equals −1.0 when the 
excimer is exclusively produced via diffusional encounters and takes more positive values 
when the excimer formation occurs by direct excitation of ground-state pyrene aggregates. 
2 1 n
he more hydrophobic polypeptides show 
Asp1Phe2)n, and (Asp1Phe3)n generate 
ydrophobic microdomains that can solubilize pyrene and provide protection from the 
lution whereas in solutions of the more hydrophilic polypeptides (Asp3Phe1)n and 
sp2Phe1)n, most pyrenes are exposed to the aqueous phase. If these conclusions are correct, 
 fraction of the pyrenes associated with the hydrophobic polypeptides should be inaccessible 
 an external quencher introduced to the solution. To this end, fluorescence quenching 
 As excimer formation was only observed for those polypeptides which were 
randomly labeled with 1−pyrenemethylamine, excimer fluorescence decays were acquired 
only with their solutions. The decays were fitted with a sum of three exponentials. The ξ 
values were determined and are listed in Table 5.5. According to those ξ values, excimers 
formed by the polypeptides having hydrophilic sequences, namely (Asp3Phe1)n and 
(Asp Phe ) , are produced through the direct excitation of ground-state pyrene aggregates. 
However those formed by pyrene labels attached to t
a very small rise time, indicating that some excimers are formed by the diffusional 
encounters of pyrene labels. This is certainly a consequence of the presence of hydrophobic 
microdomains generated by the phenylalanines which solubilize the hydrophobic pyrene.  
 To further characterize the hydrophobic microdomains generated by the polypeptides 
sequences, steady-state and time-resolved fluorescence quenching experiments were 
performed. From the I1/I3 ratios and the long decay time of the pyrene monomer, it was 







experiments were conducted on the polypeptides using pyrene as the probe and nitromethane 
as a neutral water−soluble quencher of pyrene.  
Table 5. ary of the excim cay times and pre-exponentia ors late or 














E3 ξ χ  2
RPy−(Asp)n−229  5 6 0 0.00 1.04 4 0.1 2 0.41 58 .44 
RPy−(Asp3Phe1)n−195  3 6 0.00 1.19 30 0.5 5 0.46 − − 
RPy−(Asp3Phe1)n−245  47 3 0.00 1.20 28 0. 5 0.53 − − 
RPy−(Asp2Phe1)n−56  7 8 0.00 1.17 41 0.7 6 0.23 − − 
RPy−(Asp2Phe1)n−176  3  0.00 1.26 35 0.4 58 0.57 − − 
RPy−(Asp2Phe1)n−322  0  0.00 1.19 30 0.3 54 0.70 − − 
RPy−(Asp1Phe1)n−70  3 0 0 −0. 113 −0.2 5 0.88 84 .35 19 .15 
RPy−(Asp1Phe1)n−132  7 2 0 −0 118 −0.3 3 0.54 68 .82 .27 .14 
RPy−(Asp1Phe1)n−221  5 9 0 0. 122 −0.7 2 0.98 70 .77 − 43* .25 
RPy−(Asp1Phe2)n−45  6 1 1 0 0.00 1.02 3 0.2 7 0.62 68 .13 
RPy−(Asp1Phe2)n−97  7 4 1 0 −0 132 −0.1 6 0.90 42 .28 .14 .13 
RPy−(Asp1Phe2)n−131 15 −0.26 66 0.90 127 0.35 −0.21 1.08 
RPy−(Asp Phe ) −72 30 −0.03 68 0.79 152 0.24 −0.03 1.04 1 3 n
RPy−(Asp1Phe3)n−104 13 −0.11 67 0.82 143 0.28 −0.10 1.05 
 
∗The decay times τE1 and τE2 are too close to yield a reliable ξ value. 
 
 With the addition of nitromethane, the excited pyrene is quenched which is observed 
by the decrease of the pyrene fluorescence intensity in the fluorescence spectra and by the 
shortening of the pyrene number-average decay times in the fluorescence decays.36 These 
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results are presented in the form of Stern-Volmer plots where the ratios I0/I and <τ0>/<τ> are 
plotted as a function of quencher concentrations [Q], as illustrated in Figure 5.7 for pyrene 
used as a free probe for the (Asp1Phe2)n and (Asp1Phe3)n polypeptide sequences. Here I0 and I 
represent the fluorescence intensity of the pyrene monomer in the absence and presence of 
er 
quencher, respectively.36 Similarly, <τ0> and <τ> are, respectively, the number-average 
decay times of pyrene in the absence and presence of the quencher.  
 The Stern−Volmer plots obtained by steady-state and time-resolved fluorescence do 
not overlap, implying that there is an additional quenching process. Such trends are a clear 
indication that static quenching is taking place, due to the formation of a ground-state 
complex between the chromophore and the quencher.55 This chromophore-quencher complex 
does not fluoresce upon excitation and only those chromophores which are not complexed 
emit. In steady-state fluorescence experiments all chromophores are taken into consideration 
whereas time-resolved fluorescence experiments only probe those chromophores which are 
not complexed. Hence the I0/I ratio increases more steeply with increasing quench
concentration than the <τ0>/<τ> ratio does. The ratio <τ0>/<τ> also increases with [Q] 
demonstrating that diffusional quenching of pyrene is taking place. However the <τ0>/<τ> 
ratio is observed to plateau at higher quencher concentrations. This leveling off suggests that 
the quencher is unable to quench some of the pyrenes by diffusion. These pyrenes are said to 
be protected from diffusional quenching.54 Similar results were obtained for (Asp1Phe1)n 
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ere obtained for these plots as suggested by Equation 4.11 in Chapter 4 and the parameters 
stant, were determined. 
quation 4.11 yielded KS, the equilibrium constant for complex formation between pyrene 
and it
igure 5.7. Stern-Volme plot btaine by ady-st  ( nd e-reso ed (
e2)n y] =  × 1 −6 M, lyp de] = 1.44 g/L and B) 
sp1Phe3)n, [Py] = 5.1 × 1 6 M olype e] = .84 g/ oly tide  0.01 Na2CO
ex , λem
As already discussed in Chapter 4 for (Asp1 1 n) , quenching of pyrene by 
tromethane in aqueous luti  of po pept es is th amic and stat . The
otophysical processes w  de ibed in chem  4.2 where the equations accounting f
m were derived. Mo ed rn-Volm r pl  wer obtai d for
orescence measurement arri out wi the sp Ph ) , (A Phe , and (A Phe
τ0>/ τ> as a function of 1/[Q]. Straight lin
w
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and (Asp1Phe3)n polypeptide sequences. The quenching rate constants kQ for all three 

































































that determined for pyrene in 0.01 M Na2CO3 solution at pH 9 (kQ = 9.8 × 109 M−1 s−1). The 
fa values obtained for these polypeptide sequences indicate that ~60 % of the pyrenes are 
accessible for quenching by nitromethane whereas ~40 % of the pyrenes solubilized by the 
hydrophobic domains are protected from the quencher and are still able to emit regardless of 
quencher concentration. This fraction is somewhat similar to the pre-exponential factors aM3 
determined for the polypeptides (Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n, which indicates 
that
 M−1 −1 −1  ns  ns 
 ~40-60 % of the pyrenes are long-lived. This is a clear indication that these polypeptides 
generate hydrophobic microdomains which are able to encapsulate pyrene in such a way as to 
protect it from its surroundings and hence quenching by nitromethane. 
 





10−9 ×  kQ  
M  s  
<τ0> <τL> fa 
(Asp1Phe1)n + Py 15.8 ± 0.3 0.92 ± 0.05 157 299 0.61 ± 0.01 
(Asp Phe )  + Py 26.9 ± 0.4 1.27 ± 0.11 181 309 0.63 ± 0.01 1 2 n
(Asp1Phe3)n + Py 12.6 ± 0.2 0.68 ± 0.02 222 314 0.64 ± 0.01 
 
 Quenching experiments were also performed for all the labeled polypeptides and all 
polypeptide sequences using both steady-state and time-resolved fluorescence. The Stern-
Volmer plots obtained for the (Asp3Phe1)n and (Asp1Phe3)n sequences by steady-state and 
me-resolved fluorescence measurements for the end-labeled and randomly labeled 
olypeptides are presented in Figure 5.8 (A−D). The first significant difference between 




B) as indicated by the linear increase for the I0/I and <τ0>/<τ> ratios as a function of 
quencher concentration. This is observed when efficient quenching of pyrene takes place and 
the main process for quenching is diffusion−controlled. There is also a small amount of static 
quenching shown by the slight difference between the plots obtained from the steady-state 
and time-resolved fluorescence measurements for both the end-labeled and randomly labeled 
polypeptides. The more hydrophobic sequence (Asp1Phe3)n exhibits some protective 
quenching since the <τ0>/<τ> ratio starts to plateau at higher quencher concentrations. The 
xtent of protective quenching is however less for the labeled polypeptides than for the 
uencher is ~90 % for both the end-labeled and the randomly labeled polypeptide solutions 
for the
e
polypeptide solutions where pyrene was present as a free probe. Furthermore the pyrene 
labels are more exposed to the solvent since the fraction of pyrenes accessible to the 
q
 (Asp1Phe2)n and (Asp1Phe3)n sequences. Therefore only a small fraction (~10 %) is 
found to be protected from quenching by nitromethane. Static quenching is also taking place 
in these polypeptides. The quenching rate constant kQ decreases from 6.1 × 10 9 M−1 s−1 to 
0.7 × 10 9 M−1 s−1 as the hydrophobic character of the polypeptides increases. The parameters 
kQ and fa are listed in Table 5.7.  
 The results obtained for the quenching experiments carried out using steady-state and 
time-resolved fluorescence for all the polypeptide sequences using pyrene as a free probe and 
pyrene covalently attached to the polypeptide (both end-labeled and randomly labeled) are 
illustrated in Figure 5.9. Here the quenching rate constant kQ is plotted as a function of the 
phenylalanine content of the polypeptide sequences and compared to the kQ value of pyrene 
in 0.01 M Na2CO3 solution at pH 9 obtained by steady-state fluorescence. The kQ value 
obtained for a Phe content equal to 0.0 mol% corresponds to that of RPy−(Asp)n−229. The 
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value of the quenching rate constant, kQ, obtained for molecular pyrene dissolved in 0.01 M 
Na2CO3 solution at pH 9 is clearly the highest at 9.8 × 10 9 M−1 s−1 as shown by the 
horizontal line in Figure 5.9 used as a reference. Starting from (Asp)n with zero 
phenylalanine content and moving to the far right for (Asp1Phe3)n with 75 mol% 
phenylalanine content, the quenching rate constant, kQ, shows a steady decrease in its value 
as the Phe content of the polypeptide sequence increases up to a Phe content of 66 mol%, 
above which it levels off for the (Asp1Phe2)n and (Asp1Phe3)n sequences. 
Figure 5.8. Stern−Volmer plots obtained for pyrene labeled polypeptides: by steady-state (
RPy−(Asp3Phe1)n−195, [Polypeptide] = 0.14 g/L; (C) EPy−(Asp1Phe3)n−91, [Polypeptide] = 
1.1 g/L; and (D) RPy−(Asp1Phe3)n−72, [Polypeptide] = 0.29 g/L; λex = 346 nm, λem = 374 
) and time-resolved ( ) fluorescence. (A) EPy−(Asp3Phe1)n−26, [Polypeptide] = 1.0 g/L; (B) 



































































































































 M-1s-1 (SS) 
Q
M-1s-1 (TR) 
aSample <τ > K  10−9× k 10−9 × k   f  
Na2CO3 solution 128 n.a. 9.82 ± 0.05 n.a. n.a. 
RPy−(Asp) −229 105 11.8 ± 1.1 6.23 ± 0.13 4.82 ± 0.06 1.00 n
EPy−(Asp3Phe1)−26 99 4.9 ± 0.3 6.06 ± 0.07 5.05 ± 0.15 1.00 
RPy−(Asp3Phe1)n−195 119 0.2 ± 0.3 6.12 ± 0.03 4.97 ± 0.10 1.00 
RPy−(Asp3Phe1)n−245 102 6.9 ± 1.0 6.63 ± 0.06 5.27 ± 0.14 1.00 
EPy−(Asp2Phe1)−15 101 19.4 ± 2.3 6.40 ± 0.06 4.62 ± 0.10 1.00 
RPy−(Asp2Phe1)−56 131 0.3 ± 0.9 4.72 ± 0.08 4.66 ± 0.19 1.00 
RPy−(Asp2Phe1)−176 117 4.6 ± 2.0 4.72 ± 0.33 4.21 ± 0.22 1.00 
RPy−(Asp2Phe1)−322 111 0.3 ± 1.1 4.55 ± 0.09 4.41 ± 0.13 1.00 
(Asp1Phe1)n + Py 157 15.8 ± 0.3 n.a. 0.92 ± 0.05  0.61 ± 0.01 
EPy−(Asp1Phe1)−44 127 16.7 ± 2.1 2.91 ± 0.03 2.19 ± 0.18 1.00 
RPy−(Asp1Phe1)−70 135 6.5 ± 1.0 2.80 ± 0.05 2.51 ± 0.09 1.00 
RPy−(Asp1Phe1)−132 113 12.5 ± 1.9 3.81 ± 0.06 2.82 ± 0.04 1.00 
RPy−(Asp1Phe1)−221 104 1.8 ± 0.7 3.34 ± 0.04 3.18 ± 0.05 1.00 
(Asp1Phe2)n + Py 181 26.9 ± 0.4 n.a. 1.27 ± 0.11  0.63 ± 0.01 
EPy−(Asp1Phe2)−13 147 12.2 ± 0.9 n.a. 0.98 ± 0.03  0.88 ± 0.01  
RPy−(Asp1Phe2)−45 190 4.1 ± 0.4 n.a. 0.90 ± 0.01  0.92 ± 0.00  
RPy−(Asp1Phe2)−97 168 10.1 ± 0.5 n.a. 0.85 ± 0.02  0.90 ± 0.01  
RPy−(Asp1Phe2)−131 156 8.0 ± 0.3 n.a. 0.77 ± 0.02  0.91 ± 0.00 
(Asp1Phe3)n + Py 222 12.6 ± 0.2 n.a. 0.68 ± 0.02  0.64 ± 0.01 
EPy−(Asp1Phe3)−91 138 18.7 ± 1.1 n.a. 0.67 ± 0.17 0.91 ± 0.09  
RPy−(Asp1Phe3)−72 169 16.0 ± 0.5 n.a. 1.40 ± 0.03  0.90 ± 0.00  
RPy−(Asp1Phe3)−104 140 26.3 ± 2.3 n.a. 0.91 ± 0.05  0.91 ± 0.02 
 
 The quenching results indicate that for the labeled polypeptide having a Phe content 
smaller than 50 mol%, efficient quenching is observed and linear Stern−Volmer plots are 
obtained. The alternating polypeptide (Asp1Phe1)n shows a mixed situation where protective 
quenching is observed when pyrene is dissolved as a free probe as found for the more 
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hydrophobic sequences and no protective quenching is observed when pyrene is covalently 
attached onto the polypeptide, as found for the more hydrophilic sequences. The values of the 
quenching rate constants are nearly 10 times smaller for all the solutions of the (Asp1Phe2)n 
and (Asp1Phe3)n polypeptides than for the (Asp3Phe1)n and (Asp2Phe1)n polypeptides which 
are richer in the Asp monomer. The polypeptide sequences (Asp1Phe2)n and (Asp1Phe3)n 
exhibit some protective quenching along with both dynamic and static quenching. A fraction 
of the pyrenes locate themselves in the hydrophobic microdomains generated by these two 
polypeptides and the domains enable these pyrenes to avoid being quenched by the water-
soluble quencher. The extent of protective quenching is higher when pyrene is present as a 
free probe than when it is covalently attached to the polypeptide. This observation suggests 
that when pyrene is used as a free probe, it has the freedom to access those more hydrophobic 
microdomains generated by the polypeptides, whereas when pyrene is covalently attached 
onto the polypeptide, its freedom of motion is restricted which prevents pyrene to diffuse 
towards the hydrophobic domains. Consequently, a smaller fraction of the pyrenes attached 
covalently onto the polypeptide is protected from quenching.  
 From the quenching results, the conclusions can be drawn that in the presence of the 
polypeptides (Asp3Phe1)n and (Asp2Phe1)n which are richer in Asp, pyrene quenching occurs 
predominantly by diffusion with a small amount of static quenching. The absence of 
protective quenching indicates the absence of hydrophobic microdomains since the pyrene 
labels are fully exposed to the quencher molecule. The protective quenching observed for the 
se polypeptide (Asp1Phe2)n and (Asp1Phe3)n richer in Phe demonstrates the ability of the
polypeptides to associate and generate hydrophobic microdomains which are able to 
encapsulate the chromophore pyrene whether it is present as a free molecule or as a 
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hydrophobic pendant. The alternating polypeptide falls between these two extremes as it 
ows the presence of hydrophobic microdomains evident by the occurrence of protective 
quenching when pyrene is us as a f obe. es c microdomains 
are n icient unt t omm e onc as been c
bonded to the polypeptide.  
 
i enc  ra t kQ as a function of the phenylalanine content 
eptide sequences. (×) kQ for pyrene as a free probe determined by time-resolved 
( ) and time-resolved ( ) fluorescence. Polypeptides in 0.01 M Na2CO3 solution at pH 9. 
sh
ed ree pr However th e hydrophobi
ot present in suff  amo o acc odate pyren e it h hemically 
F
in the polyp
gure 5.9. Plot of the qu hing te constan
fluorescence. kQ for the end-labeled polypeptides obtained by steady-state ( ) and time-
resolved ( ) fluorescence. kQ for the randomly labeled polypeptides obtained by steady-state 
 








































study indicated that all polypeptides sequences led to the presence of single chains and 
polypeptide aggregates. However no conclusion could be drawn regarding the extent of 
aggregation as a function of the Phe content of the polypeptides. Such conclusions could be 
drawn by conducting the fluorescence experiments. No NRET was observed from the Np 
labeled polypeptide to the Py labeled polypeptide for the more hydrophilic polypeptide 
sequences. NRET occurred from the Np−labeled polypeptide to the Py−labeled polypeptide 
for both the (Asp1Phe2)n and (Asp1Phe3)n sequences. The stronger associations generated by 
these polypeptides were further confirmed by the evidence of protective quenching which 
indicated that pyrene was able to bury itself deep inside the hydrophobic domains to avoid 
the quencher molecule present in the aqueous phase. 
Although evidence for polypeptide aggregation was obtained for (Asp1Phe2)n and 
(Asp1Phe3)n from the fluorescence energy transfer and quenching experiments in agreement 
with the DLS results, the fluorescence measurements detected no polypeptide aggregates for 
the (Asp3Phe1)n and (Asp2Phe1)n polypeptides, disagreeing with the DLS study. The different 
observation made with the two techniques, fluorescence and light scattering, results certainly 
om thfr e difference in what the two techniques probe. The fluorescence measurements 
provide a number-average representation of the species present in solution, whereas light 
scattering is more heavily weighed towards the larger species present in solution. To assess 
how those differences could affect the results presented in this thesis, additional experiments 
were performed on the unlabeled polypeptide solutions and those where pyrene was 
dissolved as a free molecule. Polypeptide solutions having polypeptide concentrations of 
0.05 g/L were prepared for all sequences. The light scattering and emission intensities were 
determined using excitation wavelengths of 450 nm and 255 nm, respectively. For the 
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samples containing pyrene, the emission spectra of pyrene were also recorded with an 
excitation wavelength of 338 nm. The polypeptide solutions were then filtered using a 20 nm 
pore size filter paper and the fluorescence experiments were repeated on the filtered 
solutions. Figure 5.10 gives the scattering and fluorescence intensities of the polypeptide 
sequences (Asp3Phe1)n and (Asp1Phe3)n before and after filtration, whereas the light 
scattering and pyrene fluorescence intensities obtained for “(Asp1Phe3)n + Py” before and 
after filtration, are presented in Figure 5.12. 
 The light scattering intensities for both the (Asp3Phe1)n and (Asp1Phe3)n sequences 
presented in Figure 5.10A and C show a substantial decrease after filtration. The decrease 
was larger for the hydrophobic sequence (85 %) than for the hydrophilic sequence (45 %). 
This decrease suggests that large particles were present in solutions which were removed 
after filtration, suggesting the existence of polymeric aggregates for both sequences as 
inferred from the DLS results. However no such decrease is observed in the fluorescence 
emission intensity for (Asp3Phe1)n after filtration as demonstrated by Figure 5.10B, whereas a 
35 % decrease in the fluorescence emission occurs for the (Asp1Phe3)n polypeptide sequence 
in Figure 5.10D. Since the fluorescence intensity is directly related to the polypeptide 
concentration, a decrease in the fluorescence signal indicates that some of the (Asp1Phe3)n 




mainly exists as individual chains in solution whereas the more hydrophobic polypeptide 
(Asp1Phe3)n is generating polymeric aggregates to a larger extent. Similar results to those 
found for (Asp3Phe1)n were obtained for the (Asp2Phe1)n and (Asp1Phe1)n sequences 
confirming their existenc  mainly as single chains. A small decrease ~10 % is observed fo
the f cence emission intensity for (Asp1Phe2)n sequence confirming its ability to form 
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polymeric aggregates, but to a lower extent than found for the (Asp1Phe3)n sequence. Figure 
5.11 summarizes these results. 
 
Figure 5.10. (A) Light scattering intensity (λex = λem = 450 nm) and (B) fluorescence 
ex
(Asp Phe )  solution. (C) Light scattering intensity (λ  = λ  = 450 nm) and (D) 
fluorescence emission spectra (λex = 255 nm) before ( ) and after ( ) 
filtration of the (Asp1Phe3)n solution. [Polypeptide] = 0.05 g/L in 0.01 M Na2CO3 solutions at 
 
emission spectra (λ  = 255 nm) before ( ) and after ( ) filtration of the 



















































































































































































































































































































Figure 5.11. (A) Light scattering intensity (λex = λem = 450 nm), (B) fluorescence intensity 
(λex = 255 nm and λem = 292 nm) for (AspxPhey)n. Grey bars: unfiltered solutions, Black bars: 
solution at pH 9. 
 
For polypeptide solutions where pyrene was used as a probe, a decrease of more than 
50 % of the light scattering intensity is found in Figure 5.12B for all three sequences. This 
decrease in light scattering is accompanied by a larger than 60 % decrease of the pyrene 
emission after filtration of the polypeptide solutions. This was observed for all three 
polypeptide sequences, the decrease being larger for the more hydrophobic sequences. These 
results suggest that pyrene targets specifically the hydrophobic domains provided by the 



























































































Figure 5.12. (A) Light scattering intensity, λex = λem =450 nm and (B) fluorescence emission 
spectra (λex = 338 nm) before ( ) and after ( ) filtration of 0.05 g/L solution 
of (Asp1Phe3)n + Py in 0.01 M Na2CO3 at pH 9. 
 
The effect observed on the self-association of a polypeptide in aqueous solution as its 
character is gradually changed from hydrophilic to hydrophobic by adjusting the polypeptide 
sequence (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n, can be 
investigated in extensive detail by the combined use of DLS and various fluorescence 
techniques such as NRET and fluorescence quenching. Using pyrene as a free probe, the 
icrodomains and polymeric aggregates could be 
 
presence and absence of hydrophobic m
established by DLS, the pyrene I1/I3 ratio, the pyrene decay times, and the fluorescence 
quenching experiments. Covalently attaching chromophores onto the polypeptides provided 
another means for characterizing the formation of the polypeptide aggregates by carrying out 




































































































































 The effect that the sequence of a polypeptide has on its solution properties was 
investigated for five different polypeptide sequences, namely (Asp3Phe1)n, (Asp2Phe1)n, 
(Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n. CD, DLS, and several fluorescence techniques 
were used to characterize these polypeptides. CD spectra (Figure 5.1) for the polypeptides 
before and after labeling with pyrene indicated no substantial change in their conformation 
after modification. It was also noted that the first four sequences show no clear conformation. 
he (Asp1Phe3)n polypeptide was observed to adopt an α-helical conformation which was 
rgy transfer experiments (Figure 5.3) performed using polypeptides singly 
beled with naphthalene as the donor molecule and pyrene as the acceptor molecule confirm 
the exi
1 2 n 1 3 n
1 3
es become richer in the Asp 
onomer. The extensive quenching studies carried out (Figures 5.7-5.9) showed that pyrene 
ttached to the hydrophilic polypeptides undergoes diffusional quenching by an external 
uencher, whereas protective quenching is observed for the more hydrophobic sequences. 
For the polypeptide solutions where pyrene is used as a probe, protective quenching was 
T
maintained even after pyrene labeling. The DLS performed in Figure 5.2, suggested that all 
polypeptide sequences generated a mixture of single chains and polypeptide aggregates. 
Fluorescence ene
la
stence of polypeptide aggregates only for those sequences richer in Phe, namely 
(Asp Phe )  and (Asp Phe ) . On the other hand, no polypeptide aggregates could be found 
by NRET for the sequences with a lower Phe content. The I /I  ratios and the pyrene 
monomer decay times determined for the polypeptides using pyrene as a probe also 
demonstrate the presence of hydrophobic pockets for the polypeptide having a Phe content of 
50 % and above. For the randomly labeled polypeptides, the ratio takes on higher values and 





observed for the three sequences (Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n. Thus the overall 
picture that emerges suggests that, those polypeptide sequences which are richer in the Asp 
monomer do not undergo intermolecular associations. The (Asp3Phe1)n and (Asp2Phe1)n 
polypeptides exist as individual polymer chains and do not provide hydrophobic 
microdomains to the pyrene labels. The more hydrophobic polypeptide sequences are able to 
generate hydrophobic microdomains both through intra− and intermolecular hydrophobic 
interactions. Pyrene present as either a free probe or a hydrophobic label is able to associate 
ith these hydrophobic domains which provide sufficient protection against quenching by a 
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 Peak diame  and their standard deviations for the four peptides sequences, (Asp3Phe ) , (Asp Phe ) , (Asp Phe )   
an
ters poly 1 n 2 1 n 1 2 n
n. 
Particle size (nm) Sample Co
g
nc. 
/L Number-average Volume-average Intensity-average 
0.05 2.5 ± 0.4 2.6 ± 0 , 14.5 5.3 ±0.9 (7 %), 16.1 ± 0.4 (6%) 4.2 ± 63.3 (85 %) (Asp
 ± 0 ±
3Phe1)n 
0.5 2.3 ± 0.4 2.4 .4 4.6 ± 0.7 (12 %), 172.5  63.8 (87 %) 
0.05 2.2 ± 0.4 2.3 ± 0 (6 %  18.4 2.4 ± 0.3 ), 94.7 ± .0 (94 %) E (Asp 26 
 ± 0 2 5 % ±
Py− 3Phe1)n−
0.5 2.7 ± 0.5 2.9 .6 .9 ± 0.5 ( ), 117.1  40.5 (94 %) 
0.05 5.2 ± 1.1 3.7 ± 0 .4 (6 6 ± 4 ), 23 2.4 ( %) .6 2.5 ± 0  %), 19. .7 (13 % 7.1 ± 12 79 R (Asp 195 
 ± 0 2. 15 % ±
Py− 3Phe1)n−
0.5 3.6 ± 0.7 4.7 .9 8 ± 0.4 ( ), 108.0  38.0 (84 %) 
0.05 6.3 ± 1.5 4.1 ± 0 4. 13 % ±.9 6 ± 0.7 ( ), 172.7  63.8 (86 %) R (Asp 245 
 ± 1 ± ), 14 .3 (8 ) 
Py− 3Phe1)n−
0.5 6.8 ± 1.4 5.5 .7 5.3 ± 0.9 (6 %), 16.1 3.4 (7 % 4.1 ± 63 5 %
0.05 3.4 ± 0.7 2.3 ± 1 4.1 .2 ± 8 (28 %), 125.0 ± 55.6 (71 %) (Asp
0.4  ± 0
2Phe1)n 
0.5 2.2 ± 2.4 .5 2.6 ± 0.4 (7 %), 105 ± 46.0 (92 %) 
0.05 3.5 ± 0.7  ± 1 4 (8 %  304.4 .0 .4 ± 0.6 ), 98.2 ± .6 (91 %) E (Asp 15 
0.9  ± 0 4 6 % ±
Py− 2Phe1)n−
0.5 4.5 ± 4.7 .9 .2 ± 0.8 ( ), 145.4  76.2 (93 %) 
0.05 3.4 ± 0.7  ± 1 4. 28 % ±2.2 .3 2 ± 0.8 ( ), 124.9  55.6 (71 %) R (Asp 56 
0.4  ± 0 2 5 % ±
Py− 2Phe1)n−
0.5 2.2 ± 4.2 .7 .1 ± 0.4 ( ), 118.0  55.1 (94 %) 
0.05 5.3 ± 1.2  ± 0 6. 33 % ±3.8 .7 9 ± 1.4 ( ), 168.6  81.1 (66 %) R (Asp 176 
1.1  ± 0 2 6 % ±
Py− 2Phe1)n−
0.5 5.5 ± 4.5 .8 .5 ± 0.5 ( ), 131.4  77.3 (93 %) 
0.05 5.5 ± 1.3  ± 0 7. 18 % ±3.7 .5 3 ± 1.2 ( ), 149.7  37.8 (81 %) R (Asp 322 
8 ± 1.4  ± 0 2  0.4 (7 %), 105.3 ±
Py− 2Phe1)n−
0.5 6. 4.9 .5 .6 ±  46.0 (92 %) 
0.05 5.8 ± 1.3  ± 15.0 .2 7.7 ± 1.9 (31 %), 128.0 ± 67.1 (68 %) (Asp
8 ± 1.0  ± 1 7.3  (18 , 105.2 ± 22.5 (21 %), 309.7 ± 51.3 (60 %) 
1Phe1)n 
0.5 6. 5.1 .1 ± 0.8  %)
0.05 3.4 ± 0.7  ± 44.4 .1 4.3 ± 1.0 (17 %), 20.5 ± 6.8 (21 %), 130.1 ± 58.1 (61 %) (
+ mo
Asp




0 2. 3.6 .6 3.8 ± 0.9 (14 %), 16.5 ± 5.3 (25 %), 135.3 ± 61.6 (59 %) 
0.05 7 ± 0.7 3.6 ± 13. .1 4.5 ± 0.9 (5 %), 153.6 ± 50.2 (95 %) E (Asp e1)n−44 
.5 8 ± 0.7 4.2 ± 1
Py− 1Ph
0 3. .2 4.6 ± 0.9 (5 %), 45.7 ± 11.5 (8 %), 173.5 ± 51.8 (86 %) 
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0.05 4.6 ± 1.0 5.0 ± 1.0 5.8 ± 1.2 (10 %), 154.0 ± 62.3 (90 %) RPy−(Asp1 1 n
0.5 4.5 ± 0.8 5.4 ± 1.2 5.3 ± 1.0 (8 %), 158.6 ± 58.6 (92 %) 
Phe ) −70 
0.05 5.0 ± 0.9 4.9 ± 1.2 5.8 ± 0.9 (14 %), 134.2 ± 69.6 (86 %) RPy−(Asp1Phe1)n−132 
0.5 4.4 ± 0.5 5.1 ± 1.1 5.2 ± 0.4 (10 %), 59.0 ± 9.8 (30 %), 229.7 ± 44.1 (60 %) 
0.05 4.2 ± 0.7 4.6 ± 1.5 4.8 ± 0.8 (9 %), 32.2 ± 6.3 (15 %), 142.5 ± 41.5 (75 %) RPy−(Asp1Phe1)n−221 
0.5 3.6 ± 1.0 4.3 ± 1.0 6.0 ± 1.8 (15 %), 139.3 ± 55.5 (84 %) 
0.05 4.1 ± 0.8 3.7 ± 0.8 3.7 ± 1.7 (21 %), 107.7 ±56.1 (77%) (Asp1Phe2)n 
0.5 3.7 ± 0.7 3.4 ± 0.8 4.3 ± 0.9 (38 %), 111.3 ± 43.0 (61 %) 
0.05 3.1 ± 0.5 3.2 ± 0.6 3.0 ± 0.6 (11 %), 25.3 ± 5.7 (10 %), 211.8 ± 74.8 (77 %) (Asp1Phe2)n 
+ molecular pyrene 0.5 3.5 ± 0.6 3.7 ± 0.6 3.6 ± 0.5 (14 %), 42.9 ± 12.1 (13 %), 240.0 ± 106.2 (71 %) 
0.05 3.8 ± 0.7 3.5 ± 1.3 4.5 ± 0.7 (9%), 115.0 ± 35.5 (90 %) EPy−(Asp1Phe2)n−13 
0.5 3.4 ± 0.7 3.8 ± 0.9 4.3 ± 0.9 (5 %), 24.9 ± 6.4 (7%), 162.6 ± 80.0 (86 %) 
0.05 3.4 ± 0.7 4.6 ± 1.2 6.3 ± 1.0 (23 %), 137.5 ± 43.1 (76 %) RPy−(Asp1Phe2)n−45 
0.5 3.4 ± 0.7 4.6 ± 0.9 3.9 ± 1.1 (36 %), 143.3 ± 114.5 (63 %) 
0.05 3.7 ± 0.7 4.8 ± 1.2 6.4 ± 1.1 (13 %), 212.3 ± 107.7 (86 %) RPy−(Asp1Phe2)n−97 
0.5 3.3 ± 0.7 4.8 ± 1.2 4.1 ± 0.9 (39%), 117.8 ± 75.6 (58 %) 
0.05 7.1 ± 1.3 4.7 ± 1.1 4.4 ± 0.8 (19 %), 152.6 ± 60.8 (80 %) RPy−(Asp1Phe2)n−131 
0.5 3.7 ± 0.7 4.5 ± 1.2 4.2 ± 0.7 (37 %), 115.4 ± 42.2 (58 %) 
0.05 7.7 ± 1.7 7.4 ± 1.8 9.6 ± 2.2 (28 %), 169.9 ± 87.8 (69 %) (Asp1Phe3)n 
0.5 6.6 ± 1.1 7.3 ± 2.7 8.7 ± 2.5 (24 %), 155.8 ± 41.1 (75 %) 
0.05 4.5 ± 1.2 3.4 ± 0.6 9.9 ± 4.1 (34 %), 219.6 ± 148.0 (65 %) (Asp1Phe3)n 
+ molecular pyrene 0.5 5.0 ± 1.4 5.8 ± 4.1 10.6 ± 5.5 (353 %), 264.0 ± 195.5 (64 %) 
0.05 4.7 ± 1.2 5.8 ± 3.7 8.6 ± 2.9 (44 %), 100.5 ± 39.5 (55 %) EPy−(Asp1Phe3)n−91 
0.5 5.1 ± 1.4 6.3 ± 2.1 8.6 ± 3.5 (43 %), 132.2 ± 71.3 (56 %) 
0.05 7.7 ± 1.7 7.4 ± 2.1 10.3 ± 2.6 (29 %), 171.4 ± 66.1 (70 %) RPy−(Asp1Phe3)n−72 
0.5 8.0 ± 1.6 7.2 ± 2.1 8.2 ± 1.6 (22 %), 147.6 ± 36.6 (77 %) 
0.05 6.3 ± 1.4 7.9 ± 2.5 10.1 ± 2.4 (18 %), 213.9 ± 89.1 (78 %) RPy−(Asp1Phe3)n−104 
0.5 6.4 ± 1.4 8.3 ± 2.3 9.3 ± 2.6 (24 %), 174.3 ± 65.2 (75 %) 
 
 
Table A-2. Pre-exponential factors and decay times of the fluorescence decays of 1.0 g/L of 










s)s) aM1 τM2 (n aM2 τM3 (ns) aM3 <τ0> (ns) χ2 
0 00 .000 7 0.07 85 0.20 114 0.72 99 1.03 
0 33 .003 23 0.19 42 0.81 − − 38 1.19 
0 41 .007 14 0.32 25 0.67 − − 22 1.22 
0. 41 011 15 0.91 27 0.09 − − 16 1.23 
0 22 .015 10 0.70 16 0.30 − − 12 1.12 
0 24 .019 2 0.15 9 0.71 15 0.14 9 1.15 
0 77 .022 6 0.35 9 0.38 12 0.27 8 1.29 
 
Table A-3 -e tia ay times of the fluores  
RPy sp 1) 5 quench y nitr
 









cence decays of 0.17 g/L of
−(A
Q], M
0.00000 17 0.14 99 0.20 146 0.66 119 1.14 
0 85 .003 15 0.17 42 0.70 51 0.12 38 1.13 
0 81 .007 2 0.21 13 0.18 26 0.61 18 1.09 
0 98 .011 3 0.19 15 0.54 21 0.27 14 1.04 
0.01530 2 0.18 13 0.64 18 0.18 12 1.14 
0.01940 5 0.29 12 0.71 − − 10 1.23 
0 20 .023 2 0.20 9 0.63 14 0.17 8 1.18 
0 80 .029 1 0.23 7 0.67 12 0.10 6 1.21 
 
Table A-4. Pre-exponential factors and decay times of the fluorescence decays of 0.29 g/L of 





τM1 (ns) aM1 τM2 (ns) aM2 τM3 (ns) aM3 <τ0> (ns) χ2 
0.00000 5 0.16 41 0.14 136 0.70 102 0.99 
0.00325 3 .1 0.1 35  0 5 18 7 46 0.68 1.20
0.00655 4 0.1 .2 .5 3  6 12 0 8 30 0 6 2 1.22
0.00984 2 0.1 .2 .6 5  7 9 0 1 21 0 1 1 0.92
0.01330 2 0.1 .2 .6 2  5 8 0 3 16 0 2 1 1.18
0.02020 2 0.1 .2  .5   6 7 0 7 12 0 6 9 1.08
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TableA- xponential factors an es of the fluorescence decays of 0.51 g/L of 
EPy−(As −15 quenched by nitromethane. 








2 (nsM1 aM1 aM2 M3 aM3 τ0> ( ) 
0.00000 6 0.10 63 0.05 114 0.85 101 1.03 
0.00352 4 0.13 38 0.8 65 0.08 36 1.18 
0.01070 2 0.17 19 0.5 30 0.33 20 1.03 
0.01600 2 0.21 14 0.75 30 0.05 12 1.20 
0.02570 2 0.24 9 0.75 37 0.01 8 1.09 











































































0.0000 35 0 0.84 − − 131 1.18 0 0.16 15
0.0034 18 2 0.81 − − 54 0.97 3 0.19 6
0.00683 14 0.24 32 0.76 − − 27 1.14 
0.01050 7 0.15 21 0.83 41 0.03 19 1.17 
0.01480 1 0.24 9 0.32 17 0.44 11 1.2 
0.02430 3 0.26 9 0.70 17 0.04 8 0.92 
0.03550 4 0.52 8 0.48 − − 6 1.26 
 



























aM2 τM3 (ns) aM3 <τ0> (ns) χ
0.00000 6 0.14 49 0.15 153 0.71 117 1.03 
0.00517 7 0.16 33 0.71 48 0.13 31 0.95 
0.00973 6 0.14 18 0.40 25 0.45 19 0.94 
0.01380 8 0.28 18 0.71 38 0.01 15 0.97 
0.01820 2 0.10 11 0.42 17 0.48 13 1.08 
0.02  2 0 0.28 11 0.98 516 .11 6 0.61 9 
0.03  0.4  0.91 210 2 0.19 7 7 10 0.33 7 




TableA-8. Pre-exponential factors and decay times of the fluorescence decays of 0.36 g/L of 
RPy−(Asp2Phe1)−322 quenched by nitromethane. 
[Q], M τM1 (ns) aM1 τM2 (ns) aM2 τM3 (ns) aM3 <τ0> (ns) χ2 
0.00000 13 0.17 62 0.17 5 0.94 151 0.6 111 
0.00389 6 0.16 34 0.37   57 0.47 40 1.20 
0.00727 3 0.11 15 0.29 0 1 3 0.6 23 1.20 
0.01120 5 0.18 18 0.76 1 6 3 0.0 16 0.93 
0.02120 2 0.22 11 0.64 7 3 1 0.1 10 1.08 
 
Ta re-ex nenti ors a  deca s of the fluorescence decays of 1.4 g/L of 
(A  solution with 2.2 × 10-6 pyren ched nitro ne. 
[Q], M τM1 (ns) aM1 τM2 (ns) aM2 τM3 (ns) aM3 <τ0> (ns) χ2 
bleA-9. P po al fact nd y time
sp1Phe2)n M e quen  by metha
0.0000 11 0.17 122 0.40 310 0.42 181 1.13 
0.00469 22 0.41 105 0.26 290 0.33 132 1.11 
0.00935 13 0.48 99 0.26 276 0.26 104 1.14 
0.01510 11 0.49 7 3 88 0.2 265 0.2 90 1.05 
0.02090 9 0.50 5 9 3  8 0.2 26 0.21 84 1.28 
0.03390 9 0.48 8 1 4   7 0.3 25 0.20 79 1.22 
0.04260 9 0.47 3 3 7   7 0.3 24 0.20 78 1.29 
0.05140 10  1 4 4   0.46 7 0.3 24 0.20 77 1.13 
 
TableA-10. Pre-exponential factors and decay times of the fluorescence decays of 0.35 g/L 
of p1Phe 13 quenched by nitromethane. 
τM1 s) τM2 s)  )  <τ0 ns) 
 EPy−(As 2)−
[Q], M  (n aM1  (n aM2 τM3 (ns aM3 > ( χ2 
0.00000 9 0.11 92 0.19 186 0.69 147 1.02 
0.00359 21 0.13 81 0.51 168 0.35 103 1.14 
0.00837 24 0.31 74 0.47 161 0.22 77 1.07 
0.01270 18 0.33 58 0.45 2 1.07 144 0.2 64 
0.01940 11 0.36 46 0.44 3  13 0.19 49 1.03 
0.02920 10 0.43 40 0.40 4  12 0.16 40 1.09 
0.36300 9 0.47 37 0.38 2  12 0.15 37 1.03 
0.04850 9 0.53 38 0.36 5  12 0.11 32 1.03 
0.05830 9 0.50 39 0.37 7  12 0.13 35 1.06 
0.07400 8 0.54 35 0.34 9   11 0.11 29 1.23 
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TableA-11. Pre-exponential factors and decay times of the fluorescence decays of 0.33 g/L 
of RPy−(Asp1Phe2)−45 quenched by nitromethane. 
τ aM <[Q], M τM1 (ns) aM1 τM2 (ns) aM2 M3 (ns) 3 τ0> (ns) χ2 
0.00000 84 0.30 − 2 0.70 1− 36 90 1.20 
0.00585 28 0.19 88  188 0.27 103 0.53 1.00 
0.01590 23 0.39 67  167 0.13 62 0.48 1.09 
0.02430 18 0.47 59 156 0.10 49 0.43 1.20 
0.03520 16 0.53 53 153 0.08 41 0.39 1.16 
0.04520 14 0.50 45 139 0.08 36 0.41 1.10 
0.05550 12 0.54 41 0.38 132 0.08 32 1.12 
0.06930 10 0.56 36 0.36 120 0.08 28 1.11 
 
TableA-12. Pre-exponenti tor cay  of the fluorescence decays of 0.11 g/L 
of p1Phe etha
τM1 ) τM2 aM τM3 (n aM <τ0> (ns) 
al fac s and de times
 RPy−(As 2)−97 quenched by nitrom ne. 
[Q], M  (ns aM1  (ns) 2 s) 3 χ2 
0.00000 20 0.14 104 0.30 240 0.56 169 1.05 
0.00634 1 79 0.52 177 0.29 96 9 0.18 0.95 
0.01270 2 68 0.54 162 0.18 72 2 0.28 0.98 
0.01990 1 56 0.53 148 0.15 57 7 0.33 1.15 
0.02920 1 55 0.46 147 0.10 48 7 0.43 1.07 
0.03810 15 0.48 49 0.43 138 0.10 41 1.19 
0.04710 13 0.47 42 0.43 126 0.10 35 1.03 
0.05700 13 0.51 40 0.40 123 0.08 33 1.04 












Table A-13. Pre-exponential factors and decay times of the fluorescence decays of 0.33 g/L 
of RPy−(Asp1Phe2)−131 quenched by nitromethane. 
 s)   s) 2 [Q], M τM1 (ns) aM1 τM2 (n aM2 τM3 (ns) aM3 <τ0> (n χ
0.00000 16 0.15 1   6 79 0.29 232 0.55 15 1.0
0.00365 11 0.16 6   17 47 0.39 190 0.45 1 1.0
0.00752 17 0.21 2   7 37 0.50 163 0.29 8 1.0
0.01460 15 0.25 8   5 15 0.51 140 0.23 6 1.1
0.02160 15 0.33 2   3 85 0.51 133 0.16 5 1.1
0.02880 12 0.35 46 0.51 125 0.14 45 1.05
0.03500 11 0.34 41 0.52 118 0.13 40 0.99
0.04120 12 0.41 41 0.48 119 0.11 38 1.01
0.04780 11 0.43 42 0.45 120 0.10 836 1.1
0.05440 11 0.45 38 0.45 114 0.10  33 1.07
0.06100 9 0.43 34 0.46 104 0.11  31 1.02
0.06730 10 0.47 34 0.44 104 0.10  30 1.09
0.07580 9 0.51 34 0.41 108 0.08 7 2 0.98
0.08340 9 0.52 34 0.40 107 0.07 6 2 1.24
0.09000 7 0.46 27 0.44 91 0.10 4 2 1.08
 
Table A-14. Pre-exponential factors a ecay  
f (Asp1Phe3)n solution with 5.1× 10−6 M pyrene quenched by nitromethane. 
nd d  times of the fluorescence decays of 1.50 g/L
o
[Q], M τM1 (ns) aM1 τM2 (ns) aM2 τM3 (ns) aM3 <τ0> (ns) χ2 
0.00000 12 0.16 130 0.24 314 0.60 222 0.97 
0.00412 19 0.27 0 0.46 167 1.05 117 .28 285 
0.00890 16   270 00.30 107 0.31 .38 141 1.09 
0.01734 14 0.34  260 0101 0.35 .31 121 1.06 
0.02630 12 0.35  252 0  94 0.37 .28 109 1.24 
0.03180 12 0.35  242 0  86 0.36 .29 105 1.15 
0.03570 13 0.34  249 0  91 0.38 .27 106 1.29 
0.04440 13 0.35  236 0.25 82 0.40 96 1.18 





Table A-15. Pre-exponential factors and decay times of the fluorescence decays of 1.1 g/L of 
EPy−(Asp1Phe3)−91 quenched by nitromethane. 
[Q], M τM1 (ns) aM1 s) M2 ns M3 s) 2 τM2 (n a τM3 ( ) a  <τ0> (n χ
0.00000 6 0.12 .66 38 485 0.22 180 0 1 1.0
0.00388 6 0.14 9 46 .40 1 96 0. 147 0 9 1.0
0.01036 16 0.23 5 54 .23 63 25 0. 128 0 1.1
0.01581 14 0.32 0 51 .16 49 05 0. 121 0 1.0
0.02139 12 0.34 3 51 .15 43 34 0. 113 0 1.1
0.02775 10 0.40 8 48 .12 35 13 0. 106 0 1.1
0.03193 11 0.42 6 45 .12 33 13 0. 102 0 1.2
0.03812 10 0.46 4 43 99 .11 30 33 0. 0 1.2
0.04339 11 0.52 35 0.39 101 0.09 28 1.25
0.04895 9 0.51 32 0.40 96 0.09 26 0.99
 
Table A-16. P ent ct dec e 36 g/L 
of p1Ph 72 quenched by nitromethane. 
τM ) τM s) s)  < ns) 
re-expon ial fa ors and ay tim s of the fluorescence decays of 0.
 RPy−(As e3)−
[Q], M 1 (ns aM1 2 (n aM2 τM3 (n aM3 τ0> ( χ2 
0.00000 26 0.11 118     0.34 226 0.56 169 1.05
0.00498 31 0.28 80 0.50    182 0.21 87 1.10
0.01078 22 0.44 62 0.40    160 0.15 59 1.10
0.01590 17 0.48 55 0.39    151 0.13 49 1.10
0.02130 16 0.55 56 0.34    147 0.11 44 1.06
0.02720 14 0.56 51 0.34    142 0.10 39 0.92
0.03220 12 0.59 48 0.32    136 0.09 35 1.05
0.03700 11 0.59 46 0.32 135 0.08 32 1.03
0.04900 9 0.58 39 0.33 126 0.09 30 1.20









Table A-17. Pre-exponential factors and decay times of the fluorescence decays of 0.26g/L 
of RPy−(Asp3Phe1)−104 quenched by nitromethane. 
[Q], M τM1 (ns) a τM a <τ0 χ2M1 2 (ns) aM2 τM3 (ns) M3 > (ns)  
0.00000 21 0.10 12 0.59 140 1.06 0.31 228 
0.00549 25 0.20 72 0.24 87 1.08 0.55 178 
0.01070 21 0.38 59 0.17 61 1.06 0.45 159 
0.01610 19 0.49 58 0.14 52 1.01 0.37 153 
0.02140 16 0.53 55 0.12 46 1.12 0.35 149 
0.02640 13 0.52 48 0.11 39 1.18 0.36 140 
0.03180 13 0.57 49 0.10 37 1.09 0.34 142 
0.03770 11 0.57 45 0.10 34 1.02 0.33 135 
0.04670 9 0.58 4 0.10 30 1.09 0 0.32 125 
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6.1. Summary of accomplished work 
 The ability of amphiphilic polymers to spontaneously self-assemble in aqueous 
solution due to weak hydrophobic in ctions eceiv onsiderable attention over the 
pa  Their -asse can sed to e r gy of ution d 
to generate various morphologies such as mice esic ods e com nd m s 
or mpou esic he properties phip po s in tion depend 
lar their lecular structure and on the balance between the hydrophilic and 
hy c segm s or . Th s spar grea  of st in  synth f 
am  polym rs tai pecific icati On their st im t 
roperty, which is of main interest to this work, is their ability to solubilize insoluble 
olecules, which makes them suitable as carriers of hydrophobic cargo.4,5 Thus amphiphilic 
olymers are of interest not only for their industrial applications but also in biomedicine as 
ell.  
The motivation for this work came from a research project carried out in our 
boratory where the alternating copolymers of styrene and maleic anhydride (SMA)6 were 
und to self-assemble in aqueous alkaline solution. Their ability to solubilize and release 
ydrophobic molecules such as pyrene, phenanthrene, and anthracene was studied using 
uorescence. The results obtained confirmed that they were suitable as carriers of 
ydrophobic cargo. However SMAs are not biocompatible and thus can not be used as 
arriers for hydrophobic drugs under physiological conditions. The ideal situation is to use 
iomolecules such as amino acids that are available for constructing amphiphilic 
olypeptides. Thus the aim of this thesis was to synthesize and characterize a series of 
mphiphilic polypeptides with well-defined sequences consisting of aspartic acid (Asp) as 
tera  has r ed c
st years.1  self mbly be u better control th heolo  sol s1,2 an
lles, v les, r , larg pou icelle
 large co nd v les.3 T of am hilic lymer solu
gely on mo
drophobi ent groups is ha ked a t deal  intere  the esis o
















the hydrophilic monomer and phenylalanine (Phe) as the hydrophobic monomer. These 
amino acids have a chemical structure similar to that of SMAs. The resulting polypeptides 
show a gradual increase from a hydrophilic  hydrophobic character and are expected to 
undergo self-assembly with increasing facility.
 The first goal of this thesis was the synthesis of these polypeptides. The approach was 
to prepare five polypeptides, (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, (Asp1Phe2)n, and 
(Asp1Phe3)n, going from an Asp rich polypeptide with a hydrophilic character to increasingly 
hydrophobic polypeptides. The synthesis of the polypeptides was carried out using the 
classical solution method7 utilizing a minimum number of steps. For polymerization 
purposes, either a tetrapeptide active ester consisting of four amino acids arranged in the 
required sequence or a tripeptide active ester having three amino acids in the required 
sequences were prepared. For the alte ide, the “tetrapeptide monomer” was 
prepared by exte Asp(OBzl)−OSu 
ester with the free H−Phe−OH using DCC (dicyclohexylcarbodiimide) as the coupling agent. 
The Boc group was removed with trifluoroacetic acid (TFA). Each subsequent amino acid 
addition went through an activation, a coupling and a deprotection step eventually resulting 
in Boc−Asp(OBzl)−Phe−Asp(OBzl)−Phe−OH. This procedure ensured minimum 
racemization throughout the synthesis. The Boc-tetrapeptide was then activated with 
N−hydroxysuccinimide (HOSu) and the Boc group removed before polymerization. All 
“peptide monomers” were prepared in a simil anner. The intermediates and the “peptide 
monomers” were obtained in good yields and gh purity as observed by their sharp melting 
points and single spots on TLC. 1H NMR for each intermediate and peptide monomer was 








weight values of the peptide monomers obtained from mass spectrometry were also as 
These absorption peaks are red shifted by 2 nm compared to those observed for Phe 
expected.  
 The polymerization was carried out in DMSO using triethylamine. The benzyl 
protecting group of the Asp side-chain was finally removed after completing the 
polymerization. 1H NMR spectra were acquired for the polypeptides before and after the final 
removal of the benzyl group. The absolute weight-average molecular weight (MW) of the 
polypeptides was obtained using static light scattering (SLS).  
 The photophysical properties of the polypeptides of the series (AspxPhey)n were 
investigated in aqueous solution at pH 9. All subsequent experiments for the polypeptides 
were performed in aqueous solutions of 0.01 M Na2CO3 at pH 9 which ensured that all the 
polypeptides were fully ionized and hence under the same conditions. The UV-Vis 
experiments resulted in absorbance peaks at 254, 260, and 264 nm due to phenylalanine 
(Phe). 
(252, 258, and 262 nm). A linear increase was observed for the absorbance of the polypeptide 
solutions as the Phe content of the polypeptide increased. The molar extinction coefficients 
for the polypeptides was found to equal 230 ± 15 L.cm−1 per mole of Phe in the polypeptide 
but similar to that found for Phe-rich polypeptides.8 This is slightly higher than that 
determined for Phe (202 L.mol−1.cm−1 in 0.1 M NaCl solution) which maybe due to the 
formation of ground-state dimers of the hydrophobic Phe as a result of its high local 
concentration in the polypeptides. Similarly the fluorescence intensity of the polypeptides 
showing a peak maximum at 290 nm increased linearly with the Phe content of the 
polypeptide. The peak maximum for Phe was at 281 nm. The fine structure obvious in the 
Phe fluorescence spectrum is lost once it is bound to the polypeptide, certainly due to the 
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hydrophobic interactions leading to ground-state Phe dimers. The lifetimes obtained for the 
polypeptides were also found to be dependent on the Phe content of the polypeptides and 
increased with increasing Phe content. They were also longer-lived than Phe. The circular 
dichroism spectra obtained for the polypeptides revealed that except for the (Asp1Phe3)n 
polypeptide which adopts an α−helical conformation, the other polypeptides show no 
evidence of any clear secondary structure. These results suggest that the photophysical 
properties of the polypeptides (Asp3Phe1)n, (Asp2Phe1)n, (Asp1Phe1)n, (Asp1Phe2)n, and 
(Asp1Phe3)n are strongly affected by the Phe content of the polypeptides and the intensity of 
these properties increases as the polypeptides become richer in Phe.  
 The examination of the associative properties in solution of the alternating 
polypeptide (Asp1Phe1)n, the polypeptide with a molecular structure similar to that of the 
alternating SMAs, was the third task undertaken in this thesis. The results obtained were 
compared to the solution properties of (Asp)n which is a random coil in a 0.01 M Na2CO3 
solution at pH 9. The polypeptide was studied in its various forms, with pyrene dissolved as a 
molecular probe, randomly labeled with 1−pyrenemethylamine, and end-labeled with 
1−pyrenebutyric acid at the amino end. Circular dichroism spectra obtained for both the 
unlabeled and randomly labeled (Asp1Phe1)n and (Asp)n resulted in no change in the CD 
spectra before and after the labeling indicating that this modification does not affect the 
polypeptide conformation. The particle size distribution obtained by dynamic light scattering 
DLS, indicated the formation of polypeptide aggregates when the light scattering data were 
analyzed using light scattering intensities. However no aggregate could be found when using 
the numbers or volumes to analyse the DLS data. Non-radiative energy transfer (NRET) 
experiments were performed using naphthalene and pyrene as the donor/acceptor pair to 
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confirm the existence of the polypeptide aggregates suggested by the DLS intensity profiles. 
No NRET was observed to take place between a naphthalene labeled polypeptide and a 
ophobic microenvironment for 
pyrene labeled polypeptide. This result agrees with the number and volume profiles obtained 
by DLS and suggests that the alternating polypeptide is essentially present as individual 
chains. 
 The I1/I3 ratio which equals 1.24 when pyrene is present as a free probe and 1.42 
when they are randomly labeled with pyrene indicated a hydr
the pyrene implying the presence of hydrophobic microdomains in (Asp1Phe1)n. The long 
lifetime of 299 ns obtained for pyrene used as a free probe also points to the existence of 
these hydrophobic domains since such a long lifetime in aerated aqueous solution is only 
possible when pyrene is protected from quenching by the atmospheric oxygen. Clear 
evidence of protective quenching was observed for pyrene used as a free probe in 
fluorescence quenching experiments carried out using nitromethane as a water-soluble 
quencher. The results showed that around 40 % of the pyrene molecules are not accessible to 
the quencher and are long-lived. Protective quenching was absent for both the randomly 
labeled and the end-labeled (Asp1Phe1)n demonstrating that pyrene is more accessible to the 
quencher, when pyrene is covalently attached to the polypeptide, preventing pyrene to target 
the hydrophobic microdomains. Static light scattering and fluorescence emission spectra 
obtained for the unlabeled polypeptide before and after filtration using a 20 nm pore size 
filter showed a large decrease in the scattering intensity which further substantiates the 
presence of polymeric aggregates. However only a negligible decrease is observed in the 
fluorescence emission spectra of the polypeptide after filtration which confirms the results 
obtained from NRET and fluorescence quenching studies that the alternating polypeptide is 
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essentially present as individual chains.  
 The final task involved the investigation of the effect of the polypeptide sequence on 
the associative properties of the polypeptides. Five polypeptides having well-defined 
repeating sequences with increasing hydrophobic character, (Asp3Phe1)n, (Asp2Phe1)n, 
(Asp1Phe1)n, (Asp1Phe2)n, and (Asp1Phe3)n were studied. It was expected that as the 
hydrophobicity of the polypeptide would increase, so would their ability to self-assemble and 
generate hydrophobic microdomains. From the CD spectra it was deduced that only 
(Asp1Phe3)n exhibited a clear conformation, that of an α−helix, whereas the other 
polypeptides did not show any obvious conformation. This α−helical conformation was 
retained even after (Asp1Phe3)n was randomly labeled with 1-pyrenemethylamine. No change 
was observed in the CD spectra of the other polypeptides after their labeling. The particle 
size distribution of the polypeptide solutions obtained from the analysis of the DLS data with 
light scattering intensity pointed towards the presence of polymeric aggregates for all 
polypeptides regardless of their sequences. However the number and volume profiles 
indicated that only single polymeric chains were present in solutions for these polypeptides. 
The absence of NRET for the (Asp3Phe1)n, (Asp2Phe1)n, and (Asp1Phe1)n polypeptides 
confirmed the presence of unimolecular micelles observed in the number and volume profiles 
by DLS experiments. Energy transfer between a naphthalene labeled polypeptide and a 
pyrene labeled polypeptide was detected for the two most hydrophobic polypeptides, 
(Asp1Phe2)n and (Asp1Phe3)n, with an energy transfer efficiency of 16 % and 30 %, 
respectively. The existence of NRET strongly suggests that these two polypeptides are able 
to undergo intermolecular hydrophobic association to generate polymeric aggregates.  
 Pyrene was used as a free probe for only the (Asp1Phe1)n, (Asp1Phe2)n, and 
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(Asp1Phe3)n polypeptides since it could not be solubilized in the solutions of the more 
hydrophilic polypeptides. The I1/I3 values which equal 1.24, 1.20, and 1.24 and the long 
decay times of  299, 309, and 314 ns observed for pyrene in, respectively, (Asp1Phe1)n, 
(Asp1Phe2)n, and (Asp1Phe3)n, confirmed the ability of these polypeptides to generate 
hydrophobic microdomains capable of encapsulating and protecting pyrene. The randomly 
labeled polypeptides show that the I1/I3 ratio gradually decreased from 1.69 to 1.29 as the 
polypeptides became richer in Phe. The decay times also show the same trend. As the Phe 
content increases, the polypeptides are more able to generate hydrophobic domains which are 
targeted by the hydrophobic pyrenes. Little pyrene excimer was observed for polypeptide 
solutions where pyrene was used as a free probe or for the end-labeled polypeptides. 
Formation of excimers was only seen for the randomly labeled polypeptides and their IE/IM 
ratios were determined. The IE/IM ratios were found to be dependent on the polypeptide 
sequence with the highest values obtained for the (Asp1Phe1)n alternating polypeptide. The 
lower excimer formation observed for the hydrophilic polypeptides (Asp3Phe1)n and 
(Asp2Phe1)n was rationalized from their extended coil conformation due to electrostatic 
repulsion from the negatively charged aspartate ions whereas the α−helical conformation 
adopted by the (Asp1Phe3)n polypeptide would reduce excimer formation due to the extended 
conformation adopted by the polypeptides.  
 The fluorescence quenching studies showed evidence of protective quenching for the 
hydrophobic polypeptides (Asp1Phe2)n and (Asp1Phe3)n whether pyrene was used as a free 
probe or covalently attached onto the polypeptide randomly or at the end. Diffusional 
quenching observed for both the randomly labeled and end-labeled hydrophilic polypeptides 
indicated that pyrene was exposed to the quencher. The quenching rate constant kQ decreased 
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as the polypeptides became richer in Phe, leveling off for the (Asp1Phe2)n and (Asp1Phe3)n 
 yield 
polypeptides. This result agrees with the NRET experiments since NRET only occurs for the 
two most hydrophobic polypeptides. The emission spectra for the polypeptides acquired 
before and after filtration showed a strong decrease in scattering intensity and a small to 
modest decrease in the emission intensity reaching a maximum value of 35 % for the 
(Asp1Phe3)n polypeptide. These results confirm those obtained by NRET and fluorescence 
quenching that (Asp3Phe1)n, (Asp2Phe1)n, and (Asp1Phe1)n are predominantly present as 
individual chains whereas (Asp1Phe2)n and (Asp1Phe3)n have the ability to generate 
polymeric aggregates via interpolymeric hydrophobic associations. 
 This thesis has demonstrated the power of fluorescence techniques in characterizing 
the associative behaviour of hydrophobically modified polypeptides in aqueous solution. The 
ability of the polypeptides to associate either intra- or intermolecularly via hydrophobic 
interactions and the hydrophobic microdomains thus generated have been investigated 
comprehensively using fluorescence energy transfer together with fluorescence quenching. 
 
6.2. Future work 
 If the polypeptide aggregates encountered in this work for the (Asp1Phe2)n and 
(Asp1Phe3)n polypeptides are to be used for drug delivery applications, their stability must be 
tested upon dilution, since diluting a solution of polypeptide aggregates should lead to their 
dissociation. Further fluorescence experiments can be carried out to investigate these effects. 
Fluorescence energy transfer experiments could be conducted with a solution of Py labeled 
(Asp1Phe3)n and a solution of Np labeled (Asp1Phe3)n that has already been shown to
NRET. The solution will be diluted ten folds with a 0.01 M Na2CO3 solution at pH 9 and the 
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fluorescence emission of either Np or Py can be monitored over time to observe whether any 
change is occurring. A decrease in the efficiency of NRET would point towards the 
dissociation of these polypeptide aggregates upon dilution. These experiments will also 
provide the time scale over which dissociation takes place. 
 Pyrene has been used as a model for hydrophobic drugs to demonstrate the ability of 
hydrophobically modified polymers to solubilize and release hydrophobic cargos into cell 
mimics such as liposomes. Duhamel et al.9 have demonstrated that microcrystals of pyrene 
can be stabilized by EAK16 II, an oligopeptide made up of glutamic acid (E), alanine (A), 
and lysine (K). The peptide is constituted of 16 amino acids arranged in a sequence that 
alternates the negatively charged glutamic acids and the positively charged lysines separated 
by a hydrophobic alanine. EAK16 II has been shown to exhibit a hydrophilic and 
hydrophobic surface when it adopts a β-sheet upon self-assembly into highly stable peptide 
aggregates. The release behavior of pyrene from EAK16 II into membrane bilayers made up 
of the egg phosphatidylcholine (EPC) vesicles was studied using fluorescence over time. 
From the release profiles obtained, it was shown that EAK16 II can be used as a potential 
carrier for a hydrophobic cargo. It would be interesting to investigate how the polypeptides 
(AspxPhey)n that exhibits a more hydrophobic character than EAK16 II would behave in 
similar conditions. It would be expected that the polypeptides richer in Phe would be better 
able to stabilize pyrene crystals since they have already been shown to take up pyrene 
through hydrophobic associations. They are also able to form polymeric aggregates thus 
providing a larger surface for pyrene crystals to be adsorbed onto. 
 Replacing phenylalanine with a more hydrophobic amino acid such as tryptophan 
(Trp) might deserve investigation. The higher hydrophobicity of Trp would be expected to 
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facilitate hydrophobic associations and the generation of a greater number of hydrophobic 
microdomains both intra- and intermolecularly. The higher hydrophobicity of Trp may make 
it possible to load a higher amount of a hydrophobic cargo like our reference, pyrene, into 
these polypeptides as it was not possible to load any significant amount of pyrene into the 
(AspxPhey)n polypeptides. This would make the (AspxTrpy)n polypeptides better candidates 
for their potential use as carriers of hydrophobic cargo. The ability of these polypeptides to 
self-assemble into aggregates can be established by using the fluorescence techniques 
outlined in this thesis. The results would be compared with those already obtained with the 
(AspxPhey)n polypeptides.  
 The polypeptides investigated in this thesis are negatively charged in their basic or 
neutral aqueous solution. Polypeptides containing lysine (Lys) instead of aspartic acid, 
(LysxPhey)n, would operate in acidic aqueous solutions. (LysxPhey)n polypeptides with an 
either random or alternating sequence have been synthesized by Arfmann et al.10 However 
their associative behaviour has not been examined. This can be done using fluorescence as 
as been shown for the (AspxPhey)n polypeptides. A more complex system could be 




se of (AspxPheyLysz)n polypeptides. This would enable the associative behavior of the 
polypeptides to be studied over the entire pH range. Such polypeptides would exhibit self-
assembling properties similar to those encountered with the EAK peptide family. Such 
polypeptides could also stabilize pyrene crystals in solution as EAK16 II with its alternating 
pairs of negatively charged and positively charged repeating units does.9 Fluorescence can be 
used to provide a comprehensive characterization of the self-assembly of these polypeptides. 
 Interaction of DNA with polycations such as poly(lysine) are used to increase the 
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efficiency of transformation of cells with plasmids and to prevent its splitting by cell 
nucleases.11,12 Since the base pairs of DNA are comprised of aromatic groups it would be 
useful to study their interaction with a hydrophobically modified poly(lysine) either with 
phenylalanine (LysxPhey)n or tryptophan, (LysxTrpy)n. The association would be expected to 
proceed via two mechanisms. First strong electrostatic interactions would take place between 
the positively charged lysine of the polypeptide and the negatively charged DNA phosphates. 
Second π−π stacking should occur between the Phe or Trp residues of the polypeptides and 
the DNA bases. The efficiency of stacking might depend on the spacing between two 
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